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1. Summary 
The conserved, ubiquitin-selective AAA ATPase Cdc48/p97 regulates numerous cellular processes, 
including protein quality control, membrane fusion, and the cell cycle. Cdc48 specificity is controlled by 
a large number of different cofactors, regulating substrate binding and processing. The heterodimer 
Ufd1-Npl4 and the UBX domain protein Shp1/p47 are two mutually exclusive substrate recruiting 
cofactors of Cdc48, which function in proteolytic and non-proteolytic ubiquitin-mediated pathways, 
respectively. In contrast to Ufd1-Npl4, cellular functions of Shp1 are still poorly understood. The aim of 
this work was therefore to further characterize the function of Shp1 in S. cerevisiae. 
Deletion of the SHP1 gene resulted in a severe growth defect and hypersensitivity to various drugs. 
Detailed analysis of shp1 mutants revealed a cell cycle delay at the metaphase to anaphase transition 
caused by activation of the spindle assembly checkpoint (SAC). 
shp1 alleles were initially identified as suppressors of high-copy protein phosphatase 1. Glc7 is the 
only protein phosphatase 1 catalytic subunit in S. cerevisiae and regulates a large number of diverse 
cellular pathways. As Glc7 phosphatase activity is reduced in lysates of shp1 null mutants, Shp1 is 
believed to be a positive regulator of Glc7. Therefore, the relationship between Shp1 and Glc7 was 
further investigated. Shp1 was demonstrated to physically interact with Glc7 in vivo, and the double 
mutant of shp1 and the glc7-129 allele was found to be inviable. Furthermore, the cell cycle defect of 
shp1 could be rescued by GLC7 overexpression. The balance of Glc7 phosphatase and Ipl1 kinase 
activity is critical for proper chromosome bi-orientation and cell cycle progression. Consequently, the 
reduced Glc7 activity in shp1 null mutants could result in unbalanced Ipl1 activity at the kinetochore. 
Indeed, a shp1 null mutation suppressed the temperature sensitivity of ipl1-321. Moreover, shp1 null 
mutants exhibited hyperphosphorylation of the Ipl1/Glc7 targets Dam1 and histone H3.  
An engineered Cdc48 binding-deficient variant of Shp1 enabled the analysis of specific Cdc48Shp1 
complex functions for the first time. Using this shp1 mutant, it could be demonstrated that the 
regulation of the metaphase to anaphase transition depends on the Cdc48Shp1 complex. Similarly to 
shp1 null mutants, the binding mutant also suppressed the ipl1-321 temperature sensitivity and 
exhibited hyperphosphorylation of histone H3. Taken together, these results establish the Cdc48Shp1 
complex as a critical regulator of Glc7 activity towards Ipl1 substrates.  
Finally, potential mechanisms by which Cdc48Shp1 regulates Glc7 activity were investigated. Glc7 
protein levels and sub-cellular localization were found to be unaffected by shp1 null mutation. 
Importantly, the interaction between Glc7 and its activator Glc8 was significantly reduced in shp1, and 
overexpression of GLC8 was able to partially rescue phenotypes of shp1 mutants. These results 
suggest that Shp1 controls the binding of Glc8 to Glc7 and thereby enhances Glc7 activation, possibly 
by facilitating Glc8 nuclear localization. 
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Zusammenfassung 
Die konservierte Ubiquitin-selektive AAA ATPase Cdc48/p97 reguliert eine Vielzahl zellulärer 
Prozesse, unter anderem Proteinqualtitätskontrolle, Membranfusion und den Zellzyklus. Die Spezifität 
von Cdc48 wird durch eine große Anzahl Kofaktoren bestimmt, die sowohl Substrat-Bindung als auch 
-Prozessierung regulieren. Das Heterodimer Ufd1-Npl4 und das UBX- Domänenprotein Shp1/p47 sind 
zwei sich wechselseitig ausschließende Substrat-rekrutierende Kofatoren von Cdc48, welche in 
proteolytischen bzw. nicht-proteolytischen Ubiquitin-vermittelten Prozessen wirken. Im Gegensatz zu 
Ufd1-Npl4 sind die zellulären Funktionen von Shp1 noch weitestgehend unbekannt. Die Zielsetzung 
dieser Arbeit war daher die Charakterisierung zellulärer Funktionen von Shp1 in S. cerevisiae. 
Die Deletion des SHP1 Gens führte zu einem stark ausgeprägten Wachstumsdefekt und zur 
Hypersensitivität gegenüber zahlreichen Stressbedingungen. Die genauere Analyse von shp1 
Mutanten ergab, dass sie aufgrund der Aktivierung des spindle assembly checkpoints (SAC) einen 
Zellzyklus-Defekt im Übergang von Metaphase zu Anaphase aufweisen. 
shp1-Allele wurden ursprünglich als suppressors of high-copy protein phosphatase 1 identifiziert. Glc7 
ist die einzige katalytische Untereinheit von Protein Phosphatase 1 in S. cerevisiae und steuert eine 
große Zahl unterschiedlichster zellulärer Prozesse. Da die Glc7 Phosphatase-Aktivität in shp1 Lysaten 
erniedrigt ist, gilt Shp1 als positiver Regulator von Glc7. Deshalb wurde die Beziehung zwischen Glc7 
und Shp1 näher untersucht. Es konnte gezeigt werden, dass Shp1 in vivo physikalisch mit Glc7 
interagiert, und die Doppelmutante aus shp1 und glc7-129 erwies sich als letal. Des Weiteren konnte 
der Zellzyklus-Defekt von shp1 durch GLC7 Überexpression gerettet werden Das Gleichgewicht 
zwischen Glc7 Phosphatase- und Ipl1 Kinase-Aktivität ist für die korrekte Bi-orientierung der 
Chromosomen während der Mitose und den Zellzyklus-Verlauf kritisch. Daher könnte die verringerte 
Glc7 Aktivität in shp1 zu unbalancierter Ipl1 Aktivität am Kinetochor führen. Tatsächlich supprimierte 
eine Nullmutation von shp1 die Temperatursensitivität von ipl1-321. Außerdem zeigten shp1 Mutanten 
eine Hyperphosphorylierung der Ipl1/Glc7 Substrate Dam1 und Histon H3. 
Eine Cdc48-Bindemutante von Shp1 ermöglichte erstmals die Analyse spezifischer Cdc48Shp1-
vermittelter Funktionen. Mit Hilfe dieser Mutante konnte gezeigt werden, dass die Regulation des 
Metaphase/ Anaphase-Übergangs von dem Cdc48Shp1-Komplex abhängt. Ähnlich wie shp1 Mutanten 
supprimierte auch die Bindemutante die ipl1-321 Temperatursensitivität und zeigte Hyper-
phosphorylierung von Histon H3. Diese Ergebnisse etablieren den Cdc48Shp1-Komplex als einen 
kritischen Regulator der Glc7 Aktivität gegenüber Ipl1 Substraten.  
Darüber hinaus wurden mögliche Mechanismen, durch welche Cdc48Shp1 die Glc7 Aktivität reguliert, 
untersucht. Weder die Proteinmenge noch die Lokalisation von Glc7 waren in shp1 verändert. Die 
Interaktion von Glc7 mit dessen Aktivator Glc8 war jedoch in shp1 deutlich reduziert und die 
Überexpression von GLC8 konnte partiell Phänotypen von shp1 Mutanten retten. Dies legt nahe, dass 
Shp1 die Bindung von Glc8 an Glc7 kontrolliert und dadurch die Glc7 Aktivierung verstärkt, 
möglicherweise indem es die nukleäre Lokalisation von Glc8 vermittelt. 
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2. Introduction 
2.1 The Ubiquitin Proteasome System (UPS) 
The ubiquitin proteasome system (UPS) is the major system for regulated, selective protein 
degradation in eukaryotes (Ravid and Hochstrasser, 2008). Short lived proteins, such as cell cycle 
regulators and misfolded polypeptides, are covalently marked with the small molecule ubiquitin and 
subsequently degraded by the 26S proteasome (Finley, 2009). However, not every modification with 
ubiquitin leads to degradation of the target protein. On the contrary, ubiquitin serves as non-proteolytic 
signal in diverse cellular processes such as endocytosis, intracellular trafficking, DNA repair, histone 
modification, and regulation of transcription (Pickart and Fushman, 2004; Mukhopadhyay and 
Riezman, 2007).  
2.1.1 Ubiquitin conjugation 
Ubiquitin is a small, 76 residue protein, which is highly conserved among all eukaryotes. During a 
posttranslational process termed ubiquitination or ubiquitinylation the C-terminus of ubiquitin is 
covalently bound to ε-amino groups of target protein lysine residues via an isopeptide bond, or in case 
of N-terminal ubiquitination to the α-amino group of the substrate (Ciechanover and Ben-Saadon, 
2004; Pickart and Eddins, 2004). The conjugation of ubiquitin to substrates occurs in three sequential 
steps: ubiquitin activation catalyzed by an E1 enzyme, the transfer of ubiquitin to an E2 conjugating 
enzyme, and finally conjugation of ubiquitin to the substrate mediated by an E3 ubiquitin ligase 
(Fig. 1). 
 
Fig. 1. The ubiquitin conjugation system. The catalytic site cysteine of the E1 ubiquitin activating enzyme (green) forms a 
thioester bond with the C-terminus of ubiquitin in an ATP hydrolyzing reaction. The activated ubiquitin is then transferred to an 
E2 conjugating enzyme (light blue), where it is again thiol-linked to the catalytic site cysteine. Depending on the type of E3 
ligase (blue) present, ubiquitin is either transferred to the E3 catalytic cysteine (HECT ligases) and then to the substrate (purple) 
lysine residue or, in case of RING E3 ligases, directly transferred from the E2 to the substrate, while the ligase serves as a 
scaffold. (Adapted from (Ravid and Hochstrasser, 2008))  
In most organisms, including yeast and mammals, a single E1 enzyme activates the C-terminus of 
ubiquitin. During this process of activation, a ubiquitin-AMP intermediate is formed first, and ubiquitin 
is then transferred to the active site cysteine of the E1 enzyme. Subsequently the thiol-linked ubiquitin 
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is passed to the active site cysteine of an E2 ubiquitin conjugating enzyme. Covalent ligation of 
ubiquitin to the large number of highly diverse substrates is mediated by numerous E3 ligases, which, 
in combination with the E2s, control substrate specificity (Pickart, 2001; Pickart and Eddins, 2004).  
Three protein families of E3 ubiquitin ligases have been described: HECT (Homologous to E6AP 
Carboxy Terminus), RING (Really Interesting New Gene), and U-box (UFD2 homology) ligases. RING 
and U-box E3s mediate ubiquitin ligation by acting as a bridging factor, whereas HECT ubiquitin 
ligases themselves form a thiol ester intermediate with ubiquitin prior to conjugation to the substrate 
(Fig. 1) (Pickart and Eddins, 2004). In some cases additional U-box containing E4s, such as Ufd2, are 
required for polyubiquitination of a substrate by extending a pre-existing ubiquitin chain (Koegl et al., 
1999). 
A target protein can be modified on a single or multiple lysine residues by one or more ubiquitin 
moieties. The fate of the substrate is determined by ubiquitin chain length and linkage type (Amerik 
and Hochstrasser, 2004). In S. cerevisiae all seven lysines (K6, K11, K27, K29, K33, K48, K63) of 
ubiquitin allow the formation of different isopeptide linkages (Fig. 2), catalyzed by specific E2- E3 
combinations that dictate the chain type (Peng et al., 2003).  
 
Fig. 2. Lysine residues of ubiquitin used for conjugation. Ribbon diagram of ubiquitin and its lysines residues used for chain 
formation (shown in red). The L8-I44-V70 hydrophobic patch, which mediates interaction of ubiquitin with other factors, is 
depicted in yellow. (From (Pickart and Fushman, 2004)) 
Most abundant are K11, K48, and K63 ubiquitin linkages, while K48 has been shown to be essential 
for viability of yeast (Finley et al., 1994; Peng et al., 2003). Polyubiquitination with more than four 
K48-linked ubiquitin moieties is thought to mark substrates for degradation by the 26S proteasome, 
while K63 linkages were shown to act as non-proteolytic signals in several cellular pathways such as 
DNA repair (Pickart and Fushman, 2004). Recently, it has been demonstrated that all ubiquitin 
linkages with the exception of K63 are increased upon proteasome inhibition and may therefore target 
substrates to proteasomal degradation (Xu et al., 2009). Conversely, it has also been found that K48 
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linkages can serve as non-proteolytic signals, as is the case during repression of the transcription 
factor Met4 (Flick et al., 2004; Li and Ye, 2008).  
Attachment of a single ubiquitin moiety to one or more lysine residues of a target protein, termed 
monoubiquitination, serves as a non-proteolytic signal in cellular pathways such as endocytosis and 
regulation of gene expression by histone modification (Hicke, 2001).  
Recently, linear polyubiquitin chains have been identified in higher eukaryotes. These chains are 
formed by conjugation of the C-terminal glycine of one ubiquitin to the α-amino group of the N-terminal 
methionine of the next ubiquitin. Such linear ubiquitin chains are generated by a ubiquitin ligase 
complex named LUBAC (linear ubiquitin chain assembly complex) and are involved in canonical 
NF-κB activation (Iwai and Tokunaga, 2009).  
Ubiquitin or ubiquitin chains can be removed by specific deubiquitinating enzymes (DUBs), making 
ubiquitination a transient and reversible posttranslational modification. In addition to removing 
conjugated ubiquitin from substrates, DUBs are also necessary to activate ubiquitin, as it is 
synthesized as an inactive precursor, either as a fusion with certain ribosomal proteins or as head-to-
tail fusions of multiple ubiquitins (Amerik and Hochstrasser, 2004).  
2.1.2 The 26S proteasome and degradation 
The eukaryotic 26S proteasome is a large 2.5 MDa protein complex that sequesters proteolytic sites to 
the inside of a barrel shaped structure and is therefore also considered to be a chambered protease. 
Cellular substrates which have been covalently marked with ubiquitin are degraded by the 26S 
proteasome, which itself consists of the 20S core and two 19S regulatory particles (Pickart and 
Cohen, 2004; Finley, 2009).  
The 20S core particle (CP) is a stack of four heteroheptameric rings α7β7β’7α’7. Three of the seven 
β-subunits of each inner ring are catalytically active. A 19S regulatory particle is attached to both ends 
of the core, itself composed of base and lid. The 19S regulatory particle is responsible for recognizing 
ubiquitinated substrates, unfolding them, removing the ubiquitin chains, opening the gates of the 20S 
proteasome, and finally moving the substrates into the proteolytic chamber for degradation (Finley, 
2009).  
Recognition of the ubiquitinated substrates in yeast is mediated by Rpn10 and Rpn13, two 
components of the regulatory particle (Wolf and Hilt, 2004; Finley, 2009). Prior to degradation 
substrates are deubiquitinated and ubiquitin is recycled. Rpn11, a component of the lid, has DUB 
activity and is critical for proteasome function by coupling deubiquitination to early steps in 
degradation (Finley, 2009).  
Proteasomal degradation of selectively ubiquitinated proteins enables the periodic fluctuation of 
certain regulators during temporal cellular processes such as cell division. Progression through the 
eukaryotic cell cycle requires the interdependent regulation of protein phosphorylation, transcription, 
and ubiquitin-proteasome-mediated degradation of cell cycle regulators, such as cyclins and Cdk1 
inhibitors. 
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2.2 The yeast cell cycle 
The eukaryotic cell cycle can be divided into four main phases: G1, S, G2, and mitosis (M), whereas 
the most prominent events are DNA replication in S-phase and chromosome segregation during 
mitosis. G1 and G2 are the gap phases needed to prepare these two major events in cell division. 
During the yeast G1 phase nutrient conditions and cell size are monitored and in late G1 phase 
START (equivalent to mammalian restriction point) marks the point after which entry into the new cell 
cycle is irreversible and bud growth begins (Fig. 3). 
 
Fig. 3. Schematic overview of the yeast cell cycle. The four cell cycle phases G1 (blue), S (orange), G2 (yellow), and mitosis 
(green) are depicted according to their approximate duration in an unperturbed WT yeast cell cycle. Three checkpoints that can 
be targeted are shown. START controls exit from G1 and can be prevented by addition of the mating pheromone α-factor to 
Mat a yeast cells. The S-phase checkpoint is activated in response to hydroxyurea (HU), while addition of the spindle 
depolymerizing agent nocodazole leads to activation of the spindle assembly checkpoint (SAC) and cell cycle arrest in mitosis. 
Schematic drawings of yeast show approximate bud growth, SPB duplication (red) as well as lengths of the mitotic spindle 
(green) in the corresponding cell cycle stages.  
Progression through the cell cycle is controlled by cyclin dependent kinases (Cdks). The activity of 
these serine/threonine kinases is mainly regulated by the binding of different cyclins (Bloom and 
Cross, 2007). Cyclin expression and protein levels fluctuate periodically and thereby modulate Cdk 
activity during cell cycle progression. The best studied Cdk and central regulator of the budding yeast 
cell cycle is the essential protein Cdc28 (Cdk1) (Hartwell et al., 1974; Mendenhall and Hodge, 1998).  
Two groups of cyclins have been classified: the G1 and the B-type cyclins. The G1 cyclins Cln1-Cln3 
mainly regulate Cdc28 activity during G1, which involves passage through START, bud emergence, 
spindle pole body (SPB) duplication, and activation of later cyclins (Bloom and Cross, 2007) (Fig. 3). 
Six B-type cyclins, Clb1-6, are expressed in three waves from START to mitosis (Mendenhall and 
Hodge, 1998). Clb5 and Clb6 are the earliest and mediate DNA replication and S-phase, whereas 
Clb1-4 are required for the later mitotic events (Bloom and Cross, 2007).  
Protein levels of all cyclins are controlled by ubiquitin-proteasome-dependent degradation. Two multi-
subunit RING E3 ligases dominate cell cycle regulation: the SCF (Skp1 Cdc53/ Cullin F-box) and the 
APC/C (anaphase promoting complex/ cyclosome). Both ligases are modular assemblies consisting of 
a constitutive core complex and variable substrate binding subunits (Deshaies and Joazeiro, 2009). 
Different SCF complexes are active throughout the cell cycle and catalyze, mostly phospho-degron 
dependent, ubiquitination and degradation of a number of substrates, including G1 cyclins and the 
Cdk1 inhibitor Sic1 (van Leuken et al., 2008). Substrate recruitment of SCF complexes is mediated by 
different F-box proteins, for example Cdc4 and Grr1 (Deshaies and Joazeiro, 2009). Degradation of 
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the cyclins Cln1 and Cln2 is mediated by SCFGrr1, Clb6 by SCFCdc4 (Bloom and Cross, 2007). The 
activity of the APC/C on the other hand is restricted to the time between anaphase onset and the end 
of G1, regulating the degradation of all mitotic cyclins except Clb6, anaphase inhibitors, components 
of the mitotic spindle, and the APC/C activator Cdc20 (Bloom and Cross, 2007; van Leuken et al., 
2008). APC/C activity is in part regulated by binding of either of the two activating subunits Cdc20 and 
Cdh1, which enhance substrate recognition. APC/CCdc20 controls the metaphase to anaphase 
transition, while binding of Cdh1 to the APC/C regulates mitotic exit and degradation in G1. Ama1 was 
described as a third APC/C activator which is only expressed during yeast sporulation (van Leuken et 
al., 2008). 
In addition to cyclin binding, Cdc28 activity is regulated through interaction with inhibitors and by 
phosphorylation (Mendenhall and Hodge, 1998). Specific Cdk-cyclin complexes are controlled by 
certain stoichiometric inhibitors, such as Sic1, which blocks activity of Cdc28-Clb, but not Cdc28-Cln 
complexes (Schwob et al., 1994). Similar to cyclins, Sic1 protein levels are also regulated by ubiquitin-
dependent degradation. Cdc28-Cln2 phosphorylates Sic1 in G1, leading to recognition and 
degradation mediated by SCFCdc4 (Feldman et al., 1997; Skowyra et al., 1997). The Cdc28-Cln 
inhibitor Far1 mediates a G1 cell cycle arrest in response to the mating pheromone α-factor and is 
itself also regulated by SCF-dependent degradation (Bloom and Cross, 2007).  
Cdc28 is phosphorylated throughout the mitotic cell cycle at residue T169 by Cak1, resulting in its 
activation (Ross et al., 2000). The morphogenesis checkpoint triggers Swe1 phosphorylation of Cdc28 
at residue Y19, which in turn inhibits Cdc28-Clb2 activity during S and G2 and thereby delays entry 
into mitosis if cells have not formed a bud (Mendenhall and Hodge, 1998; Bloom and Cross, 2007).  
2.2.1 Mitosis  
Accurate distribution of the replicated genome during cell division is essential for viability and depends 
on proper chromosome segregation. During mitosis two physically connected sister chromatids must 
be faithfully segregated to mother and daughter cell, an event controlled by the spindle assembly 
checkpoint (SAC). After replication of DNA in S-phase, the two sister chromatids are physically 
connected through cohesin (Scc1). This state is maintained until every chromosome is condensed, 
aligned, and attached to the mitotic spindle. Attachment to the mitotic spindle occurs by binding of 
kinetochores to microtubules of the mitotic spindle (Fig. 4a). Once all chromosomes are properly 
attached, the SAC is resolved and chromatid cohesion is removed, enabling chromatid segregation to 
opposite poles of the mitotic spindle. In late anaphase the nucleus passes the bud neck, and the 
mitotic exit network (MEN) is activated. This process eventually leads to the release of the 
phosphatase Cdc14 from the nucleolus, resulting in its activation and dephosphorylation of critical 
targets needed for the exit from mitosis. Once mitosis is completed the cell undergoes cytokinesis and 
mother and daughter re-enter G1 (Mendenhall and Hodge, 1998; Lew and Burke, 2003; Bloom and 
Cross, 2007; Musacchio and Salmon, 2007).  
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2.2.1.1 The spindle assembly checkpoint (SAC) 
In order for the yeast metaphase to anaphase transition to occur each kinetochore is required to 
attach to a single microtubule of the mitotic spindle (Winey et al., 1995). The attachment branch of the 
spindle assembly checkpoint is satisfied once both kinetochores of all chromosomes have bound to 
one microtubule. Additionally, it must be ensured that the two chromatids are pulled to opposite poles 
of the mitotic spindle. Thus, a second part of the SAC senses tension. Sufficient tension across the 
two chromatids is only created if the two kinetochores are attached to opposite poles of the mitotic 
spindle (Musacchio and Salmon, 2007). The SAC prevents anaphase onset until all chromosomes 
have achieved correct bi-polar attachment (Fig. 4).  
 
Fig. 4. Chromosome bi-orientation during metaphase. a) Proper Chromosome bi-orientation, each kinetochore is attached to 
one opposite SPB and sister chromatids are tightly linked by cohesin (Scc1). b) The spindle checkpoint can detect monotelic 
and syntelic attachments. Lack of attachment is sensed if only one kinetochore of either of the two sister chromatids is bound to 
microtubules. If both kinetochores are attached to the same SPB (syntelic attachment) the SAC senses lack of tension and also 
triggers a cell cycle arrest. (Adapted from (Musacchio and Salmon, 2007)) 
If proper bi-polar attachment is not achieved, the SAC is activated and delays or prevents 
chromosome segregation by keeping the E3 ubiquitin ligase APC/CCdc20 inactive. This prevents APC/C 
mediated polyubiquitination and subsequent degradation of the two key mitotic substrates Clb2 and 
Pds1 (Hwang et al., 1998; Kim et al., 1998). Pds1 (securin) is the inhibitor of the cellular protease 
separase (Esp1), which cleaves the cohesin (Scc1) complex and enables sister chromatid separation 
(Uhlmann et al., 1999; Nasmyth et al., 2000). By stabilization of the mitotic cyclin Clb2, Cdc28 remains 
active and mitotic exit is prevented (Fig. 5) (Musacchio and Salmon, 2007).  
The exact molecular mechanism by which the SAC senses improper chromosome orientation and 
sends a “wait anaphase” signal that inhibits the APC/C and prevents anaphase onset is still not 
completely resolved. Genes involved in spindle checkpoint signaling were first identified in yeast 
screens for mutants unable to arrest mitosis in the presence of the microtubule depolymerizing agents 
nocodazole and benomyl. The genes MAD1 (mitotic arrest deficient), MAD2, and MAD3 as well as 
BUB1 (budding uninhibited by benomyl), BUB2, and BUB3 were identified in these studies (Hoyt et al., 
1991; Li and Murray, 1991). They were then shown to be involved in a pathway preventing premature 
sister chromatid separation conserved in all eukaryotes (Skibbens and Hieter, 1998). 
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In addition to the BUB and MAD genes, the kinase Mps1 was shown to be required for a SAC induced 
cell cycle arrest (Weiss and Winey, 1996). MPS1 overexpression causes a constitutive checkpoint 
arrest dependent on the other SAC components (Hardwick et al., 1996), while mps1 mutants are 
checkpoint deficient in response to spindle depolymerization (Weiss and Winey, 1996). One described 
Mps1 target in spindle checkpoint signaling is Mad1, which is hyperphosphorylated upon checkpoint 
activation (Hardwick and Murray, 1995). 
Mad2 is the central component of the spindle assembly checkpoint and can bind and partially inhibit 
the APC/CCdc20 until proper chromosome attachment has been achieved. For complete inhibition, 
however, a complex termed yeast mitotic checkpoint complex (MCC) is required. This complex is 
composed of the SAC proteins Mad2, Mad3, Bub3, and Cdc20 (Zich and Hardwick, 2010). Additional 
checkpoint components are Mad1, Bub1 and the kinases Mps1 and Ipl1. Mps1 and Mad1 are required 
for the interaction of Mad2 with Cdc20 (Fig. 5a). The binding of Bub3 and Mad3 to Mad2-Cdc20 
completes the MCC, which then fully inhibits the APC/C (Fig. 5a). Once the checkpoint is satisfied, the 
MCC dissociates and Cdc20 activates the APC/C. The active APC/CCdc20 E3 ligase then ubiquitinates 
Pds1 and Clb2, which results in their degradation by the 26 S proteasome (Fig. 5b). This enables 
sister chromatid segregation and reduces Cdk1 kinase activity (Bloom and Cross, 2007; Musacchio 
and Salmon, 2007).  
 
Fig. 5. Key steps in SAC signaling that lead to APC/CCdc20 activation and anaphase onset. a) If chromosomes are not 
properly attached the APC/C is kept inactive by the MCC (mitotic checkpoint complex) containing Mad2, Mad3, Bub3, and 
Cdc20. Binding of Mad2 to Cdc20 and following formation of the MCC depends on Mps1 and Mad1. b) Once proper bi-
orientation is achieved Cdc20 binds and activates the APC/C. Pds1 and Clb2 are ubiquitinated and degraded. Degradation of 
Pds1 activates the protease separase which cleaves cohesin enabling sister chromatid separation. APC/CCdc20 degrades only 
part of the mitotic cyclin Clb2, therefore Cdk1 activity is reduced, but not abolished upon metaphase to anaphase transition. 
(Adapted from (Musacchio and Salmon, 2007)) 
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Most components of the SAC are linked to kinetochores, which are thought to be the source of the 
majority of checkpoint signals (Bloom and Cross, 2007; Musacchio and Salmon, 2007). If kinetochores 
lack attachment, binding of the Mad1-Mad2 heterodimer leads to formation of “active” Mad2, which is 
thought to be a major determinant for MCC assembly. (Musacchio and Salmon, 2007; Zich and 
Hardwick, 2010). Mad1 and Mad2 are removed directly after attachment has occurred and 
consequently, the localization of the two proteins can be used as a marker for unattached 
kinetochores in vertebrates (Skibbens and Hieter, 1998).  
In addition to sensing attachment, tension must also be monitored. If both chromatids are connected 
to the same pole (syntelic attachment, Fig. 4b) not enough tension is generated and the checkpoint is 
activated. This ensures the correct bi-polar attachment of chromosomes and ultimately equal 
distribution of chromosomes to mother and daughter cell. 
The yeast chromosomal passenger complex (CPC), consistent of Ipl1 (the only yeast Aurora kinase), 
Sli15 (INCENP), Bir1 (survivin), and Nbl1 (borealin), has been shown to promote proper chromosome 
segregation and, with the exception of Nbl1, to be required for activation of the SAC in response to 
lack of tension (Biggins and Murray, 2001; Makrantoni and Stark, 2009; Nakajima et al., 2009). 
Consistent with the inability to activate the SAC in response to lack of tension, both ipl1 and sli15 
mutants segregate chromosomes unequally due to increased syntelic attachments, while DNA 
replication, SPB duplication, spindle formation, and cytokinesis are unaffected (Biggins et al., 1999; 
Kim et al., 1999; Tanaka et al., 2002). bir1 and nbl1 mutants also display chromosome 
missegregation, albeit less severely than ipl1 or sli1 (Makrantoni and Stark, 2009; Nakajima et al., 
2009).  
Ipl1 is required for spindle checkpoint activation in response to lack of tension and has been proposed 
to activate the SAC by creating unattached kinetochores (Pinsky et al., 2006b). Proper tension 
occurring from attachment of the two chromatids to opposite poles is presumably sensed by 
kinetochore proteins. Additionally, kinetochore proteins bind spindle microtubules in a phosphorylation 
dependent manner (Cheeseman et al., 2002). Consequently, it has been demonstrated that Ipl1 
phosphorylates the kinetochore protein Ndc10 in vitro (Biggins et al., 1999). In addition to Ndc10, Sli15 
and Dam1 have been described as Ipl1 substrates at the kinetochore (Kang et al., 2001). Further 
mapping of phosphorylation sites within kinetochore proteins revealed additional putative Ipl1 targets, 
and the outer kinetochore protein Dam1 was identified as a critical downstream target of Ipl1 that 
regulates kinetochore microtubule attachments (Cheeseman et al., 2002). Phosphorylation of Dam1 
by Ipl1 inhibits the kinetochore-microtubule interaction, thereby creating unattached kinetochores 
(Cheeseman et al., 2002). These unattached kinetochores are thought to result in spindle checkpoint 
activation (Pinsky et al., 2006b). 
Moreover, it has been demonstrated that phosphorylation of the kinetochore component Ndc80 by 
Mps1 is also required for proper spindle checkpoint signaling. A phospho-mimicking mutant of Ndc80, 
in which 14 serines have been mutated to aspartate, is inviable dependent on the SAC. The alanine 
mutant, in turn, is checkpoint deficient and does not arrest after nocodazole treatment (Kemmler et al., 
2009). Furthermore, it has been shown that Mps1 phosphorylates Dam1, however, in contrast to the 
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Ipl1 mediated phosphorylation, modification by Mps1 appears to be required for kinetochore-
microtubule attachment (Shimogawa et al., 2006). 
These findings demonstrate that the phosphorylation state of kinetochore proteins is critical for SAC 
signaling. Ipl1 activity is required for checkpoint activation in response to lack of tension (Biggins and 
Murray, 2001), while Mps1 mediated phosphorylation of Ndc80 is also required for SAC signaling 
upon spindle depolymerization and therefore lack of attachment (Kemmler et al., 2009). Additionally, 
Ipl1 phosphorylates Mad3 to further enhance the checkpoint delay (King et al., 2007). 
Histone H3 was furthermore demonstrated to be a mitotic substrate of Ipl1 (Hsu et al., 2000). Mitotic 
phosphorylation of histone H3 at serine ten is conserved among eukaryotes and peaks when 
chromosomes are most condensed. However, in budding yeast a S10A mutation of histone H3 does 
not have a significant cell cycle or growth defect, suggesting a more complex regulation of 
chromosome congression and cell cycle progression (Hsu et al., 2000).  
Ipl1 mediated phosphorylation of Ndc10, histone H3, and Dam1 has been proposed to be 
counteracted by the phosphatase PP1/Glc7 (see 2.4.2) (Sassoon et al., 1999; Hsu et al., 2000; Kang 
et al., 2001; Cheeseman et al., 2002; Pinsky et al., 2006a).  
2.2.1.2 Mitotic exit 
Once the spindle checkpoint is satisfied and chromosome separation has occurred, mitotic Cdk1 
activity must be inactivated in order for cells to exit mitosis and undergo cytokinesis. In yeast 
inactivation of this activity is not completed at metaphase to anaphase transition, but is delayed until 
spindle elongation has occurred (Bardin and Amon, 2001). Degradation of mitotic cyclins as well as 
stabilization of the inhibitor Sic1 leads to Cdc28-Clb inactivation. The phosphatase Cdc14 is essential 
for this process and is the effector of a cascade of events called the mitotic exit network (MEN). During 
most of the cell cycle Cdc14 is bound to Net1 and sequestered in the nucleolus (Bloom and Cross, 
2007). In addition to Cdc14, the network comprises the protein kinases Cdc15, Dbf2, Dbf20, the GTP-
binding protein Tem1, a putative GEF (guanine nucleotide exchange factor) Lte1, a GTPase activating 
complex (GAP) consistent of Bfa1 and Bub2, and Mob1, which binds Dbf2/Dbf20 (Dumitrescu and 
Saunders, 2002).  
The mitotic exit network is activated by Tem1-GTP in late anaphase. Active Tem1 triggers a signaling 
cascade starting with the activation of Cdc15 kinase, which activates Dbf2/Mob1, and in turn leads to 
activation and release of Cdc14 from the nucleolus (Hoyt, 2000). Cdc14 dephosphorylates and 
activates the Cdk1 inhibitor Sic1, the SIC1 transcription factor Swi5, and the APC/C activator Cdh1, all 
resulting in inhibition of Cdc28-Clb activity (Fig. 6) (Sullivan and Morgan, 2007).  
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Fig. 6. The mitotic exit network (MEN). Tem1-GDP is kept in this inactive state by the GAP (GTPase activating protein) 
Bub2-Bfa1. Bub2-Bfa1 can be inhibited by phosphorylation of Bfa1, presumably by Cdc5. Activation of Tem1-GDP to 
Tem1-GTP may occur through interaction with the GEF (guanine nucleotide exchange factor) Lte1 (see text). Active Tem1-GTP 
activates the downstream kinases Cdc15 and Dbf2/Mob1 which lead to activation and release of Cdc14. The phosphatase 
Cdc14 is sequestered in the nucleolus by Net1 during most of the cell cycle. Once it is released it dephosphorylates key targets 
needed for mitotic exit. By Swi5 dephosphorylation the transcription factor is stabilized and promotes SIC1 transcription. 
Additionally, Sic1 is itself stabilized by dephosphorylation and then inhibits Cdc28-Clb2 activity. Cdh1 activates the APC/C and 
leads to degradation of the remaining mitotic cyclin Clb2, also resulting in inhibition of Cdc28. (Adapted from (Dumitrescu and 
Saunders, 2002; Lew and Burke, 2003)) 
Mitotic exit is controlled by the spindle position checkpoint. This branch of the spindle checkpoint 
ensures that the mitotic spindle is oriented along the mother-bud axis and thereby prevents 
cytokinesis as long as both sets of chromosomes remain in the mother cell (Lew and Burke, 2003).  
During most of the cell cycle Tem1 is kept in its inactive GDP-bound state by the GAP Bub2-Bfa1 
(Dumitrescu and Saunders, 2002). Most MEN components display an asymmetric localization that is 
required for proper mitotic exit to occur. The Bub2-Bfa1 complex localizes only to the daughter-bound 
SPB during anaphase and recruits Tem1 (Lew and Burke, 2003). How exactly Tem1 is then activated 
and mitotic exit triggered is considerably unclear. One mechanism proposed is that the position of the 
nucleus is sensed. The putative GEF Lte1 is localized to the bud cortex and once the nucleus passes 
the bud neck SPB localized Tem1 could be activated by its GEF. However, Lte1 only becomes 
essential at cold temperatures and the deletion mutant does not display any significant cell cycle 
defect at room temperature (Bardin and Amon, 2001). Furthermore, it has been reported that Lte1 
does not have GEF activity for Tem1 in vitro and thus proposed that Lte1 is rather required for 
asymmetric localization of Bfa1 to the daughter SPB (Geymonat et al., 2009). Therefore, it is 
conceivable that Cdc14 release and Tem1 activation are regulated by an additional mechanism 
(Bardin and Amon, 2001).  
Bfa1 and Bub2 are hyperphosphorylated and inactive in late anaphase, which allows activation of the 
mitotic exit network. Spindle misorientation prevents the phosphorylation of Bfa1 and thereby inhibits 
mitotic exit, as Tem1 is retained in its inactive GDP-bound state (Lew and Burke, 2003). The yeast 
Polo-like kinase Cdc5 is thought to be responsible for Bfa1 phosphorylation (Dumitrescu and 
Saunders, 2002; Lew and Burke, 2003).  
In addition to MEN a second network already transiently releases Cdc14 from the nucleolus in early 
anaphase. The FEAR (Cdc14 fourteen early anaphase release) network allows stabilization of the 
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mitotic spindle, segregation of ribosomal DNA, and activation of MEN (Bloom and Cross, 2007). 
Cdc14 release caused by the FEAR network is nevertheless not sufficient for cells to exit mitosis 
(Bloom and Cross, 2007).  
2.3 The AAA ATPase Cdc48/p97 
Budding yeast CDC48 (cell division cycle 48) was initially identified in a genetic screen for cold-
sensitive (cs) cell cycle alleles. The original cs allele, cdc48-1, was found to arrest with large buds, an 
undivided nucleus, and aberrant microtubules spreading from an unseparated spindle pole body at the 
non-permissive temperature (Moir et al., 1982; Frohlich et al., 1991). Four additionally identified 
cs-revertants that exhibit temperature sensitivity, also arrest with large buds at the non-permissive 
temperature of 37°C (Moir et al., 1982). 
In addition to the early mitotic phenotype described in the initial screen, additional functions of Cdc48 
during the cell cycle have been reported. The degradation of the G1 SCF substrates Far1 and Cln2 is 
dependent on Cdc48 (Fu et al., 2003; Archambault et al., 2004). Cao et. al. claim that Cdc48Ufd1-Npl4 is 
required for spindle disassembly after mitosis, possibly by mediating Cdc5 and Ase1 degradation (Cao 
et al., 2003). However, these results have been questioned (Heubes and Stemmann, 2007), and no 
further evidence for a role of Cdc48 in spindle disassembly has been brought forward. Interestingly, in 
C. elegans Cdc48Ufd1-Npl4 was shown to be required for efficient DNA replication and thereby for cell 
cycle progression through S-phase (Mouysset et al., 2008). Fission yeast Cdc48, in turn, has been 
demonstrated to be required for the stability of Cut1 (separase) and therefore necessary for proper 
sister chromatid separation (Ikai and Yanagida, 2006). Furthermore, p97Ufd1-Npl4 is essential for nuclear 
envelope formation after mitosis (Hetzer et al., 2001; Ramadan et al., 2007). Active Aurora B kinase is 
ubiquitinated, bound by p97Ufd1-Npl4, and extracted from chromatin allowing chromosome 
decondensation and nuclear envelope reassembly. Thus, Cdc48 fulfills more than one essential 
function during the cell cycle, which can either result in G1 or mitotic defects upon depletion or 
mutation. These diverse functions are possibly regulated by interaction with different sets of cofactors. 
The protein Cdc48/p97/VCP (Valosin containing protein) was characterized as an essential, highly 
conserved AAA ATPase (ATPases associated with various cellular activities), which is involved in a 
large variety of ubiquitin related cellular processes. Common to all these processes appears to be a 
“segregase” activity of Cdc48, during which energy derived from ATP hydrolysis is used to extract 
ubiquitinated proteins from protein complexes or cellular structures (Rape et al., 2001; Braun et al., 
2002; Buchberger, 2006; Jentsch and Rumpf, 2007; Buchberger, 2010).  
AAA proteins function in a vast number of different cellular processes. Common to all members of this 
family is the AAA domain, a 200- 250 amino acid ATPase module, which contains Walker-A and –B 
motifs as well as other conserved elements, most prominent the second region of homology (SRH). 
Additionally, all AAA proteins assemble into oligomers, often hexamers, and function in structural 
remodeling, unfolding, and disassembly of macromolecular complexes (Lupas and Martin, 2002; 
Hanson and Whiteheart, 2005).  
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Cdc48/p97 is assembled into a homohexameric ring, each monomer composed of an N-terminal 
domain, followed by two ATPase domains, D1 and D2, and an unstructured C-terminus (Fig. 7) 
(Hanson and Whiteheart, 2005; Buchberger, 2006). Specificity in different processes is conveyed 
through interaction with numerous cofactors (Buchberger, 2006; Jentsch and Rumpf, 2007; 
Buchberger, 2010). 
 
Fig. 7. Structure of the AAA ATPase Cdc48. a) Schematic overview of the domain architecture of Cdc48; the N-domain (blue) 
is followed by the two ATPase domains D1 (green), and D2 (orange). b) Sideward view of a Cdc48 hexamer (colors as in a) 
c) View through the central pore (colors as in a). (From (Buchberger, 2006)) 
Cdc48/p97 cofactors can be divided into two groups: substrate-processing and substrate-recruiting 
(Jentsch and Rumpf, 2007). Substrate-processing cofactors either directly alter the ubiquitination state 
of the bound substrate or modify the substrate by other means, such as deglycosylation by peptidyl-N-
glycanase (PNGase). The substrate-processing cofactors Ufd2 and Ufd3 bind to the C-terminus of 
Cdc48 in mutually exclusive manner and antagonistically regulate substrate ubiquitination (Rumpf and 
Jentsch, 2006; Böhm et al., 2011). The E4 Ufd2 elongates pre-existing ubiquitin chains, whereas Ufd3 
cooperates with the DUB Otu1 in antagonizing substrate ubiquitination (Rumpf and Jentsch, 2006).  
The two most prominent and mutually exclusive substrate-recruiting cofactors are the heterodimeric 
Ufd1-Npl4 complex and Shp1/p47. In addition to Cdc48/p97 binding domains, these cofactors possess 
specific ubiquitin binding modules, such as the UBA domain found in Shp1/p47 (Schuberth and 
Buchberger, 2008). Substrate-recruiting cofactors mediate the interaction of Cdc48 with substrates 
and direct Cdc48 to distinct cellular compartments.  
The role of Cdc48Ufd1-Npl4 has been clearly demonstrated in ER associated degradation (ERAD) (Ye et 
al., 2001; Braun et al., 2002; Jarosch et al., 2002; Neuber et al., 2005; Schuberth and Buchberger, 
2005), the ubiquitin-fusion degradation (UFD) pathway (Johnson et al., 1995), as well as during 
mobilization of the membrane anchored transcription factor Spt23 (OLE pathway) (Rape et al., 2001). 
Additional cellular processes that require Cdc48 function are the mitochondrial stress response (Heo 
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et al., 2010), transcriptional regulation (Wilcox and Laney, 2009), as well as the DNA damage 
response (Verma et al., 2011).  
p97p47 has been demonstrated to mediate homotypic membrane fusion (Kondo et al., 1997; Rabouille 
et al., 1998; Uchiyama et al., 2002), while Cdc48Shp1 has been implicated in autophagy (Krick et al., 
2010) and chromosome bi-orientation (Cheng and Chen, 2010). p47/Shp1 is a member of a large 
group of Cdc48 substrate-recruiting cofactors, the so called UBX-proteins. 
2.3.1 UBX proteins 
The ubiquitin regulatory X (UBX) domain is an 80 amino acid residue module, originally identified in 
the mammalian protein Y33K (Hofmann and Bucher, 1996). Structural comparison of the UBX domain 
with ubiquitin itself showed a close structural similarity despite the lack of significant sequence 
homology (Fig. 8) (Buchberger et al., 2001; Yuan et al., 2001). Due to the lack of a di-glycine motif at 
its C-terminus, the UBX domain is not conjugated like ubiquitin, but has rather proven to be a general 
Cdc48/p97 binding module (Buchberger et al., 2001; Yuan et al., 2001; Decottignies et al., 2004; 
Dreveny et al., 2004; Hartmann-Petersen et al., 2004; Schuberth et al., 2004). A conserved surface 
R…FPR motif, which is absent in ubiquitin and other ubiquitin-like proteins, was shown to mediate the 
interaction with the N-terminal domain of Cdc48/p97 (Buchberger et al., 2001; Yuan et al., 2001).  
 
Fig. 8. Structural comparison of ubiquitin and the UBX domain. Ribbon representation of the ubiquitin and tFAF1 UBX 
domain three-dimensional structure. Residues comprising the conserved p97/Cdc48 interaction motif R…FPR found in UBX 
domains are depicted in detail. (Modified, from (Schuberth and Buchberger, 2008)) 
UBX- or UBX-like proteins are the largest family of known Cdc48/p97 cofactors and can be subdivided 
into five larger groups: p47, FAF1, SAKS1, TUG, and UBXD1, as well as two smaller groups of 
proteins: Rep-8 and UBXD3 (Schuberth and Buchberger, 2008). In budding yeast seven UBX domain 
containing proteins have been identified: Shp1 and Ubx2- Ubx7 (Fig. 9). All seven proteins have been 
demonstrated to interact with Cdc48 (Schuberth et al., 2004; Schuberth, 2006). In addition to the 
Cdc48 binding UBX domain, some members of this group contain additional ubiquitin binding domains 
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or motifs, such as the UBA domain found in Shp1, Ubx2, and Ubx5 (Schuberth and Buchberger, 
2008).  
 
Fig.9. Overview of the domain structure of the seven S. cerevisiae UBX proteins. All proteins contain the name-giving 
UBX-domain, which mediates Cdc48 interaction (shown in red). Ubiquitin binding domains UBA and UIM are depicted in yellow. 
The SEP domain of Shp1 and the UAS domains of Ubx3 and Ubx5 are shown in gray. (Modified, from (Schuberth and 
Buchberger, 2008)) 
It has been demonstrated that most yeast UBX proteins bind to either of the two mutually exclusive 
complexes of Cdc48, containing Ufd1-Npl4 or Shp1. Ubx6 and Ubx7 can be found in complex with 
Cdc48Shp1, while Ubx2, Ubx3 and Ubx5 interact with Cdc48Ufd1-Npl4 (Schuberth, 2006). The sub-
complexes of Cdc48 are thought to mediate Cdc48 substrate specificity and recruitment to different 
cellular compartments (Schuberth, 2006; Schuberth and Buchberger, 2008).  
The integral membrane protein Ubx2 recruits Cdc48Ufd1-Npl4 to the ER and is required for stable binding 
of Cdc48Ufd1-Npl4 to ERAD substrates and ligases. Deletion of UBX2 leads to defects in degradation of 
all tested ERAD substrates (Neuber et al., 2005; Schuberth and Buchberger, 2005). Ubx4 has also 
been reported to modulate Cdc48 activity during ERAD (Alberts et al., 2009).  
Ubx5, and to some extent Ubx4, in complex with Cdc48Ufd1-Npl4 are involved in the UV-induced turnover 
of Rpb1, the largest subunit of RNA Pol II (Verma et al., 2011). The authors propose that upon DNA 
damage Rpb1 is ubiquitinated by Cul3, transferred to Cdc48Ubx5, and then degraded by the 
proteasome directly on chromatin (Verma et al., 2011).  
Although Ubx4 (Cui1), Ubx6 (Cui2), and Ubx7 (Cui3) have been implicated in meiosis (Decottignies et 
al., 2004), no substrate or interactor required for this process has so far been identified. Ubx3 may be 
localized to the Golgi and vesicles, therefore it has been speculated that it may play a role in vesicle 
trafficking (Schuberth, 2006). 
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2.3.2 Shp1/p47 
Mammalian p47 (Shp1 in S. cerevisiae) was the first identified p97 interactor and was shown to tightly 
bind the p97 hexamer in form of a trimer (Kondo et al., 1997; Beuron et al., 2006). This conserved 
p97/Cdc48 adapter protein contains three domains separated by flexible regions, namely an 
N-terminal UBA, followed by the SEP (Shp1, eyc, p47), and a C-terminal UBX domain (Fig. 10) 
(Dreveny et al., 2004; Yuan et al., 2004a).  
 
Fig. 10. Schematic overview of the Shp1 domain architecture. The Cdc48 binding modules of Shp1, namely the UBX 
domain and BS1, are shown in red. Residues within these domains that mediate Cdc48 interaction are depicted in bold letters. 
The N-terminal UBA (ubiquitin associated domain) is depicted in yellow and the SEP (Shp1, Eyc, p47) domain, which mediates 
trimerization, in gray. (Modified, from (Schuberth and Buchberger, 2008)) 
The UBA domain comprises residues 1-45 of p47 and was shown to bind mono-ubiquitin and inhibit 
polyubiquitination in vitro (Meyer et al., 2002). Accordingly, the UBA domain of Shp1 was 
demonstrated to bind ubiquitin chains in vitro and ubiquitinated proteins in vivo (Schuberth et al., 
2004). Residues 179–246 are spanned by the SEP domain, which is involved in p47 trimerization 
(Yuan et al., 2004b; Beuron et al., 2006). Both p47 and Shp1 bind to the p97 and Cdc48 N–domain, 
respectively. This interaction is mediated by (at least) two distinct binding sites in the C-terminus 
(Uchiyama et al., 2002), the UBX-domain and BS1 at the C-terminal end of the SEP domain (Fig. 10) 
(Bruderer et al., 2004; Dreveny et al., 2004). BS1 (also called SHP box) is a short linear hydrophobic 
binding motif for p97/Cdc48, which is also found in Ufd1 and other proteins implicated in the UPS 
(Bruderer et al., 2004; Hitt and Wolf, 2004; Sato and Hampton, 2006).  
The p97p47 complex is required for homotypic membrane fusion of the Golgi, ER, and nuclear 
envelope (Latterich et al., 1995; Kondo et al., 1997; Hetzer et al., 2001). It has been proposed that 
p97p47 fulfills a role similar to the AAA ATPase NSF (N-ethylmaleimide-sensitive fusion protein), which 
disassembles SNARE (soluble NSF attachment protein) complexes formed during membrane fusion. 
Indeed, p47 binds the SNARE syntaxin 5 in vitro, and is required for the efficient interaction of p97 
with syntaxin 5. Therefore, p47 is thought to recruit p97 to membrane bound SNARE complexes, 
leading to their disassembly and thereby priming syntaxin 5 for further membrane fusion events 
(Rabouille et al., 1998). However, an in vivo function of p97 in analogy to SNARE disassembly has 
also been questioned, as inhibition of p97 ATPase activity in vivo did not result in inhibition of Golgi 
reassembly (Dalal et al., 2004).  
Interestingly, the functional UBA domain of p47 is required for p97p47 mediated Golgi reassembly in 
vitro, presumably in order to recruit p97 to a ubiquitinated target on the Golgi membrane (Meyer et al., 
2002; Meyer, 2005). The deubiquitinating enzyme VCIP135 is also necessary for membrane fusion 
events of Golgi and ER, and can dissociate the stable complex of p97p47 and syntaxin 5 (Uchiyama et 
al., 2002; Wang et al., 2004; Kano et al., 2005). However, taking into account the requirement for the 
p47 UBA domain as well as the deubiquitinating activity of VCIP135, it seems improbable that 
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syntaxin 5 is the critical target of p9747 during Golgi reassembly, as the interaction with the p97p47 
complex occurs efficiently in vitro without any ubiquitin modification (Rabouille et al., 1998) (discussed 
in (Buchberger, 2006)). Nevertheless, it is possible that a critical component of the fusion process is 
ubiquitinated and must be processed, recruited, and/ or extracted by p97p47. 
Budding yeast SHP1 was first identified in a genetic screen for suppressors of the otherwise lethal 
overexpression of the protein phosphatase 1 catalytic subunit Glc7 (see 2.4). Two shp1 (suppressor of 
high-copy PP1) alleles tolerated the overexpression of GLC7 and, in turn, had phenotypes very similar 
to those of glc7 mutants. shp1-1 and shp1-2 exhibit a strong growth defect and are deficient in 
glycogen storage as well as meiosis. Consistent with the model that Shp1 is a positive regulator 
required for normal Glc7 activity, shp1 mutants have reduced PP1 activity, determined by the reduced 
capability of shp1 cell extracts to dephosphorylate glycogen phosphorylase a (Zhang et al., 1995). 
Moreover, lysates of cells deleted of SHP1 were shown to exhibit reduced phosphorylase 
phosphatase activity, indicative of reduced Glc7 activity (Wilson et al., 2005). The mechanism by 
which Shp1 influences Glc7 activity is unknown and no direct interaction between Glc7 and Shp1 has 
been demonstrated.  
Employing the yeast knockout libraries available several large-scale screens conducted over the past 
years have identified a number of phenotypes and sensitivities of shp1. Among them was the finding 
that the deletion of SHP1 leads to a defect in homotypic membrane fusion, as the knockout was 
identified in a screen for mutants with defective vacuolar morphology (Seeley et al., 2002). Indeed, 
Shp1 has been demonstrated to influence vacuolar fusion, possibly by altering localization of certain 
vacuolar proteins, among them the Glc7 activating subunit Glc8 (Thoms, 2002). However, as the 
terminal step of vacuolar membrane fusion has been reported to be regulated by Glc7/PP1 (Peters et 
al., 1999; Bryant and James, 2003), it is difficult to differentiate between secondary effects caused by 
misregulation of Glc7 in Δshp1 and phenotypes that are directly related to unique Cdc48Shp1 
function(s). Accordingly, the shp1 knockout has been found in several screens investigating 
chromosome stability and genome maintenance, a phenotype also connected to glc7 mutants (see 
2.4). shp1 was indentified in three independent screens of a study isolating chromosome instability 
(CIN) mutants and was shown to have an increased rate in loss of heterozygosity, indicating increased 
chromosome loss (Yuen et al., 2007; Andersen et al., 2008).  
Cdc48Shp1 is also involved in protein degradation. Deletion of SHP1 results in the stabilization and 
accumulation of the UFD substrate Ub-P-βGal in S. cerevisiae (Schuberth et al., 2004), as well as the 
Cdk inhibitor Rum1 in fission yeast (Hartmann-Petersen et al., 2004).  
Very recently, two studies reported novel Cdc48Shp1 functions in mitosis and autophagy (Cheng and 
Chen, 2010; Krick et al., 2010). Cheng and Chen describe a role of Cdc48Shp1 in promoting 
chromosome bi-orientation by regulation of the balance between Ipl1 kinase and Glc7 phosphatase 
activity at the kinetochore. The authors propose that reduced phosphatase activity at the kinetochore 
is an effect of abolished nuclear localization of Glc7 in Shp1 depleted cells (Cheng and Chen, 2010) 
(see following chapters).  
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Cdc48 and Shp1 were shown to be required for non-selective macroautophagy and for piecemeal 
microautophagy of the nucleus (PMN), a form of selective autophagy. In analogy to Golgi reassembly 
the authors speculate on an ubiquitin-proteasome system independent function of Cdc48Shp1 in 
extraction of Atg8 from a complex with the fusion mediator during autophagosome formation (Krick et 
al., 2010).  
2.4 Protein phosphatase 1 catalytic subunit- Glc7 
Four families of protein phosphatases have been identified in budding yeast. The PPP family 
comprises type 1 (PP1), type 2A (PP2A), type 2B (PP2B), and a group of sequence-related Ser/ Thr 
phosphatases. PP2C family proteins are also Ser/ Thr phosphatases, yet unrelated to PPP 
phosphatases. Protein tyrosine phosphatases (PTPases) and dual specificity phosphatases form the 
third group, while low molecular weight PTPases are classified as the fourth family of phosphatases 
(Stark, 1996).  
Glc7 is the only catalytic subunit of protein phosphatase 1 (PP1) found in S. cerevisiae and possesses 
a high degree of sequence homology to mammalian PP1c subunits (Fig. 11).  
 
Fig. 11. Protein sequence alignment of PP1 homologs. The amino acid sequence of S. cerevisiae Glc7, S. pombe Dis2, and 
the γ isoform of human PP1 were aligned and conserved residues depicted in shades of blue. (Jalview (Waterhouse et al., 
2009)) 
The essential gene GLC7 was first identified in a study that examined a collection of mutants with 
reduced cellular glycogen levels: glc1- glc8. glc7 mutants exhibited strongly decreased amounts of 
glycogen. Consistently, it was demonstrated that glycogen synthase was hyperphosphorylated and 
therefore inactive in glc7 mutants (Peng et al., 1990; Feng et al., 1991; Cannon et al., 1994). Further 
analysis of Glc7 revealed numerous functions in addition to the regulation of glycogen metabolism 
(Stark, 1996; Cannon, 2010). 
The majority of Glc7 is located in the nucleus, but it is also detectable in the cytosol and at the septum 
(Bloecher and Tatchell, 2000). Glc7 is stable throughout the cell cycle and enzyme activity does not 
change substantially, when analyzed by measurement of phosphorylase phosphatase activity. 
However, it has been reported that Glc7 activity increases as cultures reach stationary phase or 
glucose becomes limiting, without changes in protein levels, but rather dependent on the subunit Glc8 
(Nigavekar et al., 2002).  
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As GLC7 is an essential gene in S. cerevisiae, many different glc7 alleles have been used to identify 
the diverse processes involving Glc7. Most alleles were discovered in screens for one particular Glc7 
function, such as glycogen metabolism, and later also utilized to study the other pathways involving 
PP1 function. 
 glc7-1 glc7-10 glc7-12 glc7-127 glc7-129 glc7-T152K 
Mutation R73C (5, 19) F135L (2) N32Y, G227D (3) 
K110A, 
K112A (1) 
D137A, 
E138A (1) T152K (11) 
Altered 
subunit 
interaction 
defective in 
Gac1 
binding (19) 
n.d. n.d. n.d. 
defective in 
Bni4 
binding (4) 
defective in 
Reg1 
binding (18) 
Glycogen 
storage 
reduced 
glycogen (5, 
19) 
n.d. n.d. reduced glycogen (1) 
low 
glycogen 
(1,6) 
normal (11) 
Glucose 
repression normal (11) n.d. n.d. defective (1) normal (1) 
defective 
(11) 
Sporulation defect (5) n.d. n.d. reduced (6) reduced (6) defect (11) 
Mitosis n.d. 
G2/M delay 
(2,8) 
dependent 
on SAC (8) 
G2/M delay 
(3) no delay (1) 
G2/M delay 
(1,6) 
dependent 
on SAC (10) 
S-phase 
delay (7) 
Mitotic Glc7 
substrates n.d. 
phospho-
Ndc10 
increased 
(8) 
phospho-
Dam1 
increased 
(17) 
phospho-
Dam1 
increased 
(17) 
phospho-
Fin1 
increased 
(16)
phospho 
H3 
enhanced 
(9) 
phospho 
H3 
enhanced 
(9) 
n.d. 
Genetic 
interaction  n.d. 
suppresses 
ts of 
ipl1-321 (17) 
SL with 
cdc48-3 (14) 
 
suppresses 
ts of ipl1-2 
(9)  
slow growth 
with Δglc8 
(6)
suppresses 
ts of ipl1-2 
(9) 
SL with 
Δglc8 (6) 
n.d. 
Suppression 
of pheno-
type  
n.d. 
suppressed 
by PKC1, 
high 
osmolarity 
(1) 
mitotic 
defect 
suppressed 
by SDS22 
(3)
n.d. n.d. n.d. 
Other 
phenotypes 
membrane 
fusion 
defect 
(12,13) 
sensitive to 
high levels 
of MPS1 
(15) 
- - sensitive to HU (7) 
sensitive to 
HU (7) 
Table 1: Commonly used glc7 alleles and their most prominent phenotypes. References: 1) (Baker et al., 1997), 2) 
(Andrews and Stark, 2000), 3) (MacKelvie et al., 1995), 4) (Kozubowski et al., 2003), 5) (Cannon et al., 1994), 6) (Venturi et al., 
2000), 7) (Bazzi et al., 2010), 8) (Sassoon et al., 1999), 9) (Hsu et al., 2000), 10) (Bloecher and Tatchell, 1999), 11) (Tu and 
Carlson, 1994), 12) (Bryant and James, 2003), 13) (Peters et al., 1999), 14) (Cheng and Chen, 2010). 15) (Pinsky et al., 2009), 
16) (Akiyoshi et al., 2009b), 17) (Pinsky et al., 2006a), 18) (Tu and Carlson, 1995), 19) (Stuart et al., 1994). SL: synthetically 
lethal, n.d. not determined, ts: temperature sensitivity, HU: hydroxyurea. 
For some identified alleles the molecular basis for the phenotype is evident. The glycogen storage 
deficiency of glc7-1 is due to the inability of the mutant Glc7 protein to bind the targeting subunit Gac1, 
which is mainly responsible for mediating Glc7 function in glycogen synthesis (Baker et al., 1997). In 
most other cases however, the molecular effects of the point mutations have not been clearly 
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determined. Mutations specific for the different glc7 conditional alleles could either directly affect 
activity or stability of Glc7, or alter binding to subunits or substrates.  
2.4.1 Targeting subunits mediate Glc7 function 
Numerous and highly diverse physiological processes are regulated by Glc7. These cellular pathways 
include glycogen metabolism, glucose repression, RNA processing, sporulation, DNA damage 
recovery, actin organization, cell wall morphogenesis, and mitosis (reviewed in (Stark, 1996; Cannon, 
2010)). Glc7 itself has little or no substrate specificity, but this is rather mediated through interaction 
with different regulatory or targeting subunits (Fig. 12). These subunits modulate Glc7 phosphatase 
activity, localization, and substrate binding. At least 28 Glc7 targeting subunits have been 
demonstrated  to regulate Glc7 activity towards certain substrates in S. cerevisiae (Cannon, 2010). 
 
Fig. 12. Schematic overview depicting Glc7 regulatory and targeting subunits and their cellular function. Substrate 
specificity of Glc7 is achieved by binding of numerous targeting subunits, which regulate Glc7 phosphatase activity towards 
substrates. Glc7 opposes or regulates the activity of diverse cellular kinases, as well as other factors, such as γH2A (shown in 
gray). Glc8 and Shp1 are positive regulators of Glc7 (orange), which enhance phosphatase activity by so far mostly unknown 
mechanisms. Some targeting subunits are themselves substrates of Glc7, indicated by small black dots for phosphorylation.  
Binding of many, but not all, Glc7 regulatory subunits is mediated by an (R/K-V/I-X-F) motif (Wu and 
Tatchell, 2001). This RVxF motif binds to a hydrophobic channel formed by two β-sheets of PP1c, 
distant from the catalytic core. Mutation of the hydrophobic groove led to reduced affinity of some 
regulatory subunits towards Glc7 and in severe cases could not fulfill essential functions (Wu and 
Tatchell, 2001). At least ten regulatory subunits of Glc7 possess this motif, among them Fin1, Scd5, 
Gac1, and Reg1 (Cannon, 2010). Nevertheless, as about 10% of all mammalian proteins contain this 
peptide sequence, it is evident that this motif alone is not sufficient to define a PP1 targeting subunit. 
Additional determinants such as localization, surface exposure of the binding residues as well as 
changes in tertiary structure depending on the amino acid X play a significant role in defining the 
capability of PP1 binding (Egloff et al., 1997). In addition, proteins that do not contain an RVxF motif 
Introduction 
 
 
24 
 
can nevertheless bind PP1. The nuclear protein Sds22 is a major and strong interactor of Glc7, which 
does not possess an RVxF motif, but rather binds to Glc7 through eleven leucine-rich repeats 
(Ceulemans and Bollen, 2004; Cannon, 2010). 
2.4.2 Regulation of mitosis by PP1/Glc7 
Fungal PP1 was first discovered to play a role in mitosis in the fission yeast S. pombe (Ohkura et al., 
1989; Ishii et al., 1996). S. cerevisiae PP1 was also demonstrated to be crucial for chromosome 
segregation and consequently, several glc7 mutants arrest at or before anaphase onset (Ohkura et al., 
1989; Dombradi et al., 1990; Fernandez et al., 1992; Hisamoto et al., 1994; Black et al., 1995; 
MacKelvie et al., 1995; Ishii et al., 1996). Furthermore, the conditional alleles glc7-129 and glc7-10 
exhibit a mitotic delay dependent on the spindle assembly checkpoint (Bloecher and Tatchell, 1999; 
Sassoon et al., 1999). Protein phosphatase 1 activity is also required for progression through mitosis 
in different other eukaryotes, such as Drosophila and mammalian cells (Axton et al., 1990; Dombradi 
et al., 1990).  
Glc7 has been demonstrated to oppose Ipl1 kinase activity during chromosome bi-orientation (Biggins 
et al., 1999; Sassoon et al., 1999; Cheeseman et al., 2002). Additionally, other substrates 
phosphorylated upon SAC activation must be dephosphorylated for progression through mitosis to 
commence. This is mediated in part by PP1, as Glc7 is required for spindle checkpoint silencing both 
in response to lack of attachment and lack of tension (Pinsky et al., 2009).  
The finding that overexpression of truncated glc7 suppressed ipl1 mutations, whereas overexpression 
of full length, catalytically active Glc7 was toxic, led to the model that Glc7 and Ipl1 activity need to be 
balanced in order for proper chromosome segregation to occur (Francisco et al., 1994). Glc7 has been 
described to oppose Ipl1 kinase activity by dephosphorylating the kinetochore proteins Ndc10 and 
Dam1, as well as histone H3 (Biggins et al., 1999; Sassoon et al., 1999; Hsu et al., 2000; Kang et al., 
2001; Cheeseman et al., 2002). For Ndc10, Dam1, and histone H3 certain glc7 alleles were used to 
demonstrate hyperphosphorylation of the substrates at the non-permissive temperature, while they 
were shown to be hypophosphorylated in ipl1 mutants. Histone H3 and Dam1 phosphorylation was 
restored to approximately wild-type levels in ipl1 glc7 double mutants (Hsu et al., 2000; Pinsky et al., 
2006a).  
Certain glc7 alleles suppress the temperature sensitivity of ipl1 mutants, indicating that kinase and 
phosphatase activity must be strictly balanced (Francisco et al., 1994; Hsu et al., 2000; Pinsky et al., 
2006a). A further indication for the necessity of this kinase to phosphatase balance is the finding that 
overexpression of Glc7 targeting subunits, which are thought to decrease nuclear Glc7 activity, also 
partially suppress the ipl1 ts phenotype. Hence, overexpression of the Glc7 interactors GLC8, SCD5, 
BUD14, GIP3, GIP4, and to a lesser extent SDS22, SOL1, SOL2, and PEX31 suppressed ipl1 
temperature sensitivity (Pinsky et al., 2006a). Furthermore, ipl1 is suppressed by lack of Shp1 ((Cheng 
and Chen, 2010) and Results), again arguing in favor of the required balance. 
According to the prevalent model, Ipl1 senses incorrect attachments lacking tension during metaphase 
and phosphorylates a critical kinetochore component, possibly Dam1. Glc7 then reverses this 
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modification and thereby allows microtubule (re-)attachment. This eventually leads to correct bi-polar 
attachment and cell cycle progression (Pinsky et al., 2006b; Cannon, 2010). Although Dam1 
phosphorylation is reduced in response to tension at the kinetochore, the role of Glc7 in (tension-
dependent) dephosphorylation of Dam1 has been questioned (Keating et al., 2009). Yet there are 
other possible targets that may fulfill this function, Ndc10 or Ndc80, the mammalian homolog of which 
has recently been shown to be a target of PP1 (Deluca et al., 2011).  
Furthermore, PP1 reverses phosphorylation events that occur during spindle assembly checkpoint 
activation (Pinsky et al., 2009; Vanoosthuyse and Hardwick, 2009). GLC7 overexpression is toxic in 
wild-type cells (Zhang et al., 1995). Upon release from G1 arrest, overexpression of GLC7 leads to a 
Bub2 independent cell cycle arrest before mitotic exit with a high rate of chromosome missegregation. 
This suggests that GLC7 overexpression bypasses the spindle checkpoint and causes an additional 
defect in mitotic exit (Pinsky et al., 2009). Consequently, it could be demonstrated that Glc7 is required 
for spindle checkpoint silencing, both in response to lack of attachment and lack of tension. Cells 
overexpressing GLC7 do not activate the SAC in presence of nocodazole or cohesin defects. glc7-10 
mutants, however, are hypersensitive to constitutive SAC activation by MPS1 overexpression and are 
delayed in recovery from transient checkpoint arrest (Pinsky et al., 2009). This was similarly shown in 
S. pombe, where kinetochore localized PP1Dis2 is required for spindle checkpoint silencing 
(Vanoosthuyse and Hardwick, 2009).  
As ipl1 mutants are checkpoint proficient in response to spindle depolymerization, it is conceivable 
that Glc7 opposes additional kinases, possibly Mps1, during spindle checkpoint silencing (Pinsky et 
al., 2009). The mitotic function of Glc7 may therefore not be restricted to opposing Ipl1 kinase activity.  
The nuclear targeting subunit(s) required for the mitotic functions of Glc7 has not been identified with 
certainty. Several targeting subunits localize to the nucleus and could therefore possibly regulate the 
cell cycle functions of Glc7. Sds22 is an essential nuclear targeting subunit of Glc7, extra copies of 
which partially suppress the mitotic arrest phenotype of the glc7-12 allele (Hisamoto et al., 1995; 
MacKelvie et al., 1995). sds22 alleles display high rates of chromosome loss, as do glc7 alleles, but 
do not have a distinct mitotic arrest phenotype. However, sds22-6 suppresses the ts phenotype of 
ipl1-2, most likely by reducing nuclear localization of Glc7 (Peggie et al., 2002). Therefore Sds22 was 
suggested to be the mitotic regulator of Glc7 (Peggie et al., 2002). However, SDS22 was also isolated 
as a dosage suppressor of ipl1-321, arguing against this model (Pinsky et al., 2006a).  
Ypi1 has been shown to form a ternary complex with Sds22 and Glc7 in the nucleus (Pedelini et al., 
2007; Bharucha et al., 2008). Depletion of YPI1 or mutation of its Glc7 binding site leads to a mitotic 
arrest dependent on the spindle assembly checkpoint, similar to phenotypes of glc7 alleles. 
Additionally, the Glc7 binding mutant of Ypi1, and a loss-of function allele, both rescue ipl1-2 mutants, 
while being inviable in combination with cell cycle alleles of glc7 (Bharucha et al., 2008).  
Furthermore, the cell cycle regulated protein Fin1 has been demonstrated to be a PP1 targeting 
subunit that recruits Glc7 to the outer kinetochore. Fin1 was shown to interact with Glc7 and to be 
required for the majority of the Glc7 interaction with the kinetochore proteins Ndc80 and Dsn1 
(Akiyoshi et al., 2009b). A fin1-5A phospho-mutant was toxic when overexpressed and led to 
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monopolar spindles without SAC activation (Woodbury and Morgan, 2007). This was caused by 
misregulation of Glc7 activity at the kinetochore, which resulted in premature SAC silencing (Akiyoshi 
et al., 2009b). However, Δfin1 cells do not display a cell cycle or growth defect, are not sensitive to 
benomyl, and are not defective in SAC silencing, making it very likely that other PP1 targeting subunits 
that recruit Glc7 to the kinetochore must exist (Akiyoshi et al., 2009b).  
The positive regulator of Glc7, Glc8, has also been demonstrated to genetically interact with ipl1 
mutants. GLC8 was described in the initial genetic screen for mutants with a glycogen storage 
deficiency (Cannon et al., 1994). glc8 mutants exhibited the least pronounced reduction of cellular 
glycogen levels among the indentified mutants. The GLC8 gene shows sequence homology to the 
mammalian PP1 inhibitor-2 (I-2) (Cannon et al., 1994), and similar to I-2, Glc8 is a heat-stable protein 
that inhibits Glc7 and PP1c activity in vitro, albeit not as efficiently as I-2 (Tung et al., 1995).  
Increased dosage of GLC8 was found to suppress the temperature sensitivity of ipl1-1 (Tung et al., 
1995). Therefore, as expected, GLC8 overexpression suppressed the temperature sensitivity of 
sli15-3, a mutant of the Ipl1 activating INCENP homolog Sli15 (see 2.2.1) (Kim et al., 1999). 
Intriguingly, deletion of GLC8 also suppressed the ts phenotype of ipl1-1 and chromosome gain 
inflicted by GLC7 overexpression, indicating that Glc8 is required for Glc7 activity (Tung et al., 1995). 
Consistently, it was demonstrated that lysates of Δglc8 cells exhibit reduced PP1 activity (Tung et al., 
1995; Nigavekar et al., 2002; Wilson et al., 2005). Furthermore, Glc8 has been shown to mediate the 
increase of Glc7 activity in stationary phase upon glucose reduction (Nigavekar et al., 2002). Glc8 is 
therefore considered to be a positive regulator of Glc7 activity in vivo, becoming inhibitory only when it 
is overexpressed (Tung et al., 1995). 
Mammalian I-2 is phosphorylated at residue T72 (Hemmings et al., 1982; Park et al., 1994). The 
equivalent residue T118 in Glc8 was shown be phosphorylated and to affect the ability to rescue 
ipl1-1. Mutations of Glc8 T118 to alanine, aspartate, or glutamate enhanced the suppression of the 
ipl1 temperature sensitivity (Tung et al., 1995). The cyclin dependent kinase Pho85 in conjunction with 
the redundant cyclins Pcl6, Pcl7, Pcl8, and Pcl10 was identified to be responsible for the 
phosphorylation of Glc8 T118 in vivo (Tan et al., 2003). Additionally, it was demonstrated that the 
phosphorylation of T118 is necessary for Glc8 function, as a glc8T118A mutant was defective in 
glycogen accumulation and not able to rescue the lethality of the Δglc8 glc7R121K double mutant. 
Consistently, a negative genetic interaction between the glc7R121K allele and pho85 or pcl mutations 
has been observed (Tan et al., 2003). The Pho85 cyclins Pcl6 and Pcl7 mainly regulate glycogen 
metabolism and growth on alternate carbon sources, Pcl8 and Pcl10 regulate glycogen synthase. 
Interestingly, Pho85Pcl7 activity is highest in S-phase and it was thus speculated that Glc8 may also 
regulate cell cycle functions of Glc7 (Tan et al., 2003). 
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2.5 Aim of the work 
In contrast to p97p47 in higher eukaryotes, no function or critical substrate of the Cdc48Shp1 complex in 
S. cerevisiae had been identified at the beginning of this work. Therefore, this study was initially 
thought to identify Cdc48Shp1 substrates and eventually to determine cellular Cdc48Shp1 function(s). To 
address this, Y2H screens with mutant baits were to be performed and interactors published in large-
scale approaches to be verified. 
Additionally, the binding of Shp1 to Cdc48 and possible posttranslational modification of Shp1 were to 
be analyzed in further detail. This should then enable the construction of shp1 mutants with defined 
defects in either Cdc48-binding or modification.  
Null alleles of shp1 exhibit reduced Glc7 phosphatase activity, and Shp1 is therefore thought to be a 
positive regulator of PP1 function in vivo (Zhang et al., 1995). However, the mechanism of this 
regulation is unknown. Therefore, the main focus of the following work was to address the relationship 
of Shp1 and Glc7. To this end, shp1 cell cycle phenotypes were to be analyzed in the context of Glc7 
deregulation. Furthermore, the involvement of the Cdc48Shp1 complex in this process was to be 
investigated using the engineered shp1 mutants. Finally, possible mechanisms of Glc7 regulation by 
Shp1 should be analyzed.  
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3. Results 
3.1 Phenotypic characterization of shp1 mutants 
The budding yeast gene SHP1 was first described during a genetic screen for suppressors of high-
copy protein phosphatase 1 (Glc7). The two identified shp1 alleles displayed phenotypes similar to 
glc7 alleles (Zhang et al., 1995). Furthermore, it has also been demonstrated that deletion of SHP1 
affects protein degradation (Schuberth et al., 2004; Schuberth, 2006), and numerous large-scale 
screens have identified drug sensitivities of shp1 (SGD, www.yeastgenome.org/). In order to gain 
more insight into the cellular function of Shp1, the phenotypes of shp1 null alleles in different strain 
backgrounds were analyzed in further detail.  
3.1.1 Null mutation of shp1 causes a general growth defect 
shp1 spores exhibited very strong growth defects directly after tetrad dissection. Deletion of SHP1 in 
the DF5 strain background led to impaired growth at all temperatures analyzed and lethality at 37°C or 
below 16°C (Fig. 13 and data not shown). 
 
Fig. 13. shp1 null mutants exhibit a severe growth defect and temperature sensitivity. Fivefold serial dilutions of cultures 
of wild-type (WT) and shp1 null mutant strains were spotted onto YPD plates and incubated at the indicated temperatures.  
The Δshp1::kanMX6 strain was constructed by replacing the SHP1 ORF with a cassette carrying the 
G418 resistance (Braun et al., 2002; Schuberth, 2006). In some cases this method of gene deletion 
may lead to unwanted secondary effects caused by partial truncation of promoter or terminator 
sequences of adjacent genes. PTH2 is located 100 bp downstream of the SHP1 locus, making it 
possible that deletion of SHP1 interferes with the terminator of PTH2. Since Pth2 has been described 
to negatively regulate the ubiquitin proteasome system (Ishii et al., 2006) this was of concern. To 
exclude the possibility that some of the phenotypes of Δshp1 were caused by partial inactivation of 
PTH2 further experiments were conducted. First, a new shp1 deletion strain (shp1-400) was 
constructed, in which the cassette replacing the SHP1 ORF was truncated at the C-terminus, leaving 
the last 400 bp of the SHP1 gene intact and therefore most likely ensuring the integrity of the PTH2 
terminator. Secondly, Δshp1::kanMX6 was transformed with a centromeric plasmid encoding PTH2. 
Both approaches could not suppress or rescue any tested Δshp1 phenotype, including general growth 
and temperature sensitivity. To additionally rule out the possibility that the kanMX6 cassette itself had 
an unanticipated negative effect on growth, a third step was taken and a null allele of shp1 was 
constructed by a pop-in/ pop-out strategy. This method of strain construction enables replacement or 
mutation of parts of the endogenous ORF without constitutive integration of marker cassettes. In the 
shp1-7 allele the SHP1 start codon was replaced by ACC, leading to a null allele of shp1 (Fig. 13). 
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This strain is very similar to shp1-2, one of the two shp1 alleles identified in the initial PP1 suppressor 
screen, which is also a shp1 null allele in result of a mutated start codon (Zhang et al., 1995). The 
phenotypes of Δshp1 and shp1-7 were compared and no striking differences in growth (Fig. 13), 
sensitivity to drugs, or cell cycle phenotypes (see below) found. One difference, however, was the fact 
that homologous recombination in Δshp1 seemed to be partially defective, often yielding unexpected 
results, such as ORF duplication upon C-terminal epitope tagging or multiple integration events when 
using integrative plasmids. For all tested strain constructions in shp1-7, these aberrant recombination 
events were not observed. Other recombination defects can, however, formally not be ruled out, as no 
assays directly addressing homologous recombination activity were performed in either strain. 
Nonetheless, Δshp1 and shp1-7 strains were used in parallel, favoring the shp1-7 strain when 
possible.  
3.1.2 W303 Δshp1 is inviable 
Surprisingly, it was not possible to delete SHP1 in certain yeast strain backgrounds and further 
analysis revealed that shp1 was lethal in most strain backgrounds derived from W303, but not those 
directly descending from S288C, like DF5. Heterozygous deletion of SHP1 in W303 zygotes and 
subsequent sporulation yielded only wild-type spores,  Δshp1 spores were not viable (Fig. 14). The 
specificity of this lethality was confirmed by rescuing W303 Δshp1 by plasmid borne SHP1 (Fig. 14a). 
 
Fig. 14. SHP1 is essential in the W303 strain background. a) Rescue of Δshp1 lethality in W303 by a plasmid encoding 
wild-type SHP1. Indicated strains were first streaked on 5’FOA to counter-select against the rescuing YC33-SHP1 plasmid used 
for sporulation. Cultures of W303 Δshp1 carrying an empty YC plasmid or YC-SHP1 were then spotted in fivefold dilutions onto 
YPD plates and incubated at RT. b) Lethality of W303 Δshp1 is suppressed by 1M Sorbitol. Fivefold serial dilutions of cultures of 
haploid spores derived from one tetrad of sporulated W303 Δshp1/SHP1 were spotted on YPD or YPD/1 M Sorbitol. Plates were 
incubated at RT. 
The finding that shp1 deletion mutants are viable in one yeast strain background, but not the other, 
prompted the question what the major difference between these two backgrounds is. The rad5-535 
mutation present in the original W303 strain was one obvious possibility (Fan et al., 1996). However, 
deletion of SHP1 in W303 RAD5+ also did not result in any viable Δshp1 spores (data not shown). 
Another described difference between S288C and W303 is the polymorphic gene SSD1. Different 
alleles of SSD1 have been identified and named according to their ability to suppress the lethality of a 
SIT4 deletion. The strain backgrounds W303 and YP6D, in which deletion of SIT4 is lethal, contain 
ssd1-d2 and ssd1-d1 (dead), respectively. S288C harbors the SSD1-v1 (viable) allele, which 
suppresses Δsit4 lethality (Sutton et al., 1991). Interestingly, SSD1 was one of two potential 
suppressors isolated from a high-copy suppressor screen for a shp1 mutant in W303 (data not 
shown). 
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Ssd1 has been described to promote cell wall integrity, and SSD1-v1 can suppress the temperature 
sensitivity of mutations of the Pkc1 downstream kinase Bck1 (Costigan et al., 1992; Kaeberlein and 
Guarente, 2002). Pkc1 (protein kinase C) is a central regulator of cell wall integrity and promotes 
transcription of cell wall biosynthetic genes. Mutants in the Pkc1 kinase pathway undergo cell lysis at 
high temperatures due to a deficiency in cell wall construction. This cell lysis phenotype can be 
rescued by high extracellular osmolarity or PKC1 overexpression (Kamada et al., 1995; Kaeberlein 
and Guarente, 2002).  
Interestingly, both the lethality of W303 Δshp1 and the temperature sensitivity (ts) phenotype of DF5 
Δshp1 could be suppressed by 1 M Sorbitol (Fig. 14b and data not shown). This indicates that these 
phenotypes may be due to cell wall defects resulting in cell lysis. A defect in cell wall morphogenesis 
could in turn be sensitive to different SSD1 alleles and thereby cause lethality of W303 Δshp1. This 
assumption is supported by the finding that shp1 null mutants are sensitive to the fluorescent dye 
calcofluor white, indicative of a cell wall defect ((Ando et al., 2007) and data not shown).  
If the mutant allele ssd1-d2, which is considered a null allele of ssd1 in regard to its function in cell wall 
maintenance (Kaeberlein and Guarente, 2002), were responsible for the lethality of W303 Δshp1, then 
Δssd1 Δshp1 should be lethal in any strain background. Moreover, expression of SSD1-v1 in W303 
Δshp1 should rescue the lethality. Indeed, a strong negative genetic interaction between Δssd1 and 
Δshp1 has been reported in a large-scale genetic screen (Collins et al., 2007), performed in the 
S288C derived background BY4743 (Brachmann et al., 1998). However, expression of DF5 derived 
SSD1 did not clearly rescue W303 Δshp1 when expressed from its endogenous promoter on a low 
copy plasmid (data not shown). Since Δshp1 in DF5 exhibits a strong growth defect, a low copy 
number of SSD1 may not be sufficient to rescue growth. Thus, SSD1 still is a potential candidate for 
the difference in Δshp1 viability between strain backgrounds.  
3.1.3 Pleiotropic defects of shp1 mutants 
In addition to temperature sensitivity null mutation of shp1 led to pleiotropic defects on most stress 
plates tested. Among others, Δshp1 was sensitive to the heavy metal Cadmium, the double-strand 
break inducing drug zeocin, and the translation inhibitor cycloheximide (CHX) (Fig. 15). Additionally, 
Δshp1 was sensitive to the spindle depolymerizing agent benomyl (Fig. 25a) and calcofluor white 
(CFW) ((Ando et al., 2007) and data not shown).  
Due to the variability of Δshp1 phenotypes between individual strain backgrounds, as discussed above 
for DF5 and W303, drug sensitivities were analyzed not only using DF5 Δshp1, but also using the two 
shp1 alleles in the RCY background identified in the initial GLC7 suppressor screen (Zhang et al., 
1995) (Fig. 15).  
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Fig. 15. shp1 null mutants are hypersensitive to various drugs. Fivefold serial dilutions of cultures of the indicated strains 
were spotted on control YPD and plates containing 15μM CdCl2, 0.3 μg/ml cycloheximide (CHX), 1 μg/ml zeocin, or 100 mM 
hydroxyurea (HU). 
Comparing shp1 null mutations in the DF5 and the RCY strain backgrounds on YPD again 
demonstrated that lack of Shp1 causes a significant growth defect. This is important to stress, as it 
further confirms that introduction of the kanMX6 cassette into the SHP1 locus did not result in a 
completely SHP1-unspecific impairment of growth. DF5 Δshp1 and the shp1 alleles from the original 
GLC7 suppressor screen are zeocin and cycloheximide sensitive, whereas the cadmium sensitivity is 
only pronounced in the DF5 background (Fig. 15). Hypersensitivity towards the dNTP depleting agent 
hydroxyurea (HU) was neither detectable for DF5 Δshp1, nor for the shp1-1 or shp1-2 allele (Fig. 15). 
This may suggest that shp1 mutants are more sensitive towards specific forms of DNA damage, such 
as double strand breaks induced by zeocin. 
In summary, null mutation of shp1 in any strain background resulted in a severe growth defect or even 
lethality. Furthermore, shp1 mutants were sensitive to numerous drugs and stress conditions. Shp1 
therefore fulfills important functions that are required for normal cell growth and viability. As Shp1 has 
been described as a cofactor of Cdc48 (Braun et al., 2002; Schuberth et al., 2004; Rumpf and 
Jentsch, 2006), it is likely to regulate critical cellular pathways as part of the Cdc48Shp1 complex. 
3.2 The Shp1-Cdc48 interaction  
3.2.1 Cdc48 binding mutants of shp1 
Shp1 has been demonstrated to strongly interact with the N-domain of Cdc48. This interaction is 
mediated by the UBX domain and a second binding site (BS1) of Shp1 (Bruderer et al., 2004; Hitt and 
Wolf, 2004; Schuberth et al., 2004; Neves, 2005; Sato and Hampton, 2006). Point-mutations of 
conserved residues within BS1 and the UBX domain were shown to abolish binding of Shp1 to Cdc48 
in yeast two hybrid (Y2H) and in vitro GST-pulldown experiments (Neves, 2005). Additionally, further 
detailed bioinformatic analysis of the Shp1 protein sequence identified a third potential Cdc48 binding 
site within the unstructured region between the UBA and SEP domains (Kay Hofmann and Alexander 
Buchberger, unpublished results). To further characterize Shp1 binding to Cdc48 in vivo, yeast strains 
only expressing mutant variants of Shp1 were analyzed in co-immunoprecipitation experiments 
(Fig. 16).  
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Fig. 16. Construction of shp1 mutants defective in Cdc48 binding. a) Schematic overview of the different engineered Cdc48 
binding mutants of Shp1. Mutated residues are depicted in bold letters or as stars in the schematic overview. b) Co-
immunoprecipitation of Cdc48 with the Shp1 mutants. Lysates of the indicated shp1 mutant strains were subjected to 
immunoprecipitation with Shp1 antibodies. Co-immunoprecipitation of Cdc48 was detected by Western blot against Cdc48. 
SHP1 and shp1-7 serve as controls. 
Different combinations of point-mutations in BS1 and the R…FPR (FPI) motif, as well as deletion 
mutants of the UBA and UBX domains, were tested for their ability to interact with Cdc48 (Fig. 16).  
Deletion of the UBX domain noticeably reduced the interaction of Shp1ΔUBX with Cdc48, but did not 
abolish binding completely (Fig. 16b). Mutation of the FPR motif to G—or deletion of the UBA domain 
(Shp1-a5 and Shp1ΔUBA, respectively) did not influence the interaction with Cdc48 (Fig. 16b). This was 
expected for the deletion of the UBA domain, but somewhat surprising for Shp1-a5, as additional 
mutation of the arginine of the R…FPI motif strongly reduced Cdc48 binding (Shp1-a4). Thus, these 
results suggest that the arginine in strand 1 of the UBX domain is the major determinant in mediating 
the interaction of the Shp1 UBX domain with Cdc48. This is in some contrast to what has been 
reported for p47, as the FPR motif was demonstrated to mediate the interaction of p47 with p97. 
However, mutation of the preceding arginine in p47 also significantly reduced binding of p97 (Dreveny 
et al., 2004). This discrepancy may reflect a difference between p47 and Shp1 or could be an effect of 
the different introduced amino acid substitutions.  
As expected from previous results of Y2H and in vitro studies (Neves, 2005), the Shp1-a1 mutant was 
unable to co-immunoprecipitate detectable amounts of Cdc48 (Fig. 16b). This Shp1 variant contains 
mutations in BS1 and the R…FPR motif of the UBX domain (Fig. 16a).  
Even though no interaction of Shp1-a1 with Cdc48 was detectable in Y2H, GST pull-down (Neves, 
2005), or co-immunoprecipitation, the possibility of a residual transient interaction remained. 
Considering the identification of a third putative Cdc48 binding motif within Shp1 (Kay Hofmann and 
Alexander Buchberger, unpublished results), a further binding mutant of Shp1 was constructed. 
Mutation of the UBX domain, BS1 and the newly identified third putative binding motif resulted in the 
triple binding mutant Shp1-b1 (Fig. 16a). As expected, Shp1-b1 did not bind any detectable amounts 
of Cdc48 (Fig. 16b). However, the mutated Shp1 protein migrated more slowly than all other full length 
Shp1 variants in SDS-PAGE, possibly indicating an altered posttranslational modification. Mutating 
this third binding site alone was sufficient to induce the altered migration pattern (data not shown), 
indicating that this was a direct effect of the introduced point-mutations and not an additive effect of 
mutating all Cdc48 interacting motifs. 
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Fig. 17. Binding of Shp1 to Cdc48 is required for normal growth. a) Loss of Cdc48 binding leads to temperature sensitivity 
in DF5. Fivefold serial dilutions of DF5 wild-type (WT) or shp1-7 cultures carrying the indicated shp1 binding mutants on 
YCplac111 plasmids were spotted on SC-Leu plates. Plates were incubated at the indicated temperatures. b) The binding 
mutant shp1-a1 causes a severe growth defect in W303. W303 Δshp1::kanMX6 YC33-SHP1 additionally transformed with the 
indicated plasmids was first streaked on 5’FOA to counter-select against the wild-type SHP1 plasmid. Cultures were then 
spotted in fivefold serial dilutions on SC-Leu plates and incubated at the respective temperatures.  
To address the cellular importance of the Cdc48-Shp1 interaction, different shp1 mutants were 
analyzed for possible growth defects (Fig. 17). Deletion of the UBX or UBA domains of Shp1 alone did 
not result in any general growth defect or temperature sensitivity, neither in the DF5 nor in the W303 
strain background (Fig. 17a,b). This is consistent with previous reports that deletion of the UBA 
domain of Shp1 does not affect Cdc48 binding of Shp1 or general growth (Schuberth, 2006).  
shp1-7 transformed with a plasmid encoding the Cdc48 binding mutant shp1-a1 was temperature 
sensitive at 37°C, but did not have a strong general growth defect resembling a shp1 null mutation 
(Fig. 17a). This was surprising, as it is expected that Shp1 fulfills most, if not all, of its cellular functions 
in complex with Cdc48. Therefore, abolishing the Shp1-Cdc48 interaction should result in a phenotype 
similar to the shp1 null allele. This could indicate that Shp1 either fulfills critical cellular functions 
independently of Cdc48, or that transient interaction with Cdc48 remains possible. Further strain 
construction and phenotypic analysis of a shp1-a1 mutant constructed by a pop-in/ pop-out strategy 
(shp1-a1 in Fig. 27,32,33) revealed that this strain did have growth defects similar to shp1 null 
mutants, albeit less severe. Therefore, the growth defect of shp1-a1 at normal temperatures appears 
to be less pronounced when analyzing shp1-7 transformed with YC-shp1-a1. This could be due to 
sporadic accumulation of suppressors, or reflect growth with or without additional plasmids. 
In contrast, the triple binding mutant, shp1-b1, exhibited phenotypes nearly identical to the shp1 null 
mutant (Fig. 17a). This was not due to the altered modification state of Shp1-b1, as the shp1 variant 
containing only mutations within the third binding site exhibited wild-type growth (data not shown).  
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That abolishing Shp1 binding to Cdc48, however, results in a relevant growth defect is supported by 
the finding that YC-shp1-a1 suppresses the lethality of W303 Δshp1, but exhibits severely impaired 
growth (Fig. 17b). Given the difference between W303 and S288C, which makes SHP1 essential, a 
full rescue of W303 Δshp1 by shp1-a1 would not have been expected. Furthermore, the phenotype 
observed in W303 would be consistent with the current model that Shp1 fulfills all of its critical cellular 
functions in complex with Cdc48. If Shp1-a1 indeed transiently interacts with Cdc48, and this is 
required for viability in W303, then the triple binding mutant shp1-b1 should be inviable in W303.  
3.2.2 Ubiquitination of Shp1 depends on Cdc48 binding 
In Western blot analysis of Shp1 several more slowly migrating species could be observed, indicating 
possible posttranslational modification. Indeed, Shp1 was distinctly ubiquitinated by multiple ubiquitin 
moieties (Fig. 18). Lysates of a strain expressing endogenous Shp17His and overexpressing 
mycubiquitin were subjected to denaturing Ni-NTA pull-down and subsequent stringent myc-
immunoprecipitation (Fig. 18a). This two step purification that first enriches Shp1 and then 
ubiquitinated proteins, clearly demonstrated that Shp1 is covalently modified by ubiquitin in vivo.  
 
Fig. 18. Shp1 is ubiquitinated in vivo. a) Two-step purification of ubiquitinated Shp1. Yeast strains expressing Shp17His and 
strains additionally overexpressing mycubiquitin were first subjected to a denaturing Ni-NTA pull-down (PD) and subsequently to 
myc immunoprecipitation. Ubiquitinated Shp1 was detected by Western blot using Shp1 antibodies. b) Shp1 is not modified by 
K63-linked ubiquitin chains. Denaturing Ni-NTA pull-down from lysates of wild-type (WT) and WT overexpressing either 
Hisubiquitin or Hisubiquitin K63R. Western blot against Shp1. c) Shp1 ubiquitination depends on Cdc48 binding. Denaturing 
Ni-NTA pull-down of Hisubiquitin from lysates of WT or shp1-a1 cells overexpressing Hisubiquitin. Western blot against Shp1. 
As five to six distinct bands of modified Shp1 could be detected, it is unlikely that these are K48-linked 
ubiquitin chains marking the protein for proteasomal degradation. Additionally, Shp1 is very stable 
over hours and therefore the majority of the protein is presumably not subjected to proteasomal 
degradation ((Schuberth, 2006) and data not shown). Since K63-linked ubiquitin chains do not result in 
proteasomal degradation of the substrate, it was addressed if Shp1 is modified by a ubiquitin chain of 
this linkage type. Overexpression of wild-type and mutant K63R Hisubiquitin in the DF5 background did 
not result in significantly different ubiquitination patterns of Shp1 (Fig. 18b). Since the effect of K63R 
ubiquitin may have been masked by endogenous wild-type ubiquitin, this experiment was repeated in 
a strain background in which K63R ubiquitin is the only source of ubiquitin (Spence et al., 1995). 
However, pull-downs of K63R Hisubiquitin in this strain led to the same result, K63R had no effect on 
the pattern of Shp1 modification (data not shown).  
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As the modified bands of Shp1 are very distinct and highly reproducible, multiple mono-ubiquitination 
is conceivable. A further possibility could be mixed chains of Smt3 (SUMO) and ubiquitin assembled 
on Shp1. HisSmt3 pull-downs, however, did not contain any detectable Shp1 species, while the low 
abundant Smt3-modified Cdc48 was detectable (data not shown).  
Interestingly, the Cdc48 binding mutant of Shp1 (Shp1-a1) was not ubiquitinated (Fig. 18c). Mutation 
of the Cdc48 binding sites, BS1 and the R…FPR motif, did not affect any lysine residues. It is 
therefore unlikely that the loss of ubiquitination is a direct consequence of the introduced point 
mutations in Shp1-a1. Furthermore, ubiquitination of Shp1ΔUBX was also reduced, but not completely 
abolished (data not shown). Hence, the reduction of Shp1 ubiquitination presumably correlates with 
the degree of residual Cdc48 binding. Therefore it is plausible that Shp1 is ubiquitinated upon Cdc48 
binding. The in vivo function of this ubiquitination remains to be identified. 
To address the functional aspect of this modification the critical lysine residue was thought to be 
identified and later specifically mutated for phenotypic analysis. However, mutagenesis of random 
combinations of all 23 lysines failed to identify a critical target for ubiquitination (data not shown). 
Nonetheless, the fact that one or two forms of Shp1 ubiquitination could be reduced, while others were 
unaffected, argues against a chain of any linkage type. 
As the critical lysine(s) could not be determined, attempts to identify the responsible E2 conjugating 
enzyme were undertaken. The only reduction of Shp1 ubiquitination was detected in deletion mutants 
of the redundant “housekeeping” E2s Ubc1, Ubc4, and Ubc5 (data not shown). Thus, no relevant 
information regarding the potential Shp1 function was gained from this approach.  
3.3 Shp1 is modified by phosphorylation 
In addition to the demonstrated ubiquitination, Shp1 was also reported to be posttranslationally 
modified by phosphorylation (Ficarro et al., 2002; Gruhler et al., 2005; Li et al., 2007; Smolka et al., 
2007; Albuquerque et al., 2008). The mammalian homolog of Shp1, p47, is phosphorylated on residue 
S140 by Cdc2 (Cdk1). p47 is mainly localized to the nucleus in interphase cells. During mitosis, as 
p47 enters the cytoplasm due to nuclear envelope breakdown, phosphorylation by Cdk1 inhibits 
binding of p47 to Golgi membranes. In late mitosis p47 is dephosphorylated by an unknown 
phosphatase, enabling binding of p47 to Golgi membranes and Golgi reassembly (Uchiyama et al., 
2003).  
However, yeast undergoes a closed mitosis, and phosphorylation would not be necessary to inhibit 
premature binding to cytosolic targets. Furthermore, this specific Cdk1 target site is not conserved in 
Shp1. Nevertheless, phosphorylation could regulate Shp1 function or localization. Five major 
phosphorylation sites within Shp1 have been identified in several large-scale mass-spectrometric 
analyses: S106 (Ficarro et al., 2002; Albuquerque et al., 2008), S108 (Ficarro et al., 2002; Smolka et 
al., 2007; Albuquerque et al., 2008), S315 (Gruhler et al., 2005; Li et al., 2007; Smolka et al., 2007; 
Albuquerque et al., 2008), S321 (Smolka et al., 2007; Albuquerque et al., 2008), S322 (Li et al., 2007; 
Albuquerque et al., 2008). Additionally, six further putative phosphorylation sites within Shp1 have 
been identified (S93, S94, S97, S155, S210, S226) (Albuquerque et al., 2008). 
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Fig. 19. Phosphorylation of Shp1 at residues S106, S108, S315, S321, and S322 is not required for normal growth. 
a) Schematic overview of phosphorylated residues identified by mass-spectrometry of affinity purified Shp1myc7His. 
b) λ-phosphatase assay of yeast whole cell lysates. Lysates of stationary WT or Δshp1 YI-shp1SS106/108AA strains were incubated 
with phosphatase inhibitors and, or λ-phosphatase. Multiple phosphorylated forms of Shp1 could be detected by Western blot 
against Shp1. c) Temperature sensitivity of shp1-7 is rescued by all tested combinations of serine to alanine mutants of Shp1. 
shp1-7 was transformed with plasmids encoding the indicated serine to alanine mutants of Shp1. Fivefold serial dilutions were 
spotted on SC-Leu plates and incubated at 25°C and 37°C. shp15A is a mutant containing all five serine to alanine mutations.  
To address potential phosphorylation, modification of Shp1 in asynchronously growing cells under 
non-stressed conditions was analyzed. In order to increase sensitivity and to reduce unspecific 
background, Shp1myc7His was purified using denaturing Ni-NTA pull-downs and subsequent stringent 
myc-immunoprecipitation. Mass-spectrometric analysis without prior enrichment of phosphorylated 
peptides (Frank Siedler; MPI of Biochemistry, Martinsried) identified the known phosphorylation sites 
S106, S108, and S315 (Fig. 19a). Treatment of yeast lysates with λ-phosphatase further 
demonstrated that Shp1 was indeed phosphorylated in vivo. Stationary yeast cultures were lysed and 
treated with λ-phosphatase, phosphatase inhibitors, or both (Fig. 19b). Several more slowly migrating 
forms of Shp1 were noticeably reduced in samples treated with λ-phosphatase, but still detectable in 
samples to which phosphatase inhibitors had been added. This indicates that Shp1 is phosphorylated 
in vivo. Furthermore, a variant of Shp1, in which the two phosphorylation sites S106 and S108 had 
been mutated to alanine, migrated similarly to the dephosphorylated form of Shp1 in SDS-PAGE 
independently of phosphatase treatment. This indicates that S106/108 is a major phosphorylation site 
in Shp1 during stationary phase (Fig. 19b). However, the Shp1 serine to alanine mutants of residues 
106, 108, 315, 321, and 322 were able to suppress the growth defect as well as the temperature 
sensitivity of shp1-7 (Fig. 19c), demonstrating that phosphorylation at these sites is not required for 
normal growth. 
3.4 Identification of novel Shp1 interactors  
To identify Shp1 interactors and possibly substrates of the Cdc48Shp1 complex, robot-based yeast two 
hybrid (Y2H) screens and co-immunoprecipitation experiments were conducted.  
First two individual Y2H screens were performed, one using full-length wild-type Shp1 and the other 
using a mixture of two Cdc48 binding mutants as baits (Shp1ΔUBX with a mutated BS1 and Shp1-a1). It 
was reasoned that potential substrates of Cdc48Shp1 may be processed very quickly, making an 
interaction undetectable using the Y2H system. Therefore the Cdc48 binding mutants were used, as 
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potential substrates could interact with Shp1 but not subsequently be turned over by Cdc48. Over all, 
the screen using the mixture of two binding mutants as baits resulted in a much higher number of false 
positive interactors. The ten most strongly interacting candidates were cloned, but could not be 
verified in directed Y2H experiments (data not shown). However, Ndc80 (Tid3) was identified as a 
potential interactor on the less stringent plates during this screen. Interestingly, this candidate had 
previously also been found in a conventional Y2H screen using the same Shp1 mutants as baits 
(Neves, 2005).  
The robot-based screen using full-length Shp1 as the bait identified Cue3, Ygl108c, and Ynl155w as 
potential Shp1 interactors. The latter two candidates as well as Hda2, Tem1, and Nut2 had been 
identified as Cdc48 and Shp1 interactors in a large-scale TAP-approach (Krogan et al., 2006).  
YGL108c and YNL55w are two non-essential uncharacterized yeast ORFs that have no described 
function or reported sensitivities of the corresponding deletion mutants. Ynl155w contains a predicted 
N-terminal AN1-type zinc finger domain and localizes to the cytoplasm and the nucleus (SGD, 
www.yeastgenome.org/). Ygl108c is predicted to be palmitoylated and distinctly localizes to the cell 
periphery ((Ren et al., 2008) and data not shown). Additionally, it has been demonstrated that Ygl108c 
binds to Cdc48 via a distinct linear binding motif within its C-terminus (Christopher Stapf et al., 
manuscript in preparation). Hda2 is a subunit of the Hda1 histone deacetylase complex required for 
function (Wu et al., 2001). The essential protein Nut2 is a component of the mediator complex, which 
is a co-activator of RNA Polymerase II dependent transcription (Gustafsson et al., 1998). The GTP 
binding protein Tem1 controls mitotic exit and Ndc80 is a central component of the outer kinetochore 
(see Introduction). 
 
Fig. 20. Yeast two hybrid interaction analysis of Cdc48, Shp1, Ubx6, and Ubx7 with Cue3, Ygl108c, Ynl155w, Hda2, 
Tem1, and Ndc80. PJ69-4A cells were transformed with the indicated combinations of bait (BD) and prey (AD) plasmids and 
were spotted on SC plates lacking tryptophan and leucine (control) or additionally lacking histidine (-His), lacking histidine and 
supplemented with 3 mM 3AT (-His + 3AT), or lacking adenine (-Ade). 
To confirm that the identified candidates indeed interact with Shp1, they were analyzed in directed 
Y2H assays. In addition, candidates were also tested for their interaction with Cdc48, Ubx6 and Ubx7 
(Fig. 20). Yet none of the tested candidates interacted with Ubx6 or Ubx7. Among the putative 
interactors Ynl155w interacted most strongly with Shp1 and Cdc48 and allowed growth on all plates, 
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including the stringent SC–Ade plate. The interaction of Ynl155w with Shp1 was dependent on Cdc48 
binding of Shp1, as it was completely abolished when the binding mutant Shp1-a1 was used as the 
bait (data not shown). Ygl108c showed interaction with Shp1 and Cdc48 on the least stringent SC-His 
plate, but grew only in combination with Cdc48 on the more selective SC-His+3 AT and SC-Ade 
plates. Interaction of Cue3, Hda2, Tem1, and Nut2 with Shp1 or Cdc48 could not be confirmed using 
the Y2H system (Fig. 20 and data not shown). Ndc80 and Shp1 interact, as growth on the SC-His 
plate indicates. This interaction was not abolished when the binding mutants of Shp1 were used as 
baits (data not shown). However, the Ndc80 construct was also partially auto-activating, allowing 
some growth on SC–His when only the empty vector was co-transformed. Nonetheless, no growth 
was observed in combination with Cdc48, Ubx6, and Ubx7, making Ndc80 a possible direct interactor 
of Shp1. 
To further verify the Y2H results and to address interaction in vivo, co-immunoprecipitation 
experiments were performed. All candidate interactors were C-terminally tagged with either 9myc or 
3HA epitopes and immunoprecipitated from yeast lysates. Co-immunoprecipitation of Shp1 or 
Shp19myc, as well as Cdc48 was analyzed by Western blot (Fig. 21a,b). 
 
Fig. 21. Verification of putative Shp1 interactors by co-immunoprecipitation. a) Co-immunoprecipitation (IP) of Shp19myc 
and Cdc48 with C-terminally 3HA epitope tagged potential interactors Cue3, Ygl108c, and Ynl155w. Western blot against 
Cdc48, Shp1 and HA. Immunoprecipitation of Shp13HA and co-IP of Cdc48 serves as a control. b) Co-IP of Shp1 and Cdc48 with 
C-terminally 9myc tagged potential interactors Hda2, Tem1, and Nut2. Western blot against Cdc48, Shp1 and myc. 
With the exception of Cue3 all tested candidates could be verified as in vivo interactors of Shp1, and 
in most cases interactors of Cdc48. However, analysis of co-immunoprecipitation of Shp1 with Ndc80 
from asynchronous cultures was not conclusive, as the immunoprecipitation of kinetochore structures 
resulted in a high degree of unspecific background binding (data not shown).  
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Taken together, the strongest candidates as Cdc48Shp1 interactors are the uncharacterized proteins 
Ygl108c and Ynl155w. However, these candidates do not bind Shp1 directly, but rather bind to Cdc48. 
Nonetheless, these interactors could be substrates of a Cdc48 sub-complex and were therefore 
further analyzed. 
All potential interactors were stable in a cycloheximide shut-off experiment, independent of 
proteasomal inhibition by MG132 (data not shown). Ynl155w expression was induced by MG132 
addition, which may not be unexpected, as an Rpn4 binding site has been predicted in its promoter. 
Therefore, there is no indication that these proteins are substrates of Cdc48 that are processed and 
subsequently degraded.  
Nevertheless, ubiquitination in vivo was detected for all epitope tagged interactors with the exception 
of Cue3 (data not shown). Most strikingly ubiquitinated was the essential MEN activator Tem1, 
although this did not noticeably depend on Shp1 (data not shown). However, as Tem1 levels have 
been reported to fluctuate during the cell cycle (Bardin et al., 2000) and Tem1 was confirmed as a 
Shp1 interactor (Fig. 21b), a potential role of Shp1 in cell cycle regulation was addressed in the 
following experiments.  
3.5 Cell cycle defect of shp1 
3.5.1 shp1 mutants exhibit a cell cycle delay in mitosis 
Further analysis of shp1 phenotypes revealed that asynchronous shp1 cells accumulate with 
replicated DNA, indicating a cell cycle delay after S-phase. Analysis of the DNA content by flow 
cytometry (FACS analysis) showed a significant accumulation of cells with 2 n DNA content in Δshp1 
compared to wild-type (Fig. 22a). In asynchronous wild-type cultures the ratio of cells in G1/S to G2/M 
is nearly equal with 43 ± 3% in G1/S and 56 ± 3% in G2/M (Fig. 22b). Asynchronous Δshp1 cultures, 
however, contain only 27 ± 6% cells in G1/S and 73 ± 6% in G2/M (Fig. 22b). The accumulation of 
Δshp1 cells in G2/M was further confirmed by releasing wild-type and Δshp1 cultures from a G1 arrest 
induced by addition of α-factor (Fig. 22c). Wild-type and Δshp1 strains both entered G2/M 
approximately 60 min after release. While wild-type cells initiated G1 of the following cell cycle after 
about 120 min, the majority of Δshp1 cells remained in G2/M throughout the entire time course of the 
experiment.  
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Fig. 22. ∆shp1 cells exhibit a cell cycle delay in mitosis. a) FACS analysis of DNA content. Cultures of asynchronously 
growing wild-type (WT) and ∆shp1 strains were fixed and the DNA was stained with propidium iodide. DNA content was 
measured by flow cytometry. b) Quantification of the percentage of cells in G1/S and G2/M. DNA content of cells during 14 (WT) 
or 18 (Δshp1) independent FACS experiments, using asynchronous logarithmic cultures, was quantified. c) FACS analysis of a 
release from a G1 arrest. Cultures of WT and ∆shp1 strains were arrested in G1 with α-factor, released, and DNA content was 
monitored by flow cytometry. FACS samples were collected every 20 min and DNA was stained with propidium iodide. d) 
α-factor arrest/ release. Exponentially growing WT and ∆shp1 CLN23HA strains were arrested in G1 with α-factor and released. 
Samples were taken every 20 min and Clb2 and Cln2 (HA) levels analyzed by Western blot. 
In order to obtain direct evidence for a mitotic delay, the protein levels of the G1 cyclin Cln2 and the 
mitotic cyclin Clb2 were analyzed. Cln2 is required for progression through START and is rapidly 
degraded after S-phase entry dependent on SCFGrr1 (Bloom and Cross, 2007). The mitotic cyclin Clb2 
is expressed during mitosis, ubiquitinated by APC/CCdc20 in early anaphase and by APC/CCdh1 upon 
mitotic exit, and completely degraded prior to the following G1 phase (Bloom and Cross, 2007). 
Wild-type and Δshp1 strains expressing Cln23HA were arrested in G1 by α-factor, released, and cell 
cycle progression was monitored by Western blot against Cln2 and Clb2 (Fig. 22d). Consistent with 
the FACS data, the fluctuation of Cln2 protein levels in wild-type and Δshp1 also indicated that Δshp1 
cells are delayed after the G1/S transition. Clb2 levels persisted significantly longer in  Δshp1 upon 
release from G1 arrest, again indicating a mitotic delay of Δshp1 cells.  
3.5.1.1 The cell cycle delay of shp1 is not due to a defect in mitotic exit 
The activator of the mitotic exit network (MEN), Tem1, was confirmed as a Shp1 interactor (Fig. 21b) 
and shp1 cells were demonstrated to exhibit a mitotic defect (Fig. 22). Therefore, one possibility was 
that Shp1 directly regulates or influences Tem1 and thereby mitotic exit. Deletion of SHP1 could cause 
deregulation of Tem1 activity and subsequently lead to defects in mitotic exit. This would in turn 
increase the G2/M cell population observed in FACS analysis and cause elevated Clb2 levels. To test 
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if Shp1 is involved in regulating mitotic exit several experimental approaches that had been previously 
used to identify MEN mutants were employed (Dumitrescu and Saunders, 2002).  
The main effector of the mitotic exit network is the phosphatase Cdc14, which is released from the 
nucleolus and activated. This release and activation of Cdc14 is essential for cells to exit mitosis 
(Dumitrescu and Saunders, 2002; Bloom and Cross, 2007). Consequently, mutants of the mitotic exit 
pathway can be rescued by CDC14 overexpression (Dumitrescu and Saunders, 2002).  
CDC14 overexpression was induced in Δshp1 and the MEN mutant cdc15-2. While overexpression of 
CDC14 clearly rescued cdc15-2 at the non-permissive temperature, it had no effect on Δshp1 growth 
at 37°C (Fig. 23a) or other temperatures, nor did it suppress the G2/M accumulation observed in 
FACS analysis (data not shown).  
 
Fig. 23. Shp1 is not an essential component of the mitotic exit network (MEN). a) Overexpression of CDC143HA to test for 
mitotic exit network (MEN) involvement. Cultures of the indicated strains were serially diluted and spotted on plates with 
(promoter off) or without methionine (promoter on). ∆shp1 temperature sensitivity is not rescued by CDC143HA overexpression, 
in contrast to the positive control cdc15-2. b) Mitotic exit is not delayed in Δshp1. Cultures of exponentially growing wild-type 
(WT) and ∆shp1 SIC13HA strains were arrested in metaphase with nocodazole and then released. Samples were taken every 
20 min and Clb2, HA (Sic1), and Cdc48 (loading control) levels analyzed by Western blot. 
Upon release from the nucleolus, Cdc14 dephosphorylates and stabilizes the APC/C activator Cdh1, 
the Cdc28-Clb inhibitor Sic1 and the transcriptional activator of SIC1 expression, Swi5 (Dumitrescu 
and Saunders, 2002; Lew and Burke, 2003). Hence, Sic1 levels rise as mitotic exit is executed and 
drop again in late G1, when Sic1 is degraded in an SCFCdc4 dependent manner (Feldman et al., 1997; 
Skowyra et al., 1997).  
Wild-type and Δshp1 SIC13HA cultures were released from a mitotic arrest induced by nocodazole 
treatment and Sic1 protein levels were analyzed (Fig. 23b). Both strains displayed a stabilization of 
Sic1 approximately 60- 80 min after the release, coinciding with a strong decrease in Clb2 levels in 
wild-type and to a lesser extent in Δshp1 cells. The less pronounced decrease of Clb2 levels in Δshp1 
indicates that the release from the nocodazole arrest did not occur as efficiently as in wild-type. 
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However, Sic1 levels in Δshp1 fluctuated similarly to wild-type, indicating that mitotic exit, i.e. Cdc14 
release, was not delayed or defective.  
Furthermore, some mitotic exit mutants can also be rescued by overexpression of the Cdk1 inhibitor 
SIC1 (Dumitrescu and Saunders, 2002). Overexpression of SIC1 also did not affect growth of Δshp1 
(data not shown), again indicating that the cell cycle delay observed is not due to insufficient 
Clb-Cdc28 kinase inactivation.  
Taken together, these experiments demonstrate that Shp1 is not required for mitotic exit and that the 
cell cycle delay observed in shp1 mutants is not due to a defect in mitotic exit, despite the observed 
interaction between Tem1 and Shp1. 
3.5.1.2 Null mutants of shp1 exhibit a metaphase to anaphase delay 
Δshp1 cells delay cell cycle progression after the G1/S transition but before mitotic exit. To identify the 
time-point of the delay more precisely, the spindle morphology was analyzed in live-cell fluorescence 
microscopy. Spindle pole body (SPB) duplication starts in G1, whereas separation of the two SPBs 
requires the early mitotic cyclins. Only after separation has occurred, two SPBs can be observed in 
vivo (Jaspersen and Winey, 2004). Once the SPBs have separated the mitotic spindle starts to form 
and reaches about 1.5- 2 μm in length before anaphase onset (Yeh et al., 1995).  
 
Fig. 24. Loss of Shp1 results in a delay of cell cycle progression at the metaphase to anaphase transition. a) Δshp1 cells 
arrest with separated spindle pole bodies and short spindles after shift to 14°C. Live-cell fluorescence microscopy of cultures of 
cells wild-type (WT) or Δshp1 strains expressing GFPtubulin1 and SPC42Mars, incubated at 14°C for 7,5h prior to microscopic 
analysis. b) α-factor arrest/release of WT and shp1-7 PDS118myc strains. Cultures of the indicated strains were arrested in G1 by 
α-factor, released, and samples were taken every 20 min. Cell cycle progression was monitored by Western blots against Clb2 
and Pds1 (myc). c) Steady-state protein levels of Sic13HA and Clb2. Yeast whole cell lysates of WT and Δshp1 cultures during 
logarithmic growth (as, asynchronous), G1 arrest (α, α-factor), and mitotic arrest (noc, nocodazole). Western blot against Clb2 
and Sic1 (HA), as well as Cdc48 (loading). d) Schematic overview of cell cycle proteins used as markers for distinct cell cycle 
stages in c). The blue box indicates the assumed delay time-point of Δshp1 cells. 
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Δshp1 and wild-type cells expressing a C-terminal Mars fusion of the spindle pole body protein Spc42 
and GFPtubulin were first grown at the permissive temperature and then shifted to 14°C (Fig. 24a). 
Wild-type cells continued cycling normally (data not shown), and as expected cells with one or two 
separated SPBs and mitotic spindles of different lengths were observed (Fig. 24a). Δshp1 cells, 
however, arrested in G2/M (data not shown), and the majority of cells had two separated SPBs and a 
short mitotic spindle that divided the nucleus (Fig. 24a), indicating a delay in metaphase or early 
anaphase. In some cases the short mitotic spindle did not align perpendicular to the bud neck, but was 
rather found in the bud or at the opposite end of the mother cell (Fig. 24a and data not shown). This 
could be due to stochastic movements of the nucleus and the spindle along astral microtubules during 
the duration of the arrest, or alternatively reflect a defect in spindle positioning. 
Pds1 (securin) is degraded dependent on the APC/CCdc20 upon metaphase to anaphase transition 
(Musacchio and Salmon, 2007). Wild-type and shp1-7 PDS118myc strains were arrested in G1, 
released, and Pds1 levels were analyzed. Consistent with a metaphase to anaphase delay, Pds1 
degradation was impaired in shp1-7 cells (Fig. 24b). When released from the G1 arrest, Pds1 was 
expressed and degraded approximately 40- 80 min after release in wild-type. However, Pds1 was 
stabilized and detectable until the end of the time course in shp1-7, demonstrating that the metaphase 
to anaphase transition is impaired. The fact that Pds1 and Clb2 levels still decreased in shp1-7, albeit 
with much slower kinetics than in wild-type, reflects the fact that shp1-7 cells do not arrest but only 
delay the cell cycle at 25°C. Some cells appear to be able to overcome the mitotic defects and 
continue to progress through the cell cycle.  
A delay at the metaphase to anaphase transition was again confirmed by analysis of the steady-state 
protein levels of Clb2 and Sic1 in asynchronous wild-type and Δshp1 cultures. Clb2 levels were high 
and yet Sic1 levels still low in Δshp1 cultures (Fig. 24c,d), as would have been expected for cells that 
accumulate in metaphase. 
3.5.1.3 The cell cycle delay of shp1 is caused by activation of the spindle checkpoint  
The metaphase to anaphase transition is controlled by the spindle assembly checkpoint (SAC) 
through inhibition of the APC/CCdc20 ubiquitin ligase complex until chromosome bi-orientation is 
achieved. The delayed metaphase to anaphase transition of shp1 mutants could therefore be the 
result of a constitutively active or malfunctioning checkpoint.  
 
Fig. 25. Shp1 is not essential for the spindle assembly checkpoint. a) Benomyl sensitivity of shp1-7. Cultures of the 
indicated strains were spotted in serial dilutions on YPD/DMSO or YPD/10 μg/ml benomyl plates and incubated at 25°C. 
b) Nocodazole arrest of wild-type (WT), Δmad2, and Δshp1. FACS analysis of nocodazole arrested cultures of WT, Δshp1 and 
Δmad2. 1n, 2n and >2n DNA content is indicated in the histograms by vertical gray lines. Δmad2 shows the expected checkpoint 
override leading to higher DNA content.  
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SAC mutants and strains with spindle or kinetochore defects are sensitive to spindle depolymerizing 
agents, such as benomyl or nocodazole (Hoyt et al., 1991; Li and Murray, 1991; Wang and Burke, 
1995). To test for such defects, wild-type, shp1-7, and the SAC mutant Δmad2 were spotted on plates 
containing benomyl (Fig. 25a) and indeed, shp1-7 and the control strain Δmad2 both were sensitive to 
benomyl. This could either indicate that Shp1 is required for SAC activity or that shp1-7 mutants 
possess other defects that result in benomyl sensitivity. Hence, the ability of shp1-7 cells to activate 
the SAC was analyzed. Δshp1 cells were clearly proficient in SAC activation in response to lack of 
attachment, as they arrested in G2/M upon nocodazole treatment and did not accumulate a DNA 
content larger than 2n, as observed for the Δmad2 control strain (Fig. 25b). Therefore, the sensitivity 
towards benomyl indicates that shp1 cells have certain spindle or kinetochore defects that are 
exacerbated and result in decreased viability upon spindle depolymerization. Consistently, shp1 null 
alleles exhibited a strong negative genetic interaction with Δmad2, indicating that an intact SAC is 
critical in these cells (Fig. 26a). The very slow growing double mutant shp1-7 Δmad2 displayed a more 
equal G1/S versus G2/M distribution of cells in FACS analysis compared to the shp1-7 null mutant 
(Fig. 26b). This implies that shp1 cells possess a delayed cell cycle due to activation of the spindle 
checkpoint, and that deletion of the essential SAC component MAD2 leads to a “rescue” of this delay. 
However, as the cause of the checkpoint activation is not resolved, abrogation of the SAC results in 
more severe defects, possibly missegregation of chromosomes, and in turn in an even stronger 
growth defect.  
 
Fig. 26. The cell cycle delay of shp1 mutants is dependent on the spindle checkpoint. a) The double mutant 
Δmad2 shp1-7 displays a strong synthetic growth defect. Fivefold serial dilutions of the haploid spores of one Δmad2 x shp1-7 
tetrad were spotted on YPD plates and incubated at 25°C. b) FACS analysis of Δmad2 shp1-7 shows more cells in G1 than in 
shp1-7. Cultures of strains as in a) were asynchronously grown and the propidium iodide stained DNA content was measured 
by flow cytometry. c) Δbub2 Δshp1 exhibits a synthetic growth defect. Cultures of the haploid spores of one Δbub2 x Δshp1 
tetrad were spotted in serial dilutions on YPD plates and incubated at 25°C. d) FACS analysis of indicated strains as in b). 
A similar effect could be demonstrated for the double mutant of Δshp1 and Δbub2 (Fig. 26c,d). Bub2 is 
a component of the spindle positioning branch of the spindle checkpoint (Dumitrescu and Saunders, 
2002; Lew and Burke, 2003), and is required to prevent mitotic exit upon spindle damage, spindle 
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misorientation, and DNA damage (Wang et al., 2000). The double mutant Δshp1 Δbub2 exhibits a 
synthetic growth defect, while the FACS profile is more equally distributed (Fig. 26c,d), suggesting that 
the spindle checkpoint is activated and crucial in shp1 cells.  
3.5.2 The Cdc48Shp1 complex is required for the Shp1 cell cycle function 
Shp1 is thought to mainly, if not exclusively, function as a Cdc48 cofactor. If Shp1 is required to recruit 
Cdc48 to certain substrates or cellular compartments during the cell cycle, it would be expected that 
the observed cell cycle defects should depend on its ability to bind Cdc48. Therefore the Cdc48 
binding mutants of shp1 were analyzed for cell cycle defects and their ability to rescue shp1 
phenotypes.  
Even though the two engineered Cdc48 binding mutants shp1-a1 and shp1-b1 exhibited growth 
defects to a slightly different degree (Fig. 17a), they both displayed a cell cycle defect very similar to 
that of shp1 null mutants (Fig. 27).  
 
Fig. 27. The cell cycle function of Shp1 depends on Cdc48 binding. a) FACS analysis of the DNA content of wild-type (WT), 
shp1-7, and the binding mutants shp1-a1 and shp1-b1. Cultures of the indicated strains were grown asynchronously, DNA was 
stained with propidium iodide, and the DNA content was measured by flow cytometry. b) Clb2 levels are elevated in shp1 
mutants. Cell lysates from logarithmic, asynchronous cultures of WT and respective shp1 strains were probed for the mitotic 
cyclin Clb2. Western blot against Cdc48 serves as a loading control. Note that an irrelevant lane between shp1-b1 and shp1-a1 
was removed from the figure. All samples depicted were on the Western blot membrane and film, and therefore exposed 
identically. c) α-factor arrest/release of WT and the binding mutant shp1-a1. Cultures of WT and shp1-a1 were arrested in G1, 
released, and samples taken every 20 min. Western blot against Clb2 and Cdc48 (loading control). Note that time-points 0 min 
in both strains and 160 min in shp1-a1 are of lower total protein concentration, as evident by comparison of the loading control 
Cdc48.  
FACS analysis of asynchronous cultures of the Cdc48 binding mutants shp1-a1 and shp1-b1 showed 
a significant G2/M delay (Fig. 27a). All shp1 mutants consistently exhibited increased levels of the 
mitotic cyclin Clb2 in asynchronous cultures at room temperature, indicating that the increased G2/M 
population was indeed due to an increase in mitotic cells (Fig. 27b). Finally, release of wild-type and 
the shp1-a1 binding mutant from a G1 arrest confirmed a mitotic delay of this mutant (Fig. 27c). As 
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observed for the shp1 null mutation, sustained Clb2 protein levels indicate prolonged mitosis also in 
shp1-a1.  
 
Fig. 28. Cdc48 binding mutants of shp1 are synthetically lethal with Δmad2. shp1-7 Δmad2 cells carrying a YC33-SHP1 
(URA) plasmid were additionally transformed with YC111 plasmids encoding the indicated shp1 mutants. Cultures of these 
strains were spotted in fivefold serial dilutions onto YPD control plates or 5’FOA plates to counter-select against YC33-SHP1. 
Plates were incubated at 25°C.  
The double mutant shp1-7 Δmad2 has a strong growth defect, indicating that a functional spindle 
assembly checkpoint is required in shp1-7 cells (Fig. 26a). To address if this phenotype results from 
the lack of a Cdc48Shp1 mediated function, different Shp1 mutants were assayed for their ability to 
rescue shp1-7 Δmad2 growth at 25°C (Fig. 28). Plasmids encoding SHP1 or shp1ΔUBA fully rescued 
growth after counter-selection against the additional wild-type YC33-SHP1 plasmid on 5’FOA plates. 
This was expected, as deletion of the UBA domain does not affect Cdc48 binding (Fig. 16b). Deletion 
of the UBX domain reduces binding of Shp1 to Cdc48 and consistently this mutant suppressed the 
growth defect of shp1-7 Δmad2 at 25°C (Fig. 28), and slightly less well at higher temperatures (data 
not shown). The two Cdc48 binding mutants shp1-a1 and shp1-b1 both failed to rescue 
shp1-7 Δmad2, indicating that the negative genetic interaction between shp1 and mad2 is linked to the 
Cdc48Shp1 complex.  
Together, these results demonstrate that mutations in Shp1 which abolish Cdc48 binding result in cell 
cycle phenotypes nearly indistinguishable from those of the shp1 null mutant. The Cdc48 binding 
mutants of shp1 exhibit a cell cycle delay in mitosis and negatively interact with Δmad2. This indicates 
that the Cdc48Shp1 complex is required for proper cell cycle progression at the metaphase to anaphase 
transition. As Shp1 has been reported to positively regulate Glc7 activity, the role of Cdc48Shp1 in Glc7 
mediated cell cycle regulation was analyzed in more detail. 
3.6 Regulation of Glc7 cell cycle function by Cdc48Shp1 
shp1 mutants were first identified as suppressors of high-copy protein phosphatase 1 (Glc7) (Zhang et 
al., 1995). These shp1 alleles displayed phenotypes very similar to those of certain glc7 alleles (Zhang 
et al., 1995). Some glc7 alleles result in a G2/M accumulation dependent on the SAC at the non-
permissive temperature (Bloecher and Tatchell, 1999; Sassoon et al., 1999). Shp1 has been proposed 
to be a positive regulator of Glc7, as deletion of SHP1 results in reduced phosphatase activity (Zhang 
et al., 1995; Stark, 1996; Wilson et al., 2005; Cannon, 2010). Since the phenotypes identified for shp1 
widely overlap with those described for glc7 alleles, they may in part be caused by reduced 
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phosphatase activity and not reflect a direct role of Cdc48Shp1 in a certain cellular pathway. In order to 
be able to differentiate between Cdc48Shp1 functions and secondary effects caused by reduced 
phosphatase activity, experiments addressing the relationship of Shp1 and Glc7 were conducted. 
3.6.1 Interaction of Shp1 with Glc7 
Even though Shp1 has been described as a positive regulator of Glc7, no physical interaction has 
been reported so far (Cannon, 2010). The RVxF motif that mediates binding of some targeting 
subunits to Glc7 could also not be identified within the Shp1 sequence. As most Glc7 targeting 
subunits have been shown to interact with Glc7 using the Y2H system, these experiments were also 
conducted with Glc7, Shp1, and Cdc48. 
 
Fig. 29. Shp1 interacts with Glc7. a) The directed Y2H assay indicates no interaction of Glc7 and Shp1. PJ69-4A cells were 
transformed with the indicated combinations of bait (BD) and prey (AD) plasmids and spotted on SC plates lacking tryptophan 
and leucine (control) or additionally lacking histidine (-His) or lacking adenine (-Ade). The strong Cdc48-Shp1 interaction serves 
as a positive control. b) Co-immunoprecipitation of Shp1 with Glc7. Glc73myc was immunoprecipitated from lysates of 
asynchronous, logarithmic cultures of SHP13HA and SHP13HA GLC73myc strains. Co-immunoprecipitation of Shp13HA with Glc73myc 
was detected by Western blot using Shp1 antibodies. * denotes an unspecific cross-reactive band in the myc-blot. 
c) Co-immunoprecipitation of Glc7 with Shp13HA. Shp13HA was immunoprecipitated from lysates and co-immunoprecipitation of 
endogenous untagged Glc7 and Cdc48 analyzed by Western blot against Glc7 and Cdc48, as well as Shp1.  
No interaction between Glc7 and Shp1, nor Glc7 and Cdc48 could be detected in directed Y2H assays 
(Fig. 29a). However, a weak but reproducible interaction of Shp1 with Glc73myc could be demonstrated 
in co-immunoprecipitation experiments (Fig. 29b). This interaction was further confirmed by 
immunoprecipitating Shp13HA and weak co-immunoprecipitation of untagged endogenous Glc7 
(Fig. 29c). Interaction between Glc7 and its targeting subunits seems to be somewhat difficult to detect 
in co-immunoprecipitation experiments with endogenous proteins. Sds22 apparently forms the most 
stable and abundant complex with Glc7, while other subunits are hardly detectable (Walsh et al., 
2002). Therefore the weak but reproducible, and previously undetected, co-immunoprecipitation of 
Shp1 and Glc7 is presumably significant. 
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To test for a potential genetic interaction of shp1 and glc7, the glc7-129 allele was chosen. The 
phenotype of this cell cycle allele of Glc7 at the non-permissive temperature is a cell cycle arrest in 
G2/M as large budded cells with separated SPBs and a short mitotic spindle (Baker et al., 1997). 
Furthermore, the mitotic arrest was reported to be dependent on the SAC (Bloecher and Tatchell, 
1999). Sporulation and tetrad analysis revealed that shp1-7 glc7-129 was inviable at all temperatures 
tested (Fig. 30a and data not shown).  
 
Fig. 30. shp1-7-is synthetically lethal with glc7-129 in a Cdc48 binding dependent manner. a) The double mutant 
shp1-7 glc7-129 is inviable. Cultures of wild-type (WT), single mutants and shp1-7 glc7-129, all carrying an additional 
YC33-SHP1 plasmid (URA), were spotted in fivefold dilutions either on control (YPD) and 5’FOA plates to counter-select against 
the wild-type SHP1 plasmid. The plates were then incubated at 25°C. b) Synthetic lethality of glc7-129 shp1-7 depends on the 
Cdc48-binding ability of Shp1. glc7-129 shp1-7 cells carrying the YC33-SHP1 plasmid were additionally transformed with 
plasmids encoding the indicated shp1 mutants. Cultures of these strains were spotted in fivefold serial dilutions on control 
SC-Leu plates and 5’FOA plates to counter-select against YC33-SHP1. All plates were incubated at 25°C. 
As expected, the synthetic lethality of glc7-129 and shp1-7 was dependent on the Cdc48-binding 
ability of Shp1 (Fig. 30b). Viability of shp1-7 glc7-129 transformed with plasmids encoding mutant 
forms of shp1 was analyzed after counter-selection against the wild-type SHP1 plasmid on 5’FOA. 
Plasmids encoding SHP1 or shp1ΔUBA were able to fully rescue growth of the double mutant. 
shp1-7 glc7-129 transformed with plasmids encoding either of the two Cdc48 binding mutants of shp1 
or the empty vector was inviable. shp1ΔUBX weakly suppressed the synthetic lethality (Fig. 30), most 
likely reflecting its reduced ability to interact with Cdc48 (Fig. 16). These results demonstrate that the 
Cdc48Shp1 complex is required for viability of glc7-129.  
3.6.2 Glc7 phosphatase activity is reduced in shp1 mutants 
As deletion of SHP1 reduces Glc7 phosphatase activity (Zhang et al., 1995; Wilson et al., 2005), Glc7 
substrates are expected to be hyperphosphorylated in shp1 null mutants. Glc7 has been described to 
counteract Ipl1 kinase (the yeast Aurora B homolog) during chromosome bi-orientation (Francisco et 
al., 1994). A tight balance of kinase and phosphatase activity is required for proper cell cycle 
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progression and growth. Consistently, some mutants of glc7 suppress the ipl1 temperature sensitivity 
(Francisco et al., 1994; Hsu et al., 2000; Pinsky et al., 2006a). 
If Glc7 activity is reduced in shp1, then a double mutant of shp1 and ipl1 should also be able to 
suppress the temperature sensitivity of ipl1 mutants. To test this shp1-7 was crossed with the 
temperature sensitive allele ipl1-321, and viability of the haploid spores was analyzed at different 
temperatures (Fig. 31a). Indeed, the temperature sensitivity of ipl1-321 at 33°C and partially at 37°C 
was suppressed by the shp1 null mutant. Importantly, shp1-7 ipl1-321 in turn also suppressed the 
growth defect of shp1-7 at higher temperatures, indicating that the temperature sensitivity of shp1-7 
may in part be caused by reduced Glc7 activity towards a critical Ipl1 substrate. 
 
Fig. 31. shp1 mutants suppress the temperature sensitivity of ipl1-321 dependent their ability to bind Cdc48. a) shp1-7 
suppresses the temperature sensitivity of ipl1-321. Cultures of the haploid spores of one shp1-7 x ipl1-321 tetrad were spotted 
in serial dilutions on YPD plates. The plates were incubated at the indicated temperatures. b) Suppression of temperature 
sensitivity of ipl1-321 is dependent on Shp1 binding to Cdc48. shp1-7 ipl1-321 cells were transformed with the indicated shp1 
mutant plasmids, and serial dilutions of cultures were spotted on SC-Leu plates. The plates were incubated at the denoted 
temperatures. Note that shp1-a1 partially rescues the shp1 growth defect, therefore resulting in improved growth of the double 
mutant at 35°C. 
As for the genetic interaction with glc7, the involvement of Cdc48 in the suppression of the ipl1-321 
temperature sensitivity by shp1 was tested using the shp1 binding mutants. Indeed, the Cdc48 binding 
mutants of shp1 were able to suppress the temperature sensitivity of ipl1-321 as well as the shp1 null 
mutant (Fig. 31b). shp1ΔUBX, which displays reduced binding to Cdc48 (Fig. 16), was able to suppress 
the temperature sensitivity at 33°C, but not at 37°C. As expected, shp1ΔUBA did not rescue the ts 
phenotype to any extent, as this mutation does not affect the Shp1- Cdc48 interaction.  
These results again indicate that the genetic interaction of shp1 with ipl1 and glc7 is dependent on the 
Cdc48Shp1 complex.  
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3.6.2.1 Substrates of Glc7 and Ipl1 are hyperphosphorylated in shp1 
To directly address if substrates of Glc7 are hyperphosphorylated in shp1, modification of the 
kinetochore protein Dam1 and Histone H3 was analyzed. Both Dam1 and Histone H3 have been 
described as common substrates of Ipl1 and Glc7 that are regulated by phosphorylation during the cell 
cycle (Hsu et al., 2000; Kang et al., 2001).  
 
Fig. 32. Hyperphosphorylation of Glc7 substrates in shp1-7. a) Histone H3 phosphorylation is increased in shp1 mutants. 
Logarithmic cultures were either grown at 25°C or shifted to the non-permissive temperature (35°C) for 3 h. Whole cell lysates 
were prepared and were analyzed by Western blot against phosphorylated histone H3 S10 and total histone H3. Note that an 
irrelevant lane between shp1-b1 and shp1-a1 was removed from all blots. All samples were exposed identically, since they were 
on the same Western blot membrane and film. b) The kinetochore protein Dam1 is hyperphosphorylated in shp1-7. 
Asynchronous cultures of wild-type (WT), shp1-7, glc7-129, ipl1-321, and shp1-7 ipl1-321 DAM19myc strains were either grown at 
25°C or shifted to the non-permissive temperature for 3 h. Cell lysates were analyzed by Western blot against Dam1 (myc) and 
Cdc48 (loading control). Dam1-P indicates the more slowly migrating phosphorylated forms of Dam1.  
Residue S10 of histone H3 is phosphorylated by Ipl1 during mitosis (Hsu et al., 2000). In addition to 
being a marker for mitotic cells, H3 S10 phosphorylation has also been shown to depend on the 
balance of Ipl1 kinase and Glc7 phosphatase activity (Hsu et al., 2000).  
Thus, phosphorylation of histone H3 was analyzed by Western blot of cell lysates from asynchronous 
cultures at the permissive and non-permissive temperature (Fig. 32a). For this purpose an antibody 
specifically detecting histone H3 S10 phosphorylation was used. The phosphorylated form of H3 was 
strikingly increased in shp1-7 cells compared to wild-type. This effect was similar to the 
hyperphosphorylation observed in glc7-127 and glc7-129 cells. Interestingly, the increase in 
phosphorylated histone H3 was also observed for the Cdc48 binding mutants of shp1 (shp1-b1 and 
shp1-a1). As expected, the ipl1-321 mutant exhibited decreased phosphorylation of histone H3 at the 
non-permissive temperature. However, the double mutant shp1-7 ipl1 321 restored a wild-type 
phosphorylation state of histone H3 at both temperatures. This demonstrates that first, Ipl1 kinase 
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activity is already partially reduced at the permissive temperature and secondly, that residual kinase 
activity is still present at 35°C. Notably, reduction of Glc7 phosphatase activity, by loss of Shp1, 
restores the kinase to phosphatase balance and results in wild-type phosphorylation of histone H3 in 
ipl1-321 shp1-7. As shp1 mutation leads to an accumulation of cells in mitosis, an increase in 
phosphorylated H3 would have been expected regardless of Glc7 activity. Therefore, an additional 
Ipl1/Glc7 substrate was analyzed. 
As the previous results infer that shp1 null mutants reduce mitotic Glc7 activity, it would be expected 
that Dam1 is also hyperphosphorylated in shp1-7. To assess this, strains expressing Dam19myc were 
shifted to the non-permissive temperature and phosphorylation of Dam1 was analyzed by Western 
blot (Fig. 32b). Dam1 was indeed hyperphosphorylated in shp1-7 cells, as judged by the altered ratio 
of upper and lower bands in the Dam1 Western blot. This increase of Dam1 phosphorylation in shp1 
occurred to a similar degree as in the control strain glc7-129. It has been demonstrated that the 
hypophosphorylation of Dam1 in ipl1 mutants can in part be rescued by reducing Glc7 phosphatase 
activity (Pinsky et al., 2006a). As expected, ipl1-321 mutants exhibited a significant reduction of Dam1 
phosphorylation at the non-permissive temperature (Fig. 32b). Importantly, the phosphorylation state 
of Dam1 was shifted to a wild-type like situation upon additional null mutation of shp1, indicating that 
the phosphatase to kinase balance was restored (Fig. 32b). 
Suppression of the ipl1 temperature sensitivity as well as the hyperphosphorylation of two Glc7/Ipl1 
substrates, Dam1 and histone H3, demonstrated that shp1 mutants exhibit reduced Glc7 activity 
towards Ipl1 substrates. Furthermore, these results indicate that the Cdc48Shp1 complex is required for 
the regulation of Glc7 towards these substrates. The reduction of Glc7 activity in shp1 cells impairs the 
balance of kinase (Ipl1) and phosphatase (Glc7) required during chromosome bi-orientation and could 
therefore lead to the observed cell cycle delay in shp1 mutants.  
3.6.2.2 Overexpression of GLC7 suppresses the mitotic delay of shp1 mutants 
A general reduction of Glc7 activity in shp1 is thought to cause the pleiotropic defects observed in this 
strain (Zhang et al., 1995; Wilson et al., 2005; Cannon, 2010). Consequently, overexpression of 
functional GLC7 should, in the most direct possible mechanism of regulation, partially rescue these 
phenotypes. Overexpression of GLC7 has been described to be toxic in wild-type cells. shp1 alleles, 
however, tolerate GLC7 overexpression, presumably due to reduced basal Glc7 activity (Zhang et al., 
1995).  
GLC7 overexpression was induced in wild-type and shp1-7 strains and growth was analyzed 
(Fig. 33a). Consistent with published results, overexpression of GLC7 was toxic in wild-type, but 
tolerated by the shp1 null mutant. The binding mutants of shp1, shp1-a1 and shp1-b1, also tolerated 
GLC7 overexpression (Fig. 33a and data not shown), again indicating that the regulation of Glc7 
activity by Shp1 is linked to a Cdc48Shp1 function.  
GLC7 is one of less than 5 % of S. cerevisiae genes that contain an intron (Spingola et al., 1999). To 
rule out the possibility that the toxicity of GLC7 overexpression is caused by overloading the splicing 
machinery, overexpression of GLC7 with and without the intron was compared. Both constructs were 
Results 
 
 
53
 
toxic to wild-type but tolerated by Δshp1 (data not shown). Furthermore, toxicity of GLC7 
overexpression is dependent on a fully functional version of GLC7, as indicated by the failure of the 
partial loss of function variant Glc73HA to cause toxicity upon overexpression (data not shown). 
 
Fig. 33. GLC7 overexpression suppresses the G2/M delay of shp1 mutants. a) shp1-7 and shp1-a1  tolerate GLC7 
overexpression. GLC7 was overexpressed by fully inducing the MET25 promoter. Cultures of the indicated strains were serially 
diluted and spotted on plates containing (promoter off) or lacking methionine (promoter on). The plates were incubated at 30°C. 
b) Overexpression of GLC7 in wild-type (WT), shp1-7 and shp1-a1 cells suppresses the G2/M accumulation of shp1 cells. 
FACS analysis of logarithmic, asynchronous cultures of WT, shp1-7 and shp1-a1 pMET controls (left) in medium with and 
without methionine, and of WT, shp1-7, and shp1-a1 pMET-GLC7 (right) with uninduced (+Met) or induced (-Met) GLC7 
overexpression. c) Expression levels of Glc7 during the FACS experiment in b). Whole cell lysates of cultures from b) were 
analyzed for Glc7 expression by Western blot against Glc7. 
FACS analysis of the DNA content of wild-type cells with repressed or induced GLC7 overexpression 
confirmed that GLC7 overexpression was highly toxic (Fig. 33b, upper right row). Remarkably, GLC7 
overexpression was not only tolerated by shp1 mutants, but even suppressed the G2/M accumulation 
to yield a G1/S to G2/M distribution similar to that of wild-type (Fig. 33b). This demonstrates that the 
cell cycle phenotype of shp1 presumably results from limiting Glc7 activity. Intriguingly, the rescue 
observed for cell cycle progression did not lead to a suppression of the growth defect at any 
temperature (Fig. 33a and data not shown), indicating that the growth defect, especially the 
temperature sensitivity, and cell cycle progression are not directly linked.  
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3.6.3 Nuclear localization of Glc7 in wild-type and shp1 
All evidence provided so far is consistent with reduced Glc7 activity being the cause of severe 
phenotypes of shp1. However, the mechanism by which the Cdc48Shp1 complex modulates Glc7 
phosphatase activity is unknown. One straightforward possibility would be that deletion of SHP1 
reduces Glc7 protein stability. However, the shp1 alleles identified in the initial GLC7 overexpression 
suppressor screen were shown to have reduced PP1 activity, while Glc7 protein levels were not 
affected (Zhang et al., 1995). Indeed, steady-state protein levels of untagged endogenous Glc7 were 
not altered in shp1 mutants (Fig. 33c, 35b, 36 and data not shown), consistent with the published data 
(Zhang et al., 1995).  
Alternatively, localization of Glc7 could be altered in shp1 mutants. Glc7 localizes to the nucleus, the 
cytosol, and the septum (Bloecher and Tatchell, 2000). The Glc7 targeting subunits Ypi1 and Sds22 
have been demonstrated to mediate Glc7 nuclear localization (Peggie et al., 2002; Pedelini et al., 
2007). Depletion of Ypi1 leads to a cell cycle arrest similar to glc7 mutants, most likely due to reduced 
nuclear Glc7 levels (Bharucha et al., 2008).  
Therefore, nuclear Glc7 localization was analyzed in wild-type and shp1 using strains expressing 
Glc7GFP as the only source of Glc7. Functionality of the C-terminal GFP-fusion of Glc7 was ensured, as 
it did not significantly impair growth at any tested temperature (Fig. 34c). Furthermore, FACS analysis 
of a WT GLC7GFP strain demonstrated that this variant of Glc7 did not lead to a cell cycle defect 
(Fig. 34d), suggesting that Glc7GFP localizes normally to the nucleus and fulfills the critical cell cycle 
function(s) of Glc7.  
As reported (Bloecher and Tatchell, 2000), the majority of Glc7GFP was detected in the nucleus in 
wild-type, shp1-7, and shp1-b1 cells (Fig. 34a). In all three strains medium and large budded cells also 
showed distinct localization of Glc7GFP at the septum. Furthermore, the diffuse cytosolic staining of 
Glc7GFP was not altered in either shp1 mutant, nor could any aberrant localization or aggregation of 
Glc7GFP be observed. Quantification of the intensity of the GFP signal in the nucleus compared to the 
cytosol revealed a slight decrease of nuclear Glc7 to approximately 80% in the shp1 mutants 
(Fig. 34b).  
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Fig. 34. Loss of SHP1 slightly impairs nuclear accumulation of Glc7. a) Localization of Glc7GFP. Glc7GFP localization in 
asynchronous logarithmic cultures of indicated yeast strains was analyzed using a confocal spinning disk microscope (scale bar: 
5μm). Z-stack projection (sum) performed using ImageJ. b) Quantification of the GFP-signal in nucleus/cytosol in the analyzed 
strains. Average GFP fluorescence intensity was measured in an area of equal size in the nucleus and cytoplasm and the ratio 
was calculated. Single z-slices of confocal images were used for the analysis with ImageJ. c) Effect of chromosomal C-terminal 
epitope tagging of Glc7 on growth. Serial dilutions of cultures of the indicated strains, expressing the respective C-terminally 
tagged Glc7 variant as the only source of PP1, were spotted on YPD plates. The plates were incubated at 30°C and 37°C. 
Glc73HA causes a significant growth defect and temperature sensitivity. d) C-terminal GFP tagging of Glc7 does not cause a cell 
cycle defect. FACS analysis of asynchronous cultures of wild-type (WT) and GLC7GFP strains. 
Interestingly, in the course of these experiments, it became evident that the nuclear localization of 
Glc7GFP is influenced by the presence of untagged Glc7 in shp1 mutants. The additional expression of 
Glc7 in shp1-7 GLC7GFP strains resulted in a notable reduction of the nuclear Glc7GFP signal (Fig. 35a). 
This was dependent on the amount of untagged Glc7 additionally expressed, as a high-copy plasmid 
encoding GLC7 under control of the constitutively active ADH promoter reduced the nuclear Glc7GFP 
signal even further (Fig. 35a,b). This effect was not observed for wild-type strains, indicating that null 
mutation of shp1 does affect Glc7GFP localization. However, lack of Shp1 does not abolish nuclear 
localization of Glc7GFP if this is the only source of Glc7.  
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Fig. 35. Additional copies of GLC7 in shp1-7 negatively influence the nuclear signal of Glc7GFP. a) Wild-type (WT) or 
shp1-7 strains, expressing Glc7GFP as the only source of Glc7, were transformed with either empty YC plasmids or plasmids 
encoding the GLC7 gene under control of the wild-type promoter (YC-GLC7) or the ADH promoter (YEpADH-GLC7). 
Asynchronous logarithmic cultures of the indicated strains were used for live-cell fluorescence microscopy. GFP (Glc7) 
fluorescence, DIC images, and the overlay are depicted. b) Lysates of cultures used for microscopy in a) were analyzed by 
Western blot against Glc7 and Cdc48 (loading control). Additionally WT and shp1-7 without endogenously GFP tagged Glc7 are 
shown. * denotes an unspecific cross-reactive signal in the Glc7 Western blot.  
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The nuclear localization of Glc7 was further analyzed by testing the interaction of untagged Glc7 with 
the targeting factor Sds22, which is required for nuclear localization of Glc7 (Peggie et al., 2002; 
Pedelini et al., 2007; Bharucha et al., 2008). 
 
Fig. 36. Intact interaction of Glc7 with the nuclear targeting subunit Sds22 in shp1-7. Co-immunoprecipitation of Glc7 with 
Sds22 from lysates of wild-type (WT) and shp1-7 SDS223myc cultures. Western blot against Glc7, Shp1 and Sds22 (myc).  
Co-immunoprecipitation of Glc7 with Sds22 from lysates of wild-type and shp1-7 strains demonstrated 
that the interaction was not reduced in shp1-7 (Fig. 36). Assuming that the majority of Sds22 interacts 
with Glc7 in the nucleus (Peggie et al., 2002), this leads to the conclusion that a major reduction of 
nuclear Glc7 in shp1-7 is highly unlikely.  
In summary, the presented results rule out the possibility that the nuclear localization of Glc7 is grossly 
affected in shp1 null mutants. They are in agreement with the fact that no altered localization of Glc7 
was detected in biochemical fractionation assays performed during the initial study that identified shp1 
alleles as suppressors of GLC7 overexpression (Zhang et al., 1995). However, Shp1 appears to affect 
Glc7GFP nuclear transport under certain conditions. If untagged Glc7 is present in addition to Glc7GFP, it 
is preferentially transported into the nucleus of shp1 cells (Fig. 35a). This may either be due to 
impaired nuclear import of the larger Glc7GFP, or result from preferential binding of Sds22 to the 
untagged Glc7. 
3.6.4 Ubiquitination of Glc7 differs in shp1 
As neither protein levels nor cellular localization of Glc7 are significantly affected in shp1, Glc7 activity 
in shp1 mutants could be reduced due to altered posttranslational modification. Mammalian, fission 
yeast and several other PP1 variants are regulated by inhibitory phosphorylation through Cdc2 early in 
mitosis. However, this Cdc2 consensus site is not conserved in S. cerevisiae, and phosphorylation of 
Glc7 has not been reported (Dohadwala et al., 1994; Yamano et al., 1994; Cannon, 2010). However, 
Glc7 peptides were identified in a large-scale purification of ubiquitinated proteins (Tagwerker et al., 
2006).  
To directly analyze Glc7 ubiquitination in vivo, denaturing Ni-NTA pull-downs from yeast strains 
expressing Glc73myc and overexpressing Hisubiquitin were performed. In wild-type strains Glc7 was 
clearly modified by monoubiquitination and perhaps some polyubiquitination (Fig. 37). In Δshp1, 
however, the ubiquitination of Glc7 was noticeably shifted to multi or polyubiquitination (Fig. 37). Glc7 
was modified with multiple ubiquitins (three to four), and a slight reduction of the monoubiquitinated 
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form could be observed. This increase of Glc7 ubiquitination in null alleles of shp1 was also observed 
in strains expressing Glc7GFP instead of Glc73myc (data not shown).  
 
Fig. 37. Enhanced ubiquitination of Glc7 in shp1. Cultures of wild-type (WT), GLC73myc and Δshp1 GLC73myc strains, all 
overexpressing Hisubiquitin, were lysed and denaturing Ni-NTA pull-downs of Hisubiquitin performed. Glc7 was detected by 
Western blot against myc. 
However, both myc and GFP epitope tags contain lysine residues that could be unspecifically 
ubiquitinated. Due to the fact that Glc73HA is not fully functional (Fig. 34c) no Glc7 variant without an 
additional lysine within the epitope tag could be tested for ubiquitination. Furthermore, analysis of 
untagged endogenous Glc7 was not possible, as the Glc7 antiserum caused very high background 
signals in Western blots of Hisubiquitin pull-down samples.  
Glc7 protein levels were reported to be constant throughout the cell cycle (Nigavekar et al., 2002). 
Consequently, Glc7 was stable in wild-type and Δshp1 during a cycloheximide shut-off experiment 
(data not shown). It is therefore unlikely that this modification of Glc7 by ubiquitin would serve as a 
degradation signal for the majority of Glc7. Ubiquitination of Glc7 could only affect a very small fraction 
of the total cellular Glc7 protein, or rather have a non-proteolytic signaling function.  
Alternatively, or in result of the increased ubiquitination of Glc7, null mutation of shp1 could also affect 
Glc7 interaction with one or more of its regulatory subunits, resulting in altered Glc7 activity.  
3.7 Shp1 influences the interaction of Glc7 with Glc8 
3.7.1 Genetic interaction of shp1 with Glc7 targeting subunits 
Glc7 itself possesses little or no substrate specificity, therefore the interaction with numerous subunits 
is required to mediate activity, localization, and substrate recruitment (Stark, 1996; Cannon, 2010). 
Because altered interaction of Glc7 with its subunits could cause the reduced phosphatase activity in 
shp1, the genetic interaction of FIN1, SDS22, and GLC8 with SHP1 was analyzed.  
Fin1 has been proposed to recruit Glc7 to the kinetochore, where Glc7 opposes Ipl1 and mediates exit 
from the spindle assembly checkpoint (Akiyoshi et al., 2009b). As FIN1 is not an essential gene and a 
Δfin1 mutant does not exhibit any cell cycle defect or a delay in spindle checkpoint silencing, an 
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additional factor responsible for Glc7 kinetochore recruitment must exit (Akiyoshi et al., 2009b). 
Considering that the cell cycle delay of shp1 cells depends on the SAC (Fig. 26) and that Shp1 
possibly interacts with the kinetochore protein Ndc80 (Fig. 20), the genetic interaction between shp1 
and Δfin1 was tested. If Shp1 were required to recruit Glc7 to the kinetochore in Δfin1, then the double 
mutant Δfin1 shp1-7 should presumably exhibit stronger defects in cell cycle progression or even be 
synthetically lethal. However, no negative genetic interaction between Δfin1 and shp1-7 was observed 
(data not shown).  
Increased levels of the nuclear targeting subunit Sds22 have been demonstrated to suppress the 
mitotic phenotype of glc7-12, as well as the temperature sensitivity of ipl1-321 (MacKelvie et al., 1995; 
Pinsky et al., 2006a). The suppression of ipl1-321 by SDS22 is speculated to be due to competition of 
Sds22 with the critical, still unknown, Glc7 subunit opposing Ipl1, thereby reducing Glc7 function 
antagonizing Ipl1. As described above, null mutation shp1 does not alter Glc7 interaction with the 
nuclear subunit Sds22 (Fig. 36). 
 
Fig. 38. Overexpression of SDS22 is toxic for shp1-7. Wild-type (WT) and shp1-7 strains were transformed with YEplac195, 
YEplac195-SDS22, or YEplac195-pADH-GLC7, respectively. Cultures of these strains were spotted in serial dilutions on 
SC-Ura plates and incubated at the indicated temperatures. Overexpression of GLC7 serves as a positive control.  
Consistent with the hypothesis that null mutation of shp1 results in decreased mitotic activity of Glc7, 
shp1-7 was sensitive towards increased amounts of SDS22 (Fig. 38). Lack of Shp1 could itself affect 
the interaction of Glc7 with the unknown critical mitotic targeting subunit or substrate and 
overexpression of SDS22 would further reduce the interaction below a threshold required for cell cycle 
progression. Alternatively, null mutation of shp1 may result in reduced overall Glc7 activity and 
additionally titrating Glc7 from its critical mitotic subunit could result in even further reduced mitotic 
Glc7 activity.  
Glc8 is a positive regulator of Glc7 activity, whose Glc7 activating function depends on Pho85 
mediated phosphorylation at residue T118 (Tung et al., 1995; Cannon, 2010). Deletion of GLC8 does 
not result in any major detectable growth or cell cycle defects (Fig. 39a,c), but has been shown to 
cause a reduction of cellular glycogen levels and of Glc7 phosphatase activity (Cannon et al., 1994). 
Interestingly, the double mutant shp1-7 Δglc8 was found to be inviable (Fig. 39a), indicating that either 
Glc8 or Shp1 is required for viability, presumably to ensure sufficient Glc7 activity. 
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Fig. 39. Synthetic lethality of Δglc8 and shp1-7. a) Spotting of fivefold serial dilutions of cultures of the indicated haploid 
spores of one shp1-7 x Δglc8 tetrad, all carrying an additional YC33-SHP1 (URA) plasmid, on control YPD and 5’FOA plates to 
counter-select against the wild-type SHP1 plasmid. Plates were incubated at 25°C. b) Δglc8 shp1-7 lethality depends on Cdc48 
binding of Shp1. Δglc8 shp1-7 cells carrying the YC33-SHP1 plasmid were additionally transformed with YC111 plasmids 
encoding different shp1 mutants as well as GLC8 and glc8T118A. Cultures of these strains were spotted in fivefold serial dilutions 
on control SC-Leu and 5’FOA plates to counter-select against YC33-SHP1. Plates were incubated at 25°C. c) FACS analysis of 
DNA content of wild-type (WT), shp1-7, and Δglc8. Cultures of the indicated strains were grown at RT and the DNA content was 
measured by flow cytometry. 
Some glc7 alleles are synthetically lethal in combination with Δglc8 or non-phosphorylatable T118 
mutants of Glc8 (Tan et al., 2003). This is consistent with the finding that glc8T118A cannot rescue the 
synthetic lethality of shp1-7 Δglc8, while GLC8 restores growth (Fig. 39b). Thus demonstrating that the 
negative genetic interaction of shp1-7 and Δglc8 depends on the Glc7 activating function of Glc8. In 
addition to the phosphorylation state of Glc8, the binding of Shp1 to Cdc48 is also required for 
suppression of shp1-7 Δglc8 lethality (Fig. 39b). This again demonstrates that Cdc48 binding of Shp1 
is required for normal Glc7 regulation and activity.  
As phosphorylated Glc8 binds and activates Glc7, and is required for viability upon null mutation of 
shp1, the interaction of Glc7 and Glc8 in vivo was analyzed in wild-type and shp1 mutants. 
3.7.2 The Glc7-Glc8 interaction is reduced in shp1 null mutants 
Glc8 has been demonstrated to physically interact with Glc7 in vivo and in vitro (Tung et al., 1995). 
The effect of shp1 null mutation on the Glc7-Glc8 interaction was analyzed by co-immunoprecipitation. 
A shp1-7 GLC83HA strain was viable and did not exhibit any synthetic growth defect, indicating that 
Glc83HA was functional (data not shown). Glc7 co-immunoprecipitation with Glc83HA from lysates of 
asynchronous cultures, as well as cultures arrested in G1 by α-factor, was analyzed. The interaction of 
Glc7 with Glc8 in shp1-7 was reduced under all tested conditions. Quantification of Glc7 
co-immunoprecipitation versus Glc8 immunoprecipitation in wild-type and shp1-7 asynchronous 
cultures revealed that the Glc7-Glc8 interaction was reduced by approximately 50% in shp1-7 
(Fig. 40a,c). 
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Fig. 40. Reduced binding of Glc8 to Glc7 in shp1. a) The co-immunoprecipitation (IP) of Glc7 with Glc83HA is reduced in 
shp1-7. Glc83HA was immunoprecipitated from lysates of asynchronous wild-type (WT) GLC83HA and shp1-7 GLC83HA cultures. 
Co-immunoprecipitation of Glc7 was analyzed by Western blot against endogenous Glc7. Note that unrelated, irrelevant lanes 
were removed from the figure. All samples were on the same Western blot membrane and film and therefore exposed 
identically. b) The reduced Glc7-Glc8 interaction in shp1-7 is not caused by the cell cycle delay of shp1 mutants. Glc83HA was 
immunoprecipitated from lysates of WT Δbar1 GLC83HA  and shp1-7 Δbar1 GLC83HA strains arrested in G1 with α-factor. 
Co-immunoprecipitation of Glc7 was detected by Western blot against endogenous Glc7. c) Quantification of three independent 
co-immunoprecipitation experiments of Glc7 with Glc8 from lysates of asynchronous WT and shp1-7 GLC83HA strains as in a). 
The Western blot signal of the immunoprecipitated Glc83HA and the co-immunoprecipitated Glc7 was quantified using ImageJ. 
The ratio of Glc7 co-IP to Glc8 IP was calculated and normalized to WT. d) Live-cell microscopy of Glc8GFP. FITC (GFP) and 
DIC images of asynchronous logarithmic cultures of WT and shp1-7 GLC8GFP were acquired by live-cell fluorescence 
microscopy. e) Expression levels of Glc8GFP during microscopy. Cell lysates of strains as in d) were analyzed by Western blot 
against GFP and Cdc48 (loading control). Two independent clones of each strain were analyzed by Western blot. 
The reduced Glc7-Glc8 interaction is not an effect of the altered cell cycle distribution of wild-type and 
shp1-7, as the co-immunoprecipitation from G1 arrested cells shows (Fig. 40b). Even though the 
α-factor arrest efficiency of shp1-7 is reproducibly lower than that of wild-type, this cannot be the 
cause of the reduced Glc7-Glc8 interaction. Co-immunoprecipitation of Glc7 with Glc83HA from 
asynchronous and arrested wild-type cultures showed that the Glc7-Glc8 interaction slightly fluctuates 
during the cell cycle, with a peak in metaphase (or during an activated SAC) (data not shown). Thus, 
the inefficient G1 arrest of shp1-7 would have caused an increased Glc7-Glc8 interaction and the 
significantly reduced co-immunoprecipitation of Glc7 with Glc83HA in shp1-7 after α-factor treatment 
may be an underestimate of the actual reduction (Fig. 40b). This indicates that Shp1 enhances the 
interaction of Glc7 with its positive regulator Glc8.  
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How this is achieved remains unclear. Shp1 could not be detected in complex with Glc7 and Glc8 
(data not shown). Nevertheless, detection of Glc7 interaction with regulatory subunits by 
co-immunoprecipitation is difficult in vivo and this negative evidence therefore does not completely 
exclude the existence of such a ternary complex.  
Alternatively, altered localization of Glc8 could cause a reduced interaction with Glc7. This indeed 
appears to be the case. In wild-type cells Glc8GFP exhibits nuclear and cytosolic localization (Fig. 40d), 
consistent with published results (Huh et al., 2003). In contrast, shp1 null mutants impair the nuclear 
localization of Glc8GFP (Fig. 40d). This could possibly account for the reduced Glc7-Glc8 interaction in 
shp1, as the nuclear fraction of Glc7 would not be able to interact with Glc8. Glc8GFP is the only source 
of Glc8 in shp1-7 and this strain is viable, indicating that Glc8GFP must be able to fulfill its role as an 
activator of Glc7. Furthermore, Glc8GFP levels were similar in wild-type and shp1-7 (Fig. 40e), 
indicating that the C-terminal epitope tagging of Glc8 was equally efficient in both strains.  
3.7.3 Overexpression of GLC8 suppresses shp1-7 temperature sensitivity 
Overexpression of GLC8 has been demonstrated to suppress the ipl1 temperature sensitivity. This 
effect was proposed to be due to an inhibitory function of Glc8 towards Glc7 when it is overexpressed. 
Furthermore, it has been shown that overexpression of non-phosphorylatable T118 mutants of Glc8 is 
more effective in suppressing ipl1 temperature sensitivity (Tung et al., 1995).  
In order to determine the effect of GLC8 in shp1 mutants, GLC8 was overexpressed under control of 
the MET25 promoter in wild-type and shp1-7. This construct was able to rescue the ipl1-321 
temperature sensitivity when fully induced, demonstrating that it was functional (data not shown). If 
GLC8 overexpression is indeed inhibitory to Glc7 activity, it should be toxic to cells already 
compromised for Glc7 activity. In contrast to this model, the overexpression of GLC8 and GLC83HA 
partially suppressed shp1-7 phenotypes, rather than being toxic. The temperature sensitivity of shp1-7 
at 37°C was slightly suppressed by overexpression of GLC83HA and improved growth could be 
observed at 35°C (Fig. 41a). In contrast, overexpression of glc8T1183HA was toxic in shp1-7 cells 
(Fig. 41a), indicating that the ability of Glc8 to activate Glc7 is critical for the suppression of shp1-7 
phenotypes.  
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Fig. 41. Overexpression of GLC8 suppresses the temperature sensitivity of shp1-7. a) Overexpression of GLC8 partially 
suppresses the shp1-7 temperature sensitivity. Cultures of the indicated strains were spotted in fivefold dilutions on plates 
containing (promoter off) or lacking methionine (promoter on). Plates were incubated at the indicated temperatures. 
b) Expression levels of Glc83HA and Glc8T118A3HA in a). Whole cell lysates of strains spotted on plates at 30°C were analyzed by 
Western blot against Glc8 (HA) and Cdc48 (loading control).  
Even though GLC8 overexpression partially suppressed the shp1-7 growth defects at higher 
temperatures, it did not reproducibly rescue the cell cycle defect of shp1-7 (data not shown). 
Integration of the pMET-GLC8 construct in shp1-7, but not pMET-glc8T118A, resulted in a strongly 
varying degree of suppression of the G2/M accumulation. However, when there was any detectable 
rescue of the cell cycle defect it was far weaker than that observed after GLC7 overexpression 
(Fig. 33). Furthermore, overexpression of GLC83HA under control of the stronger constitutive GPD 
promoter did not rescue the G2/M accumulation to any extent, even though GLC83HA was significantly 
overexpressed (data not shown). Thus, the most plausible interpretation is that GLC8 overexpression 
partially suppresses temperature sensitivity, but does not affect the cell cycle defect of shp1-7, in 
agreement with previous evidence that both phenotypes are not strictly linked (Fig. 33). 
However, some uncertainties remain, as Glc8 previously has been described to regulate Glc7 by 
inhibition, inactivation, and activation depending on the stoichiometry of the two proteins (Tan et al., 
2003; Cannon, 2010). Strong overexpression of GLC8 is supposedly inhibitory, while a certain amount 
of Glc8 is required for Glc7 activity. If the ratio of Glc7 to Glc8 is tightly restricted in order for Glc8 to 
be activating, and in turn for being able to rescue Glc7 activity in shp1-7, the wild-type Glc7 to Glc8 
ratio would first have to be determined and the experiments repeated with different degrees of GLC8 
overexpression. 
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4. Discussion 
During the course of this work the Cdc48Shp1 complex was identified as a regulator of cell cycle 
progression during the metaphase to anaphase transition by positive regulation of protein 
phosphatase 1/Glc7.  
Deletion of SHP1 was found to result in severe growth defects and a mitotic delay, phenotypes similar 
to those of glc7 alleles. shp1 mutants exhibited impaired cell cycle progression at the metaphase to 
anaphase transition caused by activation the spindle assembly checkpoint (SAC). Furthermore, null 
mutations of shp1 reduced nuclear Glc7 activity, as illustrated by the finding that two Glc7 substrates 
were hyperphosphorylated in shp1. The mitotic delay of shp1 could be suppressed by deletion of a 
SAC component or by overexpression of GLC7. Unperturbed cell cycle progression requires Ipl1 
kinase activity to be opposed by Glc7 phosphatase activity (Francisco et al., 1994; Sassoon et al., 
1999; Hsu et al., 2000; Pinsky et al., 2006a). Consequently, shp1 null mutants, like glc7 alleles (Pinsky 
et al., 2006a), suppressed the ipl1-321 temperature sensitivity. Cell cycle progression and wild-type 
Glc7 activity required the Cdc48Shp1 complex, as evident from the analysis of a Cdc48 binding mutant 
of shp1. Shp1 was furthermore demonstrated to interact with Glc7 in vivo, and the double mutant of 
shp1 and glc7-129 was found to be inviable. 
While all evidence indicates that the severe shp1 phenotypes are the result of reduced Glc7 activity, 
the mechanism of Glc7 regulation by Cdc48Shp1 remains elusive. Neither Glc7 protein levels nor 
localization were significantly altered in shp1. Glc7, however, was ubiquitinated to a considerably 
higher degree in shp1 than in wild-type, which could possibly account for reduced phosphatase 
activity. Furthermore, the interaction of Glc7 with its positive regulator Glc8 was substantially reduced 
in shp1. Deletion of GLC8, or mutation of its phosphorylation site required for Glc7 activation, was 
lethal in combination with shp1 null alleles, indicating a requirement of Glc7 activation by Glc8 in shp1. 
The reduced Glc7 activity in shp1 mutants could be a direct result of the altered ubiquitination, which 
could in turn negatively affect the interaction between Glc7 and Glc8. Alternatively, the by other 
mechanisms reduced Glc7-Glc8 interaction in shp1 could cause the decreased phosphatase activity.  
4.1 Phenotypic characterization of shp1 mutants 
The mammalian homolog of Shp1, p47, has been implicated in the regulation of homotypic membrane 
fusion processes of the Golgi, ER, and nuclear envelope as part of the p97p47 complex (Kondo et al., 
1997; Hetzer et al., 2001; Meyer, 2005). Even though several large-scale approaches which assayed 
the yeast knockout libraries for drug sensitivities (SGD, www.yeastgenome.org/), had identified 
numerous phenotypes of Δshp1, no molecular function or substrate of the budding yeast Cdc48Shp1 
complex was known at the beginning of this work.  
Very recently, however, a role of the Cdc48Shp1 complex in autophagy has been reported (Krick et al., 
2010). The authors demonstrate that Δshp1 mutants block starvation induced macroautophagy and do 
not degrade the model substrate GFP-Atg8. Furthermore, Δshp1 mutants do not accumulate 
autophagic bodies in the vacuole, indicating a defect in autophagosome biogenesis. Shp1 was shown 
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to directly interact with Atg8 in vivo an in vitro. The authors propose that Cdc48Shp1 functions by 
extracting Atg8 from a complex with an unknown fusion mediator (Krick et al., 2010). While the 
interaction of Shp1 with Atg8 was demonstrated to be direct, the authors did not rule out an effect of 
reduced Glc7 activity in the assays addressing autophagy. No function of Glc7 in autophagy has been 
demonstrated, however, Glc7 has been reported to regulate intracellular membrane fusion processes, 
including vacuolar vesicle fusion (Peters et al., 1999; Bryant and James, 2003).  
4.1.1 Null mutants of shp1 exhibit severe growth defects or lethality 
Deletion of SHP1 in S. cerevisiae resulted in a strong growth defect in the DF5 strain background and 
was lethal in the W303 strain background. Substrate specificity of the AAA ATPase Cdc48 is partially 
mediated by binding of two mutually exclusive substrate-recruiting cofactors, the Ufd1-Npl4 
heterodimer and Shp1. Taking into account that Cdc48 as well as Ufd1 and Npl4 are essential for 
viability, it was not unexpected that deletion of SHP1 resulted in a severe growth defect as well.  
The surprising finding that SHP1 deletion was lethal in the W303 strain background but viable in DF5, 
was addressed by analyzing differences between the two commonly used yeast laboratory strain 
backgrounds, W303 and S288C. The mutation of RAD5 to rad5-535 in earlier W303 strains was not 
responsible for lethality, as W303 Δshp1 RAD5 was also inviable. A probable cause of this difference 
in viability of Δshp1 is the polymorphic gene SSD1, which differs in S288C and W303 (see Results). 
Ssd1 has been demonstrated to function in the maintenance of cell wall morphology (Kaeberlein and 
Guarente, 2002). Consequently, Δssd1 mutants are sensitive to cell wall damaging agents such as 
osmotin or calcofluor white (Ibeas et al., 2001; Kaeberlein and Guarente, 2002). It has been proposed 
that Ssd1 functions in a pathway parallel to Pkc1 in regulating cell wall morphogenesis, and is thought 
to become essential once the Pkc1 pathway is impaired (Doseff and Arndt, 1995; Kaeberlein and 
Guarente, 2002).  
Due to the finding that the temperature sensitivity of shp1 mutants could be suppressed by 
1 M Sorbitol, it appears likely that the loss of Shp1 results in a cell wall defect. Consistently, shp1 is 
sensitive to calcofluor white ((Ando et al., 2007) and data not shown). It is therefore conceivable that 
the ssd1-d2 allele found in W303 increases the cell wall defects already present in shp1 cells. In 
agreement with this is the finding that 1 M Sorbitol enables growth of W303 Δshp1 (Fig. 14b). 
Interestingly, PKC1 overexpression or high osmolarity also suppresses the glc7-10 temperature 
sensitivity, suggesting that Pkc1 signaling is impaired in this mutant (Andrews and Stark, 2000). This 
could possibly indicate that the shp1 cell wall defect is caused by reduced Glc7 activity, which results 
in decreased Pkc1 signaling and therefore sensitivity towards ssd1-d2.  
However, as this assumption could experimentally not yet be confirmed, further possibilities were 
analyzed. The genomes of several yeast strains have been sequenced and can be publically 
accessed (Wellcome Trust Sanger Institute). Comparison of the sequencing results confirmed the 
published data that W303 contains an ssd1 allele with a point mutation (bp 2094) leading to a 
premature stop codon and C-terminal truncation of the protein by 553 amino acids. In contrast, 
comparing the W303 and S288C sequences of Cdc48 and its adaptors did not reveal any differences, 
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nor are there mutations resulting in amino acid changes in Glc7 or the PP1 like phosphatases Ppz1 
and Ppz2. The only difference found in this limited search was a point mutation within the GLC8 gene, 
resulting in an exchange of the terminal amino acid from proline (S288C) to glutamine (W303). No 
alteration in any other analyzed Glc7 subunit was found. This presumably indicates a complex genetic 
interaction between the mutation or alteration present in W303 and shp1, as would possibly be true for 
SSD1.  
4.1.2 The cell cycle defect of shp1 
One central finding of this work was that null mutations of shp1 resulted in an accumulation of cells in 
the G2/M phases of the cell cycle. shp1 cells arrested with separated spindle pole bodies, a short 
mitotic spindle, and 2 n DNA content when shifted to the non-permissive temperature 14°C (Fig. 24), 
indicating an arrest during metaphase or early anaphase. This time-point of delay was further 
confirmed using arrest/release experiments at the permissive temperature of shp1 null alleles. shp1 
mutants stalled at the metaphase to anaphase transition, as illustrated by stabilized Clb2 and Pds1 
(Fig. 24). This phenotype had also been reported in an earlier study addressing the role of Shp1 in 
membrane fusion (Thoms, 2002), and was recently demonstrated for a glucose repressible W303 
pGAL-3HA-SHP1 strain (Cheng and Chen, 2010). As deletion of SHP1 in W303 is lethal, Cheng and 
Chen employed a galactose inducible 3HA-SHP1 strain to study the effects of Shp1 depletion upon 
galactose removal.  
Progression though mitosis is thus evidently impaired in shp1 null mutants. The cause of the G2/M 
delay could either be a spindle or bi-orientation defect that triggers the SAC or activation of the G2 
DNA damage checkpoint. Activation of either checkpoint results in an arrest at the metaphase to 
anaphase transition with stabilization of Pds1 and Clb2, one of the major defects observed in shp1 
mutants. 
Upon DNA damage, the checkpoint kinase Chk1 inhibits the transition to anaphase by phosphorylating 
Pds1, and Rad53-Dun1 phosphorylation of Bfa1 prevents Clb2 degradation and mitotic exit (Gardner 
et al., 1999; Wang et al., 2001). Pds1 is hyperphosphorylated in a Rad9 and Mec1 dependent manner 
only in response to DNA damage (Cohen-Fix and Koshland, 1997; Wang et al., 2001), which inhibits 
APC/CCdc20 mediated Pds1 ubiquitination and degradation (Agarwal et al., 2003). Additionally, 
activation of the DNA damage checkpoint induces Rad53-Dun1 mediated hyperphosphorylation of 
Bfa1, which keeps the Tem1 GAP Bfa1-Bub2 active and thereby inhibits mitotic exit (Hu et al., 2001).  
Taken together, the phosphorylation state of Bfa1 and Pds1 shows characteristic differences during an 
activated SAC compared to an active DNA damage checkpoint. Furthermore, mutants of the DNA 
damage checkpoint such as Δrad53 and Δmec1 are not sensitive to benomyl, while all spindle 
checkpoint components are (Clemenson and Marsolier-Kergoat, 2006).  
Pds1 phosphorylation is not strikingly altered in shp1 compared to wild-type (Fig. 24b), suggesting that 
the DNA damage checkpoint does not induce Pds1 stabilization. Analysis of the Bfa1 phosphorylation 
state in Δshp1 was difficult to interpret, as the G1 and mitotic arrest efficiencies of shp1 cells differed 
strongly from those of wild-type cells (data not shown). However, as it was demonstrated that shp1 
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mutants are not defective in mitotic exit (Fig. 23), Bfa1 is most likely not hyperphosphorylated by 
Rad53-Dun1 in shp1.  
Moreover, shp1 mutants are sensitive to benomyl, and negatively interact with deletion mutants of 
spindle checkpoint components such as Mad1 (Collins et al., 2007; Costanzo et al., 2010), Mad2 
((Costanzo et al., 2010) and Fig. 26), Bub2 (Fig. 26), and Bub3 (Costanzo et al., 2010), indicating the 
requirement of an intact spindle checkpoint in shp1 mutants.  
While deletion of the spindle assembly checkpoint component MAD2 led to an enhanced growth 
defect in combination with shp1, it suppressed the G2/M accumulation of cells observed by flow 
cytometry (Fig. 26). These findings were nearly identical to those published for the depletion of Shp1 
in W303 pGAL-3HA-SHP1 Δmad2 (Cheng and Chen, 2010). Upon deletion of the central SAC 
component MAD2, the cell cycle delay or arrest induced by SAC activation is abrogated, while the 
primary defect leading to SAC activation is not resolved.  
 
Fig. 42. Activation of the SAC causes the metaphase to anaphase delay in shp1 mutants. Schematic overview of possible 
mechanisms resulting in a metaphase to anaphase delay with stabilization of Pds1 and Clb2, as observed for shp1 null mutants. 
If the Cdc48Shp1 complex is lacking, either DNA damage or a spindle/ chromosome bi-orientation defect causes activation of the 
spindle assembly checkpoint (SAC). An active SAC inhibits the APC/CCdc20 mediated degradation of Pds1 and Clb2. Stabilized 
Pds1 and Clb2 inhibit the metaphase to anaphase transition. Phosphorylation of Pds1 or inhibition of the mitotic exit network 
(MEN) independently of the SAC is unlikely, as mitotic exit was demonstrated to be unimpaired in shp1 mutants and the cell 
cycle delay was shown to depend on the SAC (therefore depicted in gray).  
Therefore, it is evident that the G2 DNA damage checkpoint does not cause the metaphase to 
anaphase delay independently of the SAC in shp1. Thus, stabilization of Clb2 and Pds1 in shp1 
occurs by activation of the SAC and not by phosphorylation of Pds1 by Chk1 upon DNA damage, as 
SAC inactivation would not enable cells to overcome the inhibitory effect of Pds1 phosphorylation 
(Fig. 42). 
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However, even though the G2 DNA damage checkpoint and the spindle assembly checkpoint were 
thought to function mostly independent of each other, emerging evidence suggests a certain degree of 
crosstalk. Nocodazole treatment, and thereby activation of the SAC, also results in Mad2 dependent 
phosphorylation of the DNA damage checkpoint regulators Rad53 and Rad9, in the absence and 
presence of additional DNA damage (Clemenson and Marsolier-Kergoat, 2006). In turn, replication 
defective cdc6 mutants activate the SAC (Stern and Murray, 2001). Additionally, it has been 
demonstrated that DNA damage can activate the SAC independently of a functional kinetochore, but 
dependent on the kinases Mec1 (ATR) and Tel1 (ATM) (Kim and Burke, 2008).  
This interdependence of the G2 DNA damage checkpoint and the SAC make it even more difficult to 
speculate on the nature of the primary defect in shp1 mutants based on the presented data. The SAC 
causes the delay in shp1 null mutants, as the G2/M accumulation observed in FACS could be 
suppressed by deletion of the central SAC component MAD2. However, so far it cannot be ruled out 
that some DNA damage results in activation of the SAC in shp1 (Fig. 42).  
4.1.3 The cell cycle function of Shp1 depends on the Cdc48Shp1 complex 
This work demonstrates that the cell cycle function of Shp1 depends on the Cdc48Shp1 complex for the 
first time. Mutation of the Cdc48 binding sites within Shp1 caused a metaphase to anaphase delay 
and a synthetic growth defect in combination with Δmad2 (Fig. 27,28), which was nearly identical to 
the phenotypes observed for shp1 null mutants.  
The mitotic phenotype described for the original cold sensitive cdc48-1 allele was an arrest with 
unseparated spindle pole bodies, aberrant microtubules, and a large bud (Moir et al., 1982; Frohlich et 
al., 1991). This suggests a defect in spindle pole body duplication and/or separation, which then leads 
to a defect in mitosis as no mitotic spindle can be formed. In contrast to this early study, Cheng and 
Chen report a SAC dependent metaphase arrest for the temperature sensitive cdc48-3 allele. The 
authors suggest that a defect in kinetochore-microtubule attachment is responsible for spindle 
assembly checkpoint activation (Cheng and Chen, 2010), which would be consistent with the defects 
identified for the Cdc48 binding mutant of shp1.  
However, as Cdc48 fulfills more than one critical role during cell cycle progression (Moir et al., 1982; 
Latterich et al., 1995; Cao et al., 2003; Fu et al., 2003; Archambault et al., 2004; Cheng and Chen, 
2010), conditional alleles such as cdc48-1 and cdc48-3 presumably do not affect one isolated function 
mediated by one specific Cdc48 sub-complex. Therefore, the phenotypes of these alleles are difficult 
to interpret as they may arise from the combination of multiple Cdc48 functions and defects. In 
contrast, the Cdc48 binding mutant of shp1 is predicted to only affect Cdc48Shp1 functions and should 
not impair further critical processes that depend on other Cdc48 sub-complexes. Using this mutant, it 
could clearly be demonstrated that at least one cell cycle function of Cdc48, namely the regulation of 
the metaphase to anaphase transition, is mediated by the Cdc48Shp1 complex.  
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4.2 Regulation of Glc7 cell cycle function by Cdc48Shp1 
4.2.1 Reduction of Glc7 activity in shp1 mutants 
Shp1 has been proposed to be a positive regulator of Glc7 phosphatase activity (Zhang et al., 1995; 
Cannon, 2010). shp1 cells tolerate GLC7 overexpression, have reduced PP1 activity, and phenocopy 
certain glc7 alleles (Zhang et al., 1995; Wilson et al., 2005). Therefore, investigating the relationship 
between Shp1 and Glc7 was the main focus of this work. 
4.2.1.1 Genetic interaction of shp1 with glc7 
The shp1-7 null allele was found to be synthetically lethal with the cell cycle allele glc7-129. This 
negative genetic interaction depended on Cdc48 binding of Shp1, as demonstrated by the fact that the 
shp1 binding mutants shp1-a1 and shp1-b1 were unable to rescue the synthetic lethality of 
shp1-7 glc7-129 (Fig. 30). These findings are consistent with the negative genetic interaction reported 
for cdc48-3 and glc7-12 in the W303 background (Cheng and Chen, 2010). Therefore it is conceivable 
that Cdc48Shp1 regulates a process which is essential in glc7 mutants.  
Furthermore, it was demonstrated that the cell cycle delay of the shp1 null and the shp1-a1 binding 
mutant could be suppressed by GLC7 overexpression (Fig. 33). GLC7 overexpression has been 
reported to be involved in silencing an activated SAC (Pinsky et al., 2009). Indeed, shp1 mutants were 
demonstrated to delay the cell cycle at the metaphase to anaphase transition in dependence of an 
activated SAC (Fig. 26). Therefore, GLC7 overexpression could silence the activated checkpoint in 
shp1 mutants and result in cell cycle progression and a wild-type FACS profile. This effect would be 
similar to that observed upon checkpoint inactivation by deletion of MAD2.  
In contrast, the effect of GLC7 overexpression in shp1 mutants significantly differed from the 
phenotypes observed for the double mutant shp1 Δmad2. Deletion of the SAC component MAD2 in 
shp1 resulted in an even stronger growth defect than that observed for the single mutant shp1 
(Fig. 26,28), while GLC7 overexpression in shp1 had no negative effect on growth (Fig. 33). This 
difference was also reflected by the FACS profiles, as only GLC7 overexpression resulted in a FACS 
profile very similar to wild-type, indicating that these cells did not accumulate massive defects. 
Therefore it is likely that GLC7 overexpression in shp1 mutants does not rescue the cell cycle 
distribution by mere SAC silencing, but rather by increasing nuclear Glc7 activity against still elusive 
targets above a critical threshold required for cell cycle progression.  
4.2.1.2 The Ipl1/Glc7 balance at the kinetochore is impaired in shp1 mutants 
Consistent with the assumption that loss of Shp1 reduces Glc7 phosphatase activity, shp1-7 was 
shown to exhibit decreased nuclear Glc7 activity towards Ipl1 substrates. Null mutation of shp1 
partially rescued viability of ipl1-321 at the non-permissive temperature (Fig. 31), presumably by 
decreasing Glc7 phosphatase activity and thereby restoring the kinase to phosphatase balance. 
Furthermore, the Ipl1/Glc7 substrates histone H3 and Dam1 were demonstrated to be 
hyperphosphorylated in shp1 null mutants (Fig. 32). Both the suppression of the ipl1-321 temperature 
sensitivity as well as hyperphosphorylation of histone H3 was dependent on the loss of Cdc48 binding 
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of Shp1. Therefore, the Shp1 function in regulating Glc7 activity towards Ipl1 substrates is apparently 
mediated by the Cdc48Shp1 complex.  
W303 depleted of Shp1 was also demonstrated to suppress ipl1-321 temperature sensitivity, while 
cdc48-3 was not able to suppress this phenotype (Cheng and Chen, 2010). This may indicate that 
Cdc48 is not involved in regulating the Glc7 function in opposing Ipl1. However, the authors speculate 
that additional defects of cdc48-3 prevent the rescue of the ipl1-321 ts phenotype (Cheng and Chen, 
2010). This explanation is likely, as the data for the different shp1 mutants clearly show that 
suppression of ipl1-321 temperature sensitivity inversely correlates with the degree of Cdc48 binding 
to Shp1 (Fig. 31).  
shp1 mutants are delayed at the metaphase to anaphase transition due to an activated spindle 
assembly checkpoint. As discussed in 4.1.2 the delay depends on an intact SAC and is not caused 
solely by Pds1 and Clb2 stabilization through the G2 DNA damage checkpoint. However, which defect 
or event triggers the SAC activation is still elusive.  
Given the fact that Glc7 has been demonstrated to counteract Ipl1 in regulating attachment of 
kinetochores to microtubules (Biggins et al., 1999; Sassoon et al., 1999; Kang et al., 2001; 
Cheeseman et al., 2002; Pinsky et al., 2006a), hyperactivity of Ipl1 at kinetochores in shp1 is 
conceivable to be the cause of the attachment defect leading to SAC activation (Fig. 43). Unbalanced 
activity of Ipl1 would result in hyperphosphorylation of one or more critical kinetochore substrates and 
thereby in an increased number of unattached kinetochores, which in turn activate the SAC (Fig. 43b). 
Consistently, Cheng and Chen demonstrated that lack of Shp1 negatively affects kinetochore-
microtubule attachments. Upon Shp1 depletion, one fourth of the analyzed large budded cells 
exhibited an attachment defect, as indicated by localization of GFP-chromosome III close to one SPB 
(Cheng and Chen, 2010). 
If this assumption were correct, it would be expected that decreasing Ipl1 activity in shp1 should 
suppress the attachment defect (Fig. 43e). Indeed, reducing Ipl1 activity mutually suppressed the 
temperature sensitivity of both single mutants, as demonstrated for ipl1-321 shp1-7 and ipl1-321 upon 
Shp1 depletion (Fig. 31 and (Cheng and Chen, 2010)). Secondly, if Ipl1 phosphorylates certain 
kinetochore proteins and, due to decreased Glc7 activity in shp1 mutants, causes an accumulation of 
kinetochores lacking attachment, the SAC should be activated. Inactivation of the SAC would enable 
cells to progress through anaphase with chromosomes lacking attachment, leading to chromosome 
missegregation and presumably decreased viability (Fig. 43c), which is consistent with the observed 
defects in shp1-7 Δmad2 (Fig. 26,28). Furthermore, overexpression of GLC7 rescued the mitotic delay 
of shp1 (Fig. 33), possibly by balancing Ipl1 activity at the kinetochore and reducing the number of 
unattached kinetochores by dephosphorylation of a critical Ipl1 target (Fig. 43d).  
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Fig. 43. Reduced Glc7 activity in shp1 results in Ipl1 hyperactivity at the kinetochore and causes SAC activation due to 
lack of attachment. Hypothetical model of the Glc7/Ipl1 balance at the kinetochore in different strains. a) In a wild-type situation 
Ipl1 senses syntelic attachments to SPBs (black) and phosphorylates critical kinetochore proteins (red). This phosphorylation 
results in impairment of the kinetochore-microtubule interaction and generates kinetochores lacking attachment (orange). Lack 
of attachment activates the SAC and causes a cell cycle arrest. Glc7 counter-acts the Ipl1 kinase activity towards these 
substrates and thereby enables microtubule binding and bi-orientation, resulting in cell cycle progression. b) In shp1 mutants 
Glc7 activity is reduced and not sufficient to fully balance Ipl1 kinase activity. Ipl1 activity at the kinetochore is therefore high and 
microtubule binding is reduced. This causes a sustained activation of the SAC and a cell cycle delay. c) Deletion of the SAC 
component MAD2 in shp1 prevents the SAC activation and the cell cycle delay. However, as Ipl1 activity is not balanced at the 
kinetochore, chromosomes lacking attachment are missegregated and viability is decreased. d) GLC7 overexpression (o/e) 
presumably increases Glc7 activity at the kinetochore and the kinase to phosphatase balance is restored. The critical 
kinetochore protein is more efficiently dephosphorylated by Glc7 and microtubule binding and bi-orientation achieved. 
e) Reduced Ipl1 activity in shp1 ipl1-321 double mutants restores the kinase to phosphatase balance at the kinetochore. 
Additionally, the reduced activity of Ipl1 results in an impaired detection of syntelic attachments lacking tension, presumably 
causing increased chromosome missegregation. This may also partially be counteracted by the reduction of Glc7 activity in 
shp1-7, further increasing the number of properly bi-oriented chromosomes.  
The critical Ipl1 substrate, which must be dephosphorylated by Glc7 to allow proper cell cycle 
progression, remains to be identified. However, Ipl1 mediated Dam1 phosphorylation is essential for 
viability, as simultaneous mutation of all phosphorylation sites is lethal (Cheeseman et al., 2002). 
Furthermore, phospho-mimicking mutants of Dam1 are severely impaired in growth, but can partially 
suppress the temperature sensitivity of ipl1-2 mutants. Conversely, such Dam1 serine to aspartate 
mutants are synthetically lethal with glc7-10, while the corresponding alanine mutants of the 
phosphorylation sites are not (Cheeseman et al., 2002). This suggests that Dam1 could be a critical 
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Glc7/Ipl1 target. Thus, it will be interesting to test the Dam1 phosphorylation mutants in shp1 during 
future studies. If Ipl1 mediated phosphorylation of Dam1 were responsible for the increased lack of 
attachment and subsequent cell cycle delay in shp1, then the Dam1 serine to alanine mutants should 
at least partially rescue this effect.  
Alternatively or additionally, other kinetochore proteins such as Ndc10 or Ndc80 could also be critical 
Ipl1 substrates that must be dephosphorylated by Glc7 to enable microtubule binding to kinetochores 
(Biggins et al., 1999; Sassoon et al., 1999; Akiyoshi et al., 2009a). However, a phospho-mimicking 
mutant of Ndc80 has been demonstrated to exhibit intact kinetochore-microtubule interactions and to 
arrest with bipolar attached chromosomes (Kemmler et al., 2009), indicating that Ndc80, or these 
Ndc80 phosphorylation sites, are not involved in regulating the kinetochore-microtubule interaction.  
4.2.2 Phosphorylation of Shp1 at five major sites is not required for regulation of Glc7 activity 
Recently it was reported that Glc7 activity towards Dam1 and histone H3 is positively regulated by the 
TOR complex 1 (TORC1) (Tatchell et al., 2011). Mutations of the Tco89 subunit of TORC1 suppress 
the temperature sensitivity of ipl1-321 and exhibit hyperphosphorylation of histone H3 and Dam1. Glc7 
nuclear localization is reduced by approximately 25% upon Tco89 mutation (Tatchell et al., 2011). As 
no Glc7 phosphorylation has been reported so far, the authors speculate that regulatory subunits of 
Glc7 are modified by TORC1 (Tatchell et al., 2011). Shp1 residues S106 and S108 were identified as 
potential TORC1 sites (Huber et al., 2009), leading the authors to propose that Cdc48Shp1 may act 
downstream of TORC1 to regulate Glc7 (Tatchell et al., 2011).  
If Cdc48Shp1 indeed acts downstream of TORC1 to regulate Glc7, mutation of the predicted 
phosphorylation sites within Shp1 should suppress the ipl1-321 temperature sensitivity. No effect on 
ipl1-321 temperature sensitivity was observed in combination with the three phosphorylation mutants 
of Shp1 (shp1S106,108A, shp1S315,321,322A, shp15A) (data not shown). Furthermore, all three serine to 
alanine mutants rescued the lethality of shp1-7 glc7-129 and shp1-7 Δglc8 and did not display a 
growth or mitotic defect in FACS (Fig. 19 and data not shown). Unless a dephosphorylation event on 
Shp1 promotes Glc7 activity, these results indicate that phosphorylation of Shp1 by any kinase at the 
analyzed sites is not required for regulation of Glc7 activity. As the null mutant of shp1 exhibits 
decreased Glc7 activity, it is rather unlikely that the dephosphorylation of Shp1 is required for Glc7 
activation. However, to exclude this possibility, phospho-mimicking mutants of Shp1 would have to be 
tested for genetic interaction with ipl1, glc7, and glc8. Nonetheless, in contrast to the Cdc48 binding 
mutants, the analyzed phosphorylation mutants of Shp1 clearly do not affect the cell cycle function of 
the Cdc48Shp1 complex. 
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4.2.3 Mechanism of Glc7 regulation by Cdc48Shp1 
Many of the phenotypes identified for shp1 mutants can be attributed to a process that requires Glc7 
activity. For example, shp1 mutants have been demonstrated to be deficient in glycogen storage, 
meiosis, and vacuolar fusion, all processes known to be regulated by Glc7 (Cannon, 2010). However, 
the only process during which an effect on Glc7 substrates has been shown in shp1 is, as discussed, 
cell cycle regulation. Dam1 and histone H3 are so far the only Glc7 substrates demonstrated to be 
hyperphosphorylated in shp1.  
Even though Shp1 is considered a positive regulator of Glc7, no mechanism or model of regulation 
has been identified, nor has an interaction between Glc7 and Shp1 been reported (Cannon, 2010). 
However, the co-immunoprecipitation experiments presented in this work demonstrate that Glc7 does 
interact with Shp1 in vivo (Fig. 29).  
Shp1 could regulate Glc7 protein levels, localization, posttranslational modification, or the interaction 
with certain subunits and thereby mediate phosphatase activity. Removal of an unidentified inhibitor 
from Glc7 may also be plausible. However, strong overexpression of GLC7 should generate a large 
excess over the inhibitor and completely restore Glc7 activity. As GLC7 overexpression neither fully 
rescues shp1 nor is toxic in shp1, this mechanism of regulation appears unlikely.  
4.2.3.1 Protein levels and localization of Glc7 in shp1 
Protein levels and localization of Glc7 have been demonstrated to be unaffected by shp1 null mutation 
(Zhang et al., 1995), a finding that was verified in this work.  
Cheng and Chen, however, postulate that the Cdc48Shp1 complex mediates nuclear transport or 
localization of Glc7 and thereby regulates the Glc7/Ipl1 balance required for proper chromosome 
bi-orientation (Cheng and Chen, 2010). The authors demonstrate that GFPGlc7 is excluded from the 
nucleus upon Shp1 depletion in a W303 pGAL-3HA-SHP1 GLC7 strain. This is contradictory to what 
was observed in the DF5 shp1-7 GLC7GFP strain (Fig. 34,35). Nuclear levels of Glc7GFP are, if at all, 
slightly reduced in shp1-7, but Glc7GFP is by no means excluded from the nucleus. Furthermore, the 
interaction of Glc7 with its nuclear targeting subunit Sds22 was also demonstrated to be intact in 
shp1-7 (Fig. 36). The study by Cheng and Chen employed a strain expressing GFPGlc7 in addition to 
the endogenous untagged Glc7. The authors did not analyze protein levels of GFPGlc7 compared to 
endogenous Glc7, nor did they comment on the functionality of the N-terminally epitope tagged Glc7 
variant (Cheng and Chen, 2010). Additional expression of untagged Glc7 in shp1 strains resulted in a 
reduced nuclear Glc7GFP signal (Fig. 35). This most likely reflects the difference between the results 
presented in this work and by Cheng and Chen. Therefore, it is improbable that nuclear localization of 
Glc7 in shp1 is significantly reduced and it is highly unlikely to be the cause of reduced Glc7 activity 
towards Ipl1 substrates.  
Moreover, Shp1 is thought to be a positive regulator of global Glc7 activity (Cannon, 2010). Lysates of 
shp1 strains have reduced total phosphatase activity and deletion mutants are defective in glycogen 
accumulation (Zhang et al., 1995; Wilson et al., 2005). If the only effect of SHP1 deletion were 
decreased nuclear localization of Glc7, one would expect that cytosolic functions of Glc7 should not be 
affected. Therefore, other or additional mechanisms of Glc7 activity regulation by Cdc48Shp1 must 
exist. The observed slightly decreased nuclear localization could be a consequence rather than the 
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cause of the actual regulatory mechanism, such as posttranslational modification or altered interaction 
with targeting subunits.  
4.2.3.2 Glc7 ubiquitination is altered in shp1 
As Glc7 protein stability, expression, and localization are not altered in shp1 mutants, one further 
possible regulatory mechanism of phosphatase activity is alteration of posttranslational modification. 
This work demonstrates for the first time that Glc7 is ubiquitinated in vivo and this modification was 
furthermore shown to be significantly altered in Δshp1 cells.  
Activity of Glc7 must be regulated during the cell cycle by some mechanism, as Glc7 has been 
demonstrated to be required for chromosome bi-orientation and silencing of the spindle checkpoint. 
While Glc7 activity is required at the kinetochore to counteract Ipl1 during chromosome bi-orientation, 
Glc7 must at the same time be restrained from prematurely silencing the spindle checkpoint. This 
could either be achieved by altering Glc7 localization or by modulating its activity either by binding of 
regulatory subunits or by modification.  
Ubiquitination of Glc7 in vivo could directly inhibit phosphatase activity and thereby mediate Glc7 
function. Alternatively, ubiquitination could result in degradation of Glc7. However, Glc7 protein levels 
have been demonstrated to be constant throughout the cell cycle (Nigavekar et al., 2002) therefore, 
degradation could only affect small amounts of the overall protein. Furthermore, ubiquitination could 
serve as a non-proteolytic signal and mediate extraction of Glc7 from certain cellular structures, 
possibly by Cdc48. If Glc7 ubiquitination would function to enable Glc7 extraction, then the sub-
complexes from which it must be removed are most likely inhibitory, as it is otherwise not reasonable 
why Glc7 activity should be reduced in shp1. Inhibition of Glc7 within these complexes could be 
caused by the inability of activating or other regulatory subunits to bind Glc7. 
Either degradation or deubiquitination of Glc7 would depend on Cdc48Shp1, as ubiquitinated forms of 
Glc7 are enriched in shp1 cells. Interestingly, the DUB Otu1 has been found to exhibit a synthetic 
growth defect in combination with a glc7 allele (Logan et al., 2008). Furthermore, Cdc48 and Shp1 
have been demonstrated to interact with Otu1 (Rumpf and Jentsch, 2006). In a highly speculative 
model Cdc48Shp1 in complex with Otu1 could regulate Glc7 ubiquitination. The DUB Otu1 would trim 
ubiquitin chains on Glc7 required for activation of the phosphatase. Null mutation of shp1 would result 
in increased ubiquitination as Cdc48 and Otu1 could not be recruited to the substrate Glc7 by Shp1. 
This altered ubiquitination of Glc7 could in turn result in reduction of phosphatase activity and cause a 
cell cycle defect due to decreased Glc7 activity.  
This would be similar to the mechanism described for the p97p47 dependent regulation of homotypic 
membrane fusion during Golgi reassembly (Wang et al., 2004; Meyer, 2005). During Golgi 
fragmentation so far unidentified critical components are ubiquitinated. Upon activation of p47 in 
telophase, the p97p47 complex binds these ubiquitinated substrates and the associated 
deubiquitinating enzyme VCIP135 removes ubiquitin, enabling Golgi reassembly (Wang et al., 2004).  
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4.2.3.3 Interaction of Glc7 with regulatory subunits in shp1 
The described altered posttranslational modification or other mechanisms could also influence the 
interaction of Glc7 with its regulatory subunits. As Glc7 has little or no substrate specificity this could 
result in phenotypes resembling glc7 alleles.  
As discussed, binding of the nuclear targeting subunit Sds22 to Glc7 was not affected by shp1 null 
mutation. However, overexpression of SDS22 was toxic in shp1 cells. Increased expression of SDS22 
suppresses both the mitotic phenotype of glc7-12 as well as the ipl1 temperature sensitivity 
(MacKelvie et al., 1995; Pinsky et al., 2006a). It has been proposed that SDS22 suppresses ipl1 by 
titrating the critical targeting subunit opposing Ipl1 away from Glc7 and thereby reducing phosphatase 
activity at the kinetochore (Pinsky et al., 2006a). This suggests that the interaction of Glc7 with the 
critical Ipl1 opposing subunit is essential in shp1, presumably because Glc7 activity is reduced. 
Furthermore, Shp1 was found to genetically interact with the positive Glc7 regulator Glc8. The double 
mutant of shp1 and Δglc8 was demonstrated to be inviable, supporting the hypothesis that both Glc8 
and Shp1 are activators of Glc7. However, the mechanism of Glc7 activation by Glc8 is poorly 
understood. Several glc7 alleles have been demonstrated to depend on phosphorylatable Glc8 for 
viability (Tan et al., 2003). The mammalian Glc8 homolog I-2 presumably fulfills a chaperone 
analogous function towards PP1 (Alessi et al., 1993). Hence, it has been speculated that Glc8 
modulates Glc7 conformation and function, which becomes essential for viability in strains that have 
particular, not yet defined, Glc7 defects (Cannon, 2010). The synthetic lethality of shp1-7 Δglc8 could 
not be rescued by Cdc48 binding mutants of shp1, nor by the phosphorylation mutant of glc8 
(Fig. 39b), indicating a requirement of Glc7 activation by Cdc48Shp1 or phospho-Glc8. The decreased 
Glc7 activation in Δglc8 combined with a reduced Glc7 activity in shp1 mutants may therefore cause 
lethality due to insufficient phosphatase activity.  
Interestingly, the interaction of Glc7 with Glc8 was significantly impaired in shp1 null mutants. 
However, no ternary complex of Shp1, Glc7 and Glc8 could be demonstrated in vivo. Thus, if Shp1 
does not directly mediate the interaction of Glc7 with Glc8, an altered localization of Glc8, the 
ubiquitination state of Glc7, or other mechanisms may be responsible for the reduced interaction. 
Glc8GFP nuclear localization appears to be reduced in shp1 cells (Fig. 40d). Therefore, the nuclear 
pool of Glc7 presumably cannot interact with Glc8, which may account for the observed reduction of 
the Glc7-Glc8 interaction in shp1-7. Additionally, impaired nuclear localization of Glc8 could also affect 
its phosphorylation state, as Pho85 kinase has been reported to localize mainly to the nucleus (Huh et 
al., 2003). A reduction of Glc8 phosphorylation would in turn result in a reduced ability of Glc8 to 
activate Glc7. However, it remains unclear if the altered localization of Glc8 is caused by defects or 
modification of Glc7 or indicates a mislocalization of Glc8 due to the lack of Shp1.  
Nonetheless, consistent with the assumption that a reduced Glc7-Glc8 interaction in shp1 results in 
decreased Glc7 activity was the finding that overexpression of GLC8 partially suppressed the 
temperature sensitivity of shp1. Consequently, overexpression of the glc8T118A mutant, which cannot 
be phosphorylated by Pho85 and is therefore impaired in Glc7 activation, was toxic in shp1 mutants 
(Fig. 41).  
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This is in contrast to what has been observed for the suppression of ipl1 temperature sensitivity. 
Deletion of GLC8 and overexpression both suppress the ipl1 temperature sensitivity. According to the 
currently accepted model GLC8 overexpression inhibits Glc7 activity. Furthermore, the suppression of 
the ipl1 temperature sensitivity is increased by overexpression of non-phosphorylatable mutants of 
GLC8 (Tung et al., 1995). As the suppression of the shp1-7 temperature sensitivity by overexpression 
of GLC8 depended on the phosphorylation sites required for Glc7 activation, it is conceivable that Glc7 
activity was not inhibited but rather increased upon overexpression of GLC8 in shp1. The finding that 
overexpression of the glc8T118A mutant was toxic in shp1 suggests that this Glc8 mutant further 
reduces Glc7 activity in shp1. The non-phosphorylatable Glc8 mutant presumably interacts with Glc7 
without being able to activate phosphatase activity, and, as it is overexpressed, titrates the “active” 
Glc8 away from Glc7, further reducing phosphatase activity.  
The presented results are so far consistent with a model in which Cdc48Shp1 regulates the interaction 
of Glc7 with its activating subunit Glc8. Impairing the interaction of Glc8 with Glc7 in shp1 reduces 
Glc7 activity and therefore leads to the observed phenotypes. However, inconsistent with this 
hypothesis is the fact that GLC8 is neither essential, nor does the deletion mutant display any strong 
phenotype. Deletion of GLC8 results in slightly reduced glycogen levels and reduced Glc7 
phosphatase activity, but does not lead to a growth or cell cycle defect ((Cannon et al., 1994), Fig. 39). 
Therefore, the impaired interaction of Glc7 with Glc8 in shp1 mutants cannot be the only cause of the 
severe phenotypes of shp1 mutants.  
Furthermore, GLC8 overexpression does not clearly rescue the cell cycle defect of shp1, as 
overexpression of GLC7 does. Conversely, GLC7 overexpression restores a wild-type FACS profile, 
but does not rescue the temperature sensitivity of shp1. This would suggest that GLC7 and GLC8 
overexpression affect two distinct aspects of shp1 phenotypes.  
The temperature sensitivity of shp1 was partially suppressed by 1 M Sorbitol, suggesting that this 
phenotype may be caused by cell wall defects that result in cell lysis at higher temperatures. The cell 
lysis defect of glc7-10 at 37°C and the growth defect are suppressed by 1 M Sorbitol or PKC1 
overexpression, while the mitotic defect is unaffected (Andrews and Stark, 2000). This indicates that at 
least two distinct substrates cause the cell morphology and the mitotic defect of glc7 mutants. 
Similarly, overexpression of GLC8 in shp1 could possibly affect a Glc7 function required for cell wall 
morphogenesis and be independent of the mitotic function of Glc7. If the Glc8 interaction with Glc7 
were required for the function in cell wall morphogenesis, GLC7 overexpression may not be sufficient 
to suppress this defect, as “active” or correctly localized Glc8 could be limiting. The reduced 
interaction of Glc7 with Glc8 found in shp1 could in turn cause the cell wall integrity defect and 
temperature sensitivity. As Δglc8 mutants are not temperature sensitive (data not shown) and do not 
have any reported cell wall defect, the interaction of Glc7 with Glc8 is not required for cell wall 
morphogenesis in wild-type yeast cells. However, negative genetic interactions of Δglc8 with Δssd1 
(see 4.1.1) and deletion mutants of the kinases Bck1 and Slt2, which act downstream of Pkc1, have 
been reported (Fiedler et al., 2009), suggesting a requirement of Glc8 in mutants with cell wall defects.  
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However, further complicating an interpretation is the reported requirement of a certain Glc7-Glc8 
stoichiometry for activation of Glc7 phosphatase activity by a so far poorly understood mechanism 
(Tan et al., 2003; Cannon, 2010). Therefore, the results of GLC7 and GLC8 overexpression may also 
differ due to the degree of induction and cellular abundance of the respective binding partner. Further 
experiments have to be performed to address the stoichiometry of Glc7 to Glc8 required for partial 
suppression of shp1 phenotypes.  
Furthermore, shp1 mutants could have multiple defects resulting in temperature sensitivity and growth 
impairment. This appears plausible, as the double mutant of ipl1-321 and shp1-7 also partially 
suppresses the temperature sensitivity of shp1, even though Ipl1 is linked to a mitotic function of Glc7. 
It may therefore be useful to test combinations of partially suppressing conditions, such as the 
simultaneous overexpression of GLC7 and GLC8 in shp1, or the phenotypic analysis of ipl1-321 shp1 
in 1 M Sorbitol or upon PKC1 overexpression. 
In summary, at least two Shp1-dependent mechanisms appear to regulate Glc7 activity. First, Shp1 
affects the activating Glc8-Glc7 interaction, possibly by mediating nuclear localization of Glc8. Second, 
the Cdc48Shp1 complex positively regulates the activity of nuclear Glc7 opposing Ipl1 kinase and 
thereby ensures unperturbed cell cycle progression.  
Material and Methods 
 
 
79
 
5. Material and Methods 
5.1. Material 
5.1.1 Chemicals and reagents 
Unless otherwise indicated commonly used chemicals were obtained from Roth, Sigma Aldrich, 
Merck, and Serva.  
5.1.2 Databases 
The following electronic databases were used: PubMed (http://www.ncbi.nlm.nih.gov/pubmed/), the 
“Saccharomyces Genome Database” (SGD, http://www.yeastgenome.org/), the Biological General 
Repository for Interaction Datasets (BioGRID, http://thebiogrid.org/index.php), UniProt 
(http://www.uniprot.org/), the Saccharomyces Genome Resequencing Project BLAST server 
(http://www.moseslab.csb.utoronto.ca/sgrp/), and the vector database (VectorDB, http://genome-
www.stanford.edu/vectordb/).  
5.1.3 Media and plates 
5.1.3.1 S. cerevisiae media and plates 
YPD (Yeast Peptone Dextrose) 
 2% (w/v) glucose (Sigma Aldrich) 
 1% (w/v) bacto yeast extract (Difco, BD) 
 2% (w/v) bacto peptone (Difco, BD) 
Master-mix for drop-out mixtures 
 20 g alanine    (Merck) 
 20 g arginine    (Merck) 
 20 g asparagine    (Merck) 
 20 g aspartic acid    (Sigma Aldrich) 
 20 g cysteine    (Merck) 
 20 g glutamine    (Merck) 
 20 g glutamic acid    (Fluka) 
 20 g glycine     (Merck) 
 20 g inositol     (Sigma Aldrich) 
 20 g isoleucine    (Merck) 
 20 g lysine     (Merck) 
 2 g para-aminobenzoic acid  (Merck) 
 20 g phenylalanine   (Merck) 
 20 g proline    (Merck) 
 20 g serine    (Merck) 
 20 g threonine   (Merck) 
 20 g tyrosine   (Merck) 
 20 g valine    (Merck) 
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Drop-out mixtures for SC-media and plates 
 36.7 g master-mix  
 addition of the following supplements with the exception of the drop-out(s) of interest 
 2 g histidine (Merck) 
 4 g leucine  (Merck) 
 2 g uracil  (Sigma Aldrich) 
 2 g tryptophan (Merck) 
 2 g methionine (Merck) 
 0.5 g adenine (Sigma Aldrich) 
SC (Synthetic Complete)  
      2% (w/v) glucose (Sigma Aldrich) added after autoclaving 
 0.67% (w/v) yeast Nitrogen Base (Difco, BD) 
   0.2% (w/v) drop-out mixture 
For most applications 2xSC was used and the pH adjusted to 5.8 prior to autoclaving 
(if necessary) 
YPD and SC- plates 
2% (w/v) agar (Difco, BD) was added directly to YPD medium or after autoclaving to 2xSC-
medium 
Antibiotic selection plates (YPD) 
  G418 (Roth)   200 mg/l 
  Nourseothricin (HKI Jena)  100 mg/l 
  Hygromycin B (Calbiochem)  300 mg/l 
 added to YPD with 2% (w/v) agar after autoclaving at 55°C 
5’FOA plates 
 2% (w/v) glucose (Sigma Aldrich) added after autoclaving 
   0.67% (w/v) yeast Nitrogen Base (Difco, BD) 
     0.2% (w/v) SC-complete drop-out powder 
 0.003% (w/v) adenine (Sigma Aldrich) 
 0.003% (w/v) uracil (Sigma Aldrich) 
       2% (w/v) agar (Difco, BD)  
 0.1% (w/v) 5’fluoroorotic acid (Zymo Research) added after autoclaving 
Benomyl plates 
The appropriate amount of a 1.5 mg/ml Benomyl (Sigma Aldrich) stock solution in DMSO was 
added to YPD/ 2% (w/v) agar directly after autoclaving. 
Further plates for phenotypic analysis 
All drugs, with the exception of benomyl, were added to YPD/ 2% (w/v) agar after autoclaving 
at 55°C. 
5.1.3.2 E. coli media and plates 
Luria-Bertani-Medium (LB) 
    1% (w/v) tryptone (Difco, BD) 
 0.5% (w/v) yeast extract (Difco, BD) 
    1% (w/v) NaCl 
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LB-ampicillin/ -kanamycin plates 
 ampicillin 50 mg/l 
kanamycin  30 mg/l  
added to LB/ 1.5% (w/v) agar after autoclaving at 55°C 
5.1.4 Plasmids 
Plasmid Source 
pGBD-C1,2,3 
pGAD-C1,2,3 (James et al., 1996) 
YIplac 211, 204, 128 
YCplac 33, 22, 111 
YEplac 195, 112, 181 
(Gietz and Sugino, 1988) 
pUG36 (Niedenthal et al., 1996) 
pGBT9-SHP1 (Schuberth et al., 2004) 
pGBD-shp1ΔUBX (Schuberth, 2006) 
pGBD-shp1S4ΔUBX (Neves, 2005) 
pGBD-shp1S1S3S4 (Neves, 2005) 
pGBT9-CDC48 (Braun et al., 2002) 
pGAD-CUE3 this work 
pGAD-YGL108c this work 
pGAD-YNL155w this work 
pGAD-HDA2 this work 
pGAD-TEM1 this work 
pGAD-NDC80 this work 
pGAD-GLC7 this work 
pGBD-GLC7 this work 
YEpCUP-6xHisubiquitin (Hoege et al., 2002) 
YCplac33-SHP1 (Schuberth, 2006) 
YCplac111-SHP1 (Schuberth, 2006) 
YCplac111-shp1-a1 this work 
YCplac111-shp1ΔUBA (Schuberth, 2006) 
YCplac111-shp1ΔUBX (Schuberth, 2006) 
pUG36-GFP-tubulin this work 
YCplac111-GLC7 this work 
YCplac111-GLC8 this work 
YCplac111-glc8T118A this work 
YEplac195-pADH-GLC7  this work 
YCplac111-shp1SS106108AA this work 
YCplac111-shp1S315,321,322A this work 
YCplac111-shp1S106,108,315,321,322A this work 
YEplac195-SDS22 (MacKelvie et al., 1995) 
Table 2. Plasmids used in this study. 
5.1.5 E. coli strains 
XL1 Blue.  supE44, hsd R17, rec A1, gyr A46, thi, rel A1, lac-, F’ [proAB +, lac lq, lacZ M15, 
Tn10(tet r)] 
XL10 Gold:  Tetr ∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 
lac I [F´ proAB lacIqZ∆M15 Tn10 (Tetr) Amy Camr]. 
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5.1.6 S. cerevisiae strains 
Strain Genotype Source 
DF5a MATa ura3-52, leu2-3,-112 lys2-801, trp1-1, his3Δ200 
(Finley et al., 
1987)  
W303 MATa/α leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 RAD5 
(Thomas and 
Rothstein, 1989) 
PJ69-4a 
MATa, trp1-901, leu2-3,-112, ura3-52, 
his3D200,gal4Δ, gal80Δ, GAL2-ADE2, LYS2::GAL1-
HIS3, met2::GAL7-lacZ 
(James et al., 
1996) 
RCY3-1C MATa leu2-3,112 ura3-52 HIS3::GAL10-FLP1 [cir0] (Zhang et al., 1995) 
YPH499 MATa, ura3-52, lys2-801amber, ade2-101ochre, trp1Δ63, his3Δ200, leu2Δ 
(Sikorski and 
Hieter, 1989) 
SUB280 
MATa lys2-801 leu2-3,112 ura3-52 his3- Δ 200 trp1-
1[am] ubi1-Δ1::TRP1 ubi2-Δ2::ura3 ubi3-Δub-2 ubi4-
Δ2::LEU2 [pUB39] [pUB100] 
(Spence et al., 
1995) 
SUB413 
MATa lys2-801 leu2-3,112 ura3-52 his3- Δ 200 trp1-
1[am] ubi1-Δ1::TRP1 ubi2-Δ2::ura3 ubi3-Δub-2 ubi4-
Δ2::LEU2 [pUB-K63R] [pUB100] 
(Spence et al., 
1995) 
shp1-1 RCY MATa leu2-3,112 ura3-52 HIS3::GAL10-FLP1 shp1-1 [cir0] 
(Zhang et al., 
1995) 
shp1-2 RCY MATa leu2-3,112 ura3-52 HIS3::GAL10-FLP1 shp1-2 [cir0] 
(Zhang et al., 
1995) 
Δshp1 DF5a Δshp1::kanMX6 (Braun et al., 2002) 
ySB838/ shp1-7 DF5a shp1 ATG->ACC pop-in pop-out this work 
ySB958/ shp1-b1 DF5a shp1ΔCdc48 pop-in pop-out this work 
ySB944/ shp1-a1 DF5a shp1a-1 pop-in pop-out this work 
ySB185/ shp1-a1 DF5a Δshp1::kanMX6 YIplac211-shp1a-1::URA3 this work 
ySB218/ shp1-a3 DF5a Δshp1::kanMX6 YIplac211-shp1a-3::URA3 this work 
ySB219/ shp1-a4 DF5a Δshp1::kanMX6 YIplac211-shp1a-4::URA3 this work 
ySB220/ shp1-a5 DF5a Δshp1::kanMX6 YIplac211-shp1a-5::URA3 this work 
ySB155/ shp1ΔUBA DF5a Δshp1::kanMX6 YIplac211-shp1ΔUBA::URA3 this work 
ySB154/ shp1ΔUBX DF5a Δshp1::kanMX6 YIplac211-shp1ΔUBX::URA3 this work 
ySB320 W303a/α Δshp1::kanMX6/SHP1 this work 
ySB272 W303a Δshp1::kanMX6 YC33-SHP1 this work 
ySB756/757 W303a Δshp1::kanMX6 (1 M Sorbitol) this work 
ySB217 DF5 shp1myc7His::kanMX4 this work 
ySB293 DF5 shp17His::kanMX4 this work 
ySB196 DF5a Δshp1::kanMX6 YIplac211-shp1SSAA::URA3 this work 
ySB565 DF5a SHP13HA::HIS3MX6 this work 
yCS160 YPH499 SHP19myc::klTRP1 (Schuberth, 2006) 
ySB30 YPH499 CUE33HA::HIS3MX6 SHP19myc::klTRP1 this work 
ySB29 YPH499 YGL108c3HA::HIS3MX6 SHP19myc::klTRP1 this work 
ySB31 YPH499 YNL155w3HA::HIS3MX6 SHP19myc::klTRP1 this work 
ySB36 DF5 HDA29myc::HIS3MX6 this work 
ySB37 DF5a TEM19myc::HIS3MX6 this work 
ySB38 DF5 NUT29myc::HIS3MX6 this work 
ySB223 DF5 YI211-pADH-HisUb::URA3 this work 
ySB234 DF5a YI211-pADH-HisUbK63R::URA3 this work 
ySB448 DF5a CLN23HA::klTRP1 this work 
ySB449 DF5a Δshp1::kanMX6 CLN23HA::klTRP1 this work 
ySB423/424 DF5a Δshp1::kanMX6 YIplac128-pMET25-CDC143HA::LEU2 (clone 4 and 5) this work 
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cdc15-2 W303 a cdc15-2 W. Seufert 
ySB425/426 W303 a cdc15-2 YIplac128-pMET25-CDC143HA::LEU2 (clone 2 and 3) this work 
ySB967 DF5 a SIC13HA::klTRP1 this work 
ySB427 DF5 a Δshp1::kanMX6 SIC13HA::klTRP1 this work 
ySB332 DF5a SPC42Mars:: nat-NT2 this work 
ySB341 DF5a Δshp1::kanMX6 SPC42Mars::nat-NT2 this work 
ySB1164 DF5a PDS118myc::klTRP1 this work 
ySB1165 DF5a shp1-7 PDS118myc::klTRP1 this work 
ySB1039 DF5a Δmad2::HIS3MX6 this work 
ySB1036 DF5a shp1-7Δmad2::HIS3MX6 this work 
ySB370 DF5α Δbub2::HIS3MX6 this work 
ySB369 DF5 Δbub2::HIS3MX6 Δshp1::kanMX6 this work 
ySB566 DF5a GLC73myc::HIS3MX6 SHP13HA::klTRP1 this work 
ySB542 DF5a GLC73myc::HIS3MX6 this work 
ySB554 DF5a Δshp1::kanMX6 GLC73myc::HIS3MX6 this work 
ySB569 DF5a SHP13HA:: klTRP1 this work 
ySB501 DF5a GLC73HA::klTRP1 this work 
ySB1040 DF5α glc7-127 pop-in pop-out this work 
ySB1042 DF5α glc7-129 pop-in pop-out this work 
ySB1088 DF5 shp1-7 glc7-129 YC33-SHP1 this work 
ySB1098 DF5α ipl1-321 pop-in pop-out this work 
ySB1168 DF5 shp1-7 ipl1-321 this work 
ySB506 DF5a DAM19myc::HIS3MX6 this work 
ySB1204 DF5α ipl1-321 DAM19myc::klTRP1 this work 
ySB1203 DF5α glc7-129 DAM19myc::klTRP1 this work 
ySB1205 DF5 shp1-7 ipl1-321 DAM19myc::klTRP1 this work 
ySB676 DF5a YIplac128-pMET25::LEU2 this work 
ySB1220 DF5a shp1-7 YIplac128-pMET25::LEU2 this work 
ySB581 DF5a YIplac128-pMET25-GLC7::LEU2 this work 
ySB933 DF5a shp1-7 YIplac128-pMET25-GLC7::LEU2 this work 
ySB1209 DF5a shp1-a1 YIplac128-pMET25::LEU2 this work 
ySB1210 DF5a shp1-a1 YIplac128-pMET25-GLC7::LEU2 this work 
ySB497 DF5a GLC7GFP::klTRP1 this work 
ySB886/1061 DF5a shp1-7 GLC7GFP::klTRP1 this work 
ySB1078 DF5a shp1-b1 GLC7GFP::klTRP1 this work 
ySB665 DF5α Δglc8::hph-NT1 this work 
ySB1178 DF5  shp1-7Δglc8::hph-NT1 YC33-SHP1 this work 
ySB688 DF5a SDS223myc::klTRP1 this work 
ySB927 DF5a shp1-7 SDS223myc::klTRP1 this work 
ySB924 DF5a GLC83HA::klTRP1 this work 
ySB925 DF5a shp1-7 GLC83HA::klTRP1 this work 
ySB460 DF5a Δbar1::hph-NT1 this work 
ySB1064 DF5a shp1-7 Δbar1::hph-NT1 this work 
ySB1066 DF5a GLC83HA::klTRP1 Δbar1::hph-NT1 this work 
ySB1067 DF5a shp1-7 GLC83HA::klTRP1Δbar1::hph-NT1 this work 
ySB1216 DF5a YIplac128-pMET25-GLC83HA::LEU2 this work 
ySB1218 DF5a YIplac128-pMET25-glc8T118A3HA::LEU2 this work 
ySB1224 DF5a shp1-7 YIplac128-pMET25-GLC83HA::LEU2 this work 
ySB1227 DF5a shp1-7 YIplac128-pMET25-glc8T118A3HA::LEU2 this work 
ySB1256/1257 DF5a GLC8GFP::klTRP1 (clone 1 and 2) this work 
ySB1258/1259 DF5a shp1-7 GLC8GFP::klTRP1 (clone 1 and 3) this work 
Table 3. S. cerevisiae strains used in this study. 
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5.1.7 Antibodies 
5.1.7.1 Primary antibodies 
Antigen Type Dilution for Western blot 
Amount 
for IP Source 
Shp1 rabbit polyclonal 1:1000- 1:10000 2 μl Jentsch Department (MPI of Biochemistry, Martinsried) 
Cdc48 rabbit polyclonal 1:1000- 1:5000  AB95, Jentsch Department (MPI of Biochemistry, Martinsried) 
Myc (9E10) mouse monoclonal  4.5 μl Sigma Aldrich 
Myc (9E10) mouse monoclonal 1:1000  Santa Cruz Biotechnology Inc. 
HA (F7) mouse monoclonal 1:1000  Santa Cruz Biotechnology Inc. 
Glc7 goat antiserum 1:5000  C. Chan, University of Texas at Austin- ICMB (Tung et al., 1995) 
Clb2 rabbit polyclonal 1:2000  Santa Cruz Biotechnology Inc. 
GFP mouse monoclonal 1:1000  Clontech 
Phospho-
Histone H3 
rabbit polyclonal 1:1000  Millipore (Upstate) 
Histone H3 
ChiP grade 
rabbit polyclonal 1:1000  Abcam 
Table 4. Primary antibodies used in this study. 
5.1.7.2 Secondary antibodies, horseradish peroxidase (HRP) coupled  
Goat anti-rabbit  Jackson Immunoreseach (Dianova) dilution 1:7500 
Goat anti-mouse Jackson Immunoreseach (Dianova) dilution 1:7500 
Donkey anti-goat Jackson Immunoreseach (Dianova) dilution 1:7500 
5.2. Methods 
The following methods are based on standard biochemical, microbiological and molecular biological 
protocols previously described (Ausubel et al., 1987; Sambrook and Russell, 2001) and were modified 
and applied as denoted. Certain S. cerevisiae protocols were adapted from methods described in 
(Abelson et al., 1991; Abelson et al., 1997). 
5.2.1 Protein biochemical methods 
5.2.1.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Denatured protein samples were applied to 8%, 10%, 12%, or 15% polyacrylamide gels and 
separated by electrophoresis as described (Laemmli, 1970). Separating gels were of the above 
mentioned acrylamide (Acrylamide/Bis Solution, 37.5:1, Serva) concentrations, stacking gels were 
always 4%. To denature protein samples they were incubated at 65°C for 10 min in HU buffer/ DTT 
(8 M urea, 5% SDS, 0.2 M Tris pH 6.8, bromophenol blue and 0.1M DTT prior to use). Electrophoresis 
of mini gels (Hoefer Mini Gel System) was carried out using Laemmli running buffer (25 mM Tris, 
192 mM glycine, 0.1 % SDS) at 20 mA per gel and depending on application a maximum of 150 V. 
Approximate protein size was estimated by comparison to a pre-stained protein standard (AllBlue, 
BioRad). 
5.2.1.2 Western blot 
After SDS-PAGE proteins were blotted to PVDF membrane (Millipore) using a semi-dry blotting 
system. The membrane and Whatman filter papers were cut to gel size and soaked in blotting buffer 
(25 mM Tris, 192 mM glycine, 0.01 % SDS, 20 % methanol). Gels were blotted at constant current 
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(150 mA per mini gel) and limited to 15 V for 2-3 hours. After blotting the membranes were blocked 
using 5 % non-fat milk (Merck) in TBS-T (TBS/ 0.02% Tween20) for at least 30 min. For immunological 
detection of blotted proteins incubation with primary antibody in blocking solution (with 0.065% sodium 
azide) was carried out overnight at 4°C. After washing with TBS-T (1x5min, 3x10min) the membrane 
was incubated with horseradish peroxidase coupled secondary antibody for 1-2 h at room 
temperature. This was again followed by washing with TBS-T (6x10 min) and once with ddH2O. For 
chemiluminescent detection the ECL reagent mixture (GE Healthcare) was added to each membrane, 
spread evenly, and the signal detected using ECL-Hyperfilm (GE Healthcare). Developed films were 
scanned and processed using Adobe Photoshop (Adobe Systems Inc.) and/ or ImageJ 
(http://imagej.nih.gov/ij/) software. 
5.2.1.3 Yeast whole cell lysates- TCA precipitation  
The necessary amount of cells (release/ FACS cell amount in 1 ml of OD600=0.6, otherwise in 1 ml of 
OD600=1; OD600=1 is approximately equal to 107 cells/ ml) was harvested by centrifugation and then 
resuspended in 1 ml ddH2O. Alternatively the appropriate amount of cells was resuspended in 1 ml 
ddH2O directly from plates. To lyse cells, 150 μl 1.85% NaOH/ 7.5 % β-mercaptoethanol were added 
and the samples were vortexed. After incubation for 10 min on ice 150 μl 55 % TCA were added to the 
samples, they were vortexed and again incubated on ice for 10 min. Protein precipitates were then 
collected by centrifugation (20000 g, 10 min, 4°C), the supernatant was aspirated, and the pellet was 
centrifuged again to remove the remaining liquid. Pellets were then resuspended in 50 μl HU/ DTT and 
incubated at 65°C for 10 min. If necessary the pH of the samples was adjusted by addition of 2-4 μl 
2 M Tris-base. 
5.2.1.4 Immunoprecipitation (IP) 
Yeast cultures were grown in YPD to an OD600 of 1, harvested and washed once with cold ddH2O/ 
1 mM PMSF (1000 g, 4°C, 5 min). Cells were then lysed in IP buffer (50 mM Tris/ HCl pH 7.5, 
100 mM KCl, 5 mM MgCl2, 0.1%  NP-40, 10% glycerol, 10 mM NaF, 2 mM PMSF, complete protease 
inhibitor cocktail (Roche)) by addition of zirconia beads (Biospec) and vortexing (6x 30sec). After lysis 
the NP-40 concentration was increased to 1%, and the extracts were centrifuged at 2,600 g for 5 min, 
followed by centrifugation at 20,000 g for 25 min. An input sample (10 μl) was taken prior to antibody 
addition and denatured by adding an equal amount of HU/ DTT and incubation at 65°C for 10 min. The 
supernatants were incubated with 20 μl pre-coupled HA-antibody (Santa Cruz Biotechnology Inc.), or 
4.5 μl myc, or 2 μl Shp1 antibodies and rotation at 4°C over night. Immunocomplexes were then either 
bound to 20 μl protein A sepharose beads (GE Healthcare) for three hours (4°C) or directly washed if 
pre-coupled beads were used. Beads were washed four times (600 μl IP buffer/ 1% NP-40 for 10 min, 
800 μl IP buffer/ 1%NP-40 8 min, 800 ml IP-buffer 5 min, 1 ml IP buffer) and eluted in 25 μl HU/ DTT, 
10 min, 65°C.  
5.2.1.5 Denaturing Ni-NTA Pull-down 
Denaturing Ni-NTA pull-downs of yeast overexpressing 6xHis epitope tagged ubiquitin were used to 
detect in vivo ubiquitination of proteins. Yeast strains were either transformed with YE-pCUP-HisUb, or 
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strains in which YI211-pADH-HisUb had been integrated were used. Overnight cultures were grown in 
selective medium without induction of the copper promoter. 200 ml selective medium were inoculated 
to OD600 of 0.1 and incubated at 30°C or 25°C. In the case of strains carrying pCUP-HisUb, 
overexpression of Hisubiquitin was induced approximately 3 h before harvesting the cultures by 
addition of 100 µM CuSO4 to the culture. Upon reaching OD600 0.8-1.0, the cultures were harvested by 
centrifugation (5500 g, 10 min, 4°C), were resuspended in 10 ml ice-cold sterile ddH2O and were 
transferred to 50 ml round-bottom tubes. After centrifugation (3500 g, 10 min, 4°C), the supernatant 
was discarded and the pellets were frozen in liquid nitrogen. Cells were lysed by resuspending the 
frozen pellet in 5 ml 1.85 N NaOH/ 7.5 % β-mercaptoethanol and incubation on ice for 15 min. 
5 ml 55 % (w/v) TCA were added, the samples were vortexed and incubated on ice for 15 min. 
Precipitated proteins were collected by centrifugation (3500 g, 10 min, 4°C) and the pellet was washed 
twice with 5 ml ice cold (-20°C) acetone. The protein pellets were then thoroughly resuspended in 2 ml 
denaturing buffer A (6 M guanidinium chloride, 0.1 M NaH2PO4, 10 mM Tris, 0.05 % Tween20 pH 8) 
and were incubated at RT and 80 rpm for one hour to further increase solubilization of the TCA-
precipitate. Remaining insoluble material was removed by centrifugation (23000 g, 20 min, 4°C). The 
imidazole concentration of the supernatant was increased to 20 mM and a 10 % input sample was 
taken. The lysate was then incubated with 50 µl magnetic Ni-NTA agarose (Qiagen) at 4°C overnight. 
Using a magnetic rack (Dynal), the beads were washed three times with 800 µl buffer A/ 20 mM 
imidazole and then five times with 800 µl buffer C (8 M urea, 0.1 M NaH2PO4, 10 mM Tris pH 6.3 and 
0.05% Tween20). To elute bound proteins the beads were incubated with 30 µl 1 % SDS for 10 min at 
65°C. The eluate was then concentrated using a speed-vac (25 min, 45°C) and was resuspended in 
15 µl HU/ DTT and 10 µl ddH2O. Input samples were subjected to TCA-precipitation (see 5.2.1.3) and 
were finally resuspended in 25 µl HU/ DTT. Both samples were incubated at 65°C for 10 min prior to 
SDS-PAGE. Typically 3 µl input and 7 µl pull-down were loaded on SDS-PAGE gels.  
5.2.1.6 Two step purification of phosphorylated Shp1 for mass-spectrometry 
Strains expressing Shp1myc7His were grown to OD600 of 1-1.5 and harvested. Lysis and Ni-NTA pull-
down were performed as described above for Hisubiquitin pull-downs. Most (25 µl) of the SDS eluate 
was directly diluted 1:24 with RIPA*** (50 mM Tris, 5 mM EDTA, 150 mM NaCl, 1.25 % Triton X-100) 
buffer and incubated with 20 μl of pre-coupled anti-myc beads (Santa Cruz Biotechnology Inc.) 
overnight. The remaining 5 µl were used as a PD eluate/ IP-input control. The beads were then 
transferred to empty protein columns (BioRad), the flow-through was collected and the beads were 
then washed six times with 600 µl RIPA* (50 mM Tris, 5 mM EDTA, 150 mM NaCl, 1.25 % Triton 
X-100, 0.1 % SDS) buffer and bound protein was eluted in 50 µl 1 % SDS. The eluate was 
concentrated using a speed-vac and then resuspended in 7.5 µl HU/ DTT and 12.5 µl ddH2O.  
For mass-spectrometry the sample was analyzed on a pre-cast 10% Gel and run with MOPS buffer 
(Invitrogen). The strong band at approximately 50 kD was excised and analyzed using an OrbiTrap 
mass spectrometer and peptides were identified using Mascot Daemon software (all performed by 
Frank Siedler MPI of Biochemistry, Martinsried).  
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5.2.2 E. coli Methods 
5.2.2.1 Preparation of competent E. coli  
Electrocompetent E. coli 
An overnight culture of XL1 blue cells in LB-tetracycline was diluted in LB medium and grown at 37°C 
to a final OD600 of 0.7. The culture was then rapidly cooled by incubation on ice for 30-60min. Cells 
were harvested by centrifugation (10 min, 4°C), quickly washed with 500 ml sterile ice-cold ddH2O and 
were resuspended in 250 ml sterile ice-cold 10% glycerol. After 30 min incubation on ice the cells 
were harvested and resuspended in 10 ml ice cold 10 % glycerol and again incubated on ice for 
30 min. After harvesting the cells (6000 rpm, 10min) the pellet was resuspended in an approximately 
equal volume of 10% glycerol and aliquots were frozen in liquid nitrogen and stored at -80°C. 
CaCl2 competent E. coli 
The overnight culture of XL1 blue cells was diluted in LB medium and grown at 37°C to final OD of 
0.6-0.8. Cultures were then cooled on ice and cells were harvested by centrifugation. The pellet was 
resuspended in 100 mM ice-cold sterile CaCl2 solution and incubated on ice for 10 min. Cells were 
harvested (5000 rpm, 4°C, 10 min) and the pellet was resuspended in 1/10 volume CaCl2, incubated 
at least 10 min on ice and DMSO was added to a final concentration of 10%. Aliquots of cells were 
frozen in liquid nitrogen and stored at -80°C.  
5.2.2.2 Transformation of E. coli with DNA 
To transform CaCl2 competent E. coli 50 µl of cells were incubated with approximately 250 ng plasmid 
DNA on ice for 20 min. They were then subjected to heat-shock for 1 min at 42°C and cooled on ice. 
Depending on the application phenotypic expression was carried out for at least 30 min at 37°C.  
Electrocompetent cells were transformed by transferring the mixture of 50 µl cells and 1.5 µl ligation 
product or plasmid DNA to a 0.1 cm electroporation cuvette (BioRad, VWR). The pre-installed settings 
for E .coli and 0.1 cm cuvettes were used (1.8 kV, 1 pulse; Micropulser, BioRad). Directly after 
electroporation LB medium was added and phenotypic expression was carried out for 45 min at 37°C. 
5.2.2.3 Plasmid isolation from E. coli cultures 
Small amounts of plasmid DNA were extracted from E. coli by mini preparation. Single clones were 
inoculated in 5 ml LB medium with the applicable antibiotic. After harvesting the cells different mini 
preparation kits (Machery Nagel, Bioneer, Qiagen, Zymoprep) were used for isolation of plasmid DNA. 
All kits were based on the alkaline lysis method (Birnboim and Doly, 1979).  
5.2.3 Molecular biology methods 
5.2.3.1 Polymerase chain reaction (PCR) 
For amplification of DNA fragments from plasmids or genomic DNA Phusion DNA polymerase (NEB) 
was used. Annealing temperature and elongation time were chosen depending on primer composition 
and fragment length. For the amplification of fragments from genomic DNA, polymerase activity of 
about 1 kb/ min was used for calculation of the elongation time.  
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To amplify the knockout and tagging cassettes used for yeast strain construction, a mixture of Taq and 
Vent polymerases (NEB) was used. PCR reaction conditions and buffers were used as described 
(Knop et al., 1999; Janke et al., 2004).  
5.2.3.2 Site-directed mutagenesis 
Site-directed mutagenesis was carried out using the QuikChange Multi, XL and Lightning Kits 
(Stratagene/ Agilent) according to the manufacturer’s protocol. In most cases more DpnI digested 
mutagenesis reaction was transformed into XL10 Gold cells (Stratagene/ Agilent) than denoted in the 
protocol.  
5.2.3.3 Restriction digest 
Manufacturer (NEB or Fermentas) instructions for buffer and digest conditions were followed. For 
cloning generally 2 μg plasmid DNA were digested and 600 ng of mini-prep DNA for control digests. 
5.2.3.4 Electrophoresis and DNA extraction from agarose gels 
Depending on the application 0.8- 1.6% agarose gels in TBE buffer were used. DNA was visualized by 
addition of 0.2 μg/ml ethidium bromide (Roth). Prior to applying the DNA samples to the gel, loading 
buffer (0.1 M EDTA, 1 % SDS, 20 % glycerol, 0.2 % bromophenol blue and xylencyanol) was added. 
The DNA samples, as well as a DNA size standard (1 kb ladder, Invitrogen; GeneRuler 1 kb ladder, 
Fermentas) were separated by electrophoresis at 80- 120 V. After 20- 60 min DNA was visualized 
using a UV-transilluminator and size and amount of the DNA samples was estimated by comparison 
with the DNA standard.  
In case of preparative digests for cloning, the appropriate DNA fragment was excised using a scalpel. 
The DNA was isolated from the agarose as described in the manufacturer’s protocol for gel extraction 
kits (Machery Nagel, Bioneer). The extracted DNA was typically eluted in 30 μl of the supplied elution 
buffer. 
5.2.3.5 Vector dephosphorylation and ligation 
To reduce the number of false-positive transformants due to vector re-ligation during cloning, digested 
vector fragments were dephosphorylated according to the manufacturer’s protocol using Antarctic 
Phosphatase (NEB). Approximate amounts of dephosphorylated vector and insert were determined by 
agarose gel electrophoresis and a ratio of about 5:1 for insert to vector was used for the ligation 
reaction. DNA fragments were ligated using T4 DNA ligase (NEB, Fermentas) and in most cases the 
reaction was carried out at 16°C overnight. 
5.2.3.6 Sequencing 
Sequencing reactions were either performed by the MPI core facility (MPI of Biochemistry, 
Martinsried) or by GATC Biotec (Konstanz). Sequencing results were analyzed using the Lasergene 
software package (DNASTAR, Inc.). 
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5.2.4 S. cerevisiae methods  
5.2.4.1 Preparation of competent yeast cells (Knop et al., 1999) 
Overnight cultures of yeast strains grown in the appropriate medium were diluted to OD600 of 0.1 and 
grown at 25°C or 30°C until reaching a final OD600 of 0.5-0.7. The cells were then harvested by 
centrifugation (1000 g, 5 min, 24°C) and washed once with an equal volume of sterile ddH2O. The 
cells were pelleted again and were resuspended in 0.2 volumes of SORB buffer (100 mM LiOAc, 
10 mM Tris-HCl pH 8, 1 mM EDTA/ NaOH pH 8, 1 M Sorbitol; pH 8 with acetic acid). After 
centrifugation excess SORB buffer was removed and the pellet was resuspended in 360 µl SORB 
buffer per 50 ml culture volume. 40 µl of denatured salmon sperm DNA (10 mg/ml, Invitrogen) were 
added and the competent cells were aliquoted and stored at -80°C. 
5.2.4.2 Transformation of competent yeast cells (Knop et al., 1999) 
To transform yeast either with plasmid DNA or PCR products and integrative plasmids, 10 or 50 µl 
competent cells were thawed, respectively. After addition of the DNA to the cells, six volumes PEG 
buffer (10 mM Tris-HCl pH 8.0; 1 mM EDTA; 100 mM lithium acetate (Sigma Aldrich); 40% PEG3350 
(Sigma Aldrich)) were added, the mixture was vortexed, and incubated for 30 min at RT. Prior to the 
heat shock 1/9 Vol DMSO was added and the transformation mixture was then incubated at 42°C for 
15 min in a water bath (less for ts alleles). After cooling on ice, the cells were pelleted (500 g, 2 min, 
24°C) and resuspended in ddH2O or SC-medium and plated on the respective selection plates. For 
PCR cassettes with antibiotic resistance markers the transformed cells were incubated in 5 ml YPD for 
3 h (G418) or 6 h (hph-NT1, nat-NT2) and then pelleted and plated on the antibiotic containing plates. 
5.2.4.3 Integration of YIplac plasmids using homologous recombination 
YIplac plasmids (Gietz and Sugino, 1988) do not contain an origin of replication and therefore must be 
integrated into the yeast genome in order to be stably propagated. By linearization either within the 
selection marker or within the cloned yeast genomic insert, these constructs can be integrated into the 
chromosomal leu, trp or ura loci, or the genomic locus of interest, respectively. To this end, 
approximately 2 μg of YIplac constructs were digested using a restriction enzyme that cuts once either 
within the auxotrophy marker or the insert (typically: URA3: StuI, LEU2: ClaI, EcoRV, BstXI, TRP1: 
EcoRV). One fifth of the restriction digest was then directly transformed into 50 μl competent yeast 
cells. Once proper integration of the plasmid had been confirmed, the strains were also cultured using 
non-selective YPD or SC media. 
5.2.4.4 Yeast colony-PCR 
To verify chromosomal integration of knockout or epitope tagging cassettes, as well as for the 
identification of positive pop-in/ pop-out transformants, colony-PCR was used. A small amount of 
yeast cells was resuspended in 20 μl 0.02 N NaOH and approximately the same volume glass beads 
(Roth) were added. After 5 min incubation at 99°C and 1400 rpm the supernatant was collected and 
2 μl were directly used as a template for PCR. The PCR reaction was carried out using Thermopol 
buffer and Taq polymerase (both NEB) and was set up in 25 μl. For standard products smaller than 
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1kb the following PCR program used: 94°C 30 sec, 52°C 30 sec, 72°C 1 min for 30 cycles. 10 μl PCR 
product was analyzed on an agarose gel.  
5.2.4.5 Extraction of genomic DNA (gDNA) 
Genomic DNA was extracted using a protocol based on glass bead lysis and phenol/ chloroform 
extraction. At least 5 ml stationary overnight culture were harvested and washed with 1 ml ddH2O. The 
cell pellet was resuspended in 400 μl breaking buffer (100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA, 
1 % SDS, 2 % Triton X-100) and glass beads (Roth) as well as a mixture of phenol:chloroform:isoamyl 
alcohol (25:24:1) was added. The mixture was then vigorously vortexed for 5 min at RT. 200 μl TE 
buffer (10 mM Tris pH 8.0, 1 mM EDTA) were added, the mixture was shortly vortexed, and the 
phases were separated by centrifugation (10 min, 5000 g, RT). 500 μl aqueous supernatant were 
collected and extracted twice with equal volumes of chloroform. 1 ml 100 % EtOH was added to the 
aqueous supernatant and the DNA was precipitated by incubation at -20 C for 1-2 hours. The genomic 
DNA was harvested and was washed once with 1 ml 70 % EtOH. The DNA pellet was dried and 
resuspended in 25 μl ddH2O.  
Alternatively, a kit for extraction of yeast genomic DNA (Yeast-Geno-DNA-Template Kit, 
Gbiosciences). The protocol of the manufacturer was followed, in which the major difference to the 
previous protocol was a zymolyase digest to enable lysis. The genomic DNA extracted with the kit 
yielded better results regarding quantity and template quality for a subsequent (Phusion) PCR. 
5.2.4.6 Pop-in/ pop-out gene replacement 
The pop-in/ pop-out two-step method allows replacement of genes without introduction of any 
exogenous sequence elements such as resistance marker cassettes or loxP sites (Scherer and Davis, 
1979; Rothstein, 1991). The URA3 plasmid carrying the mutant gene is first integrated into the 
chromosomal locus, resulting in a duplication containing the wild-type gene and the mutant version 
separated by the plasmid sequence. By subsequent 5’FOA counter-selection, one of the two copies is 
removed and clones are screened for mutant phenotypes. This method was used to construct the 
shp1 mutant strains as well as for the introduction of glc7 and ipl1 conditional alleles into the DF5 
background.  
shp1 ATG?ACC mutagenesis was performed on YIplac211-SHP1 including promoter and terminator 
sequences. The mutated plasmid was linearized within the SHP1 ORF by restriction digest with 
BamHI and was then integrated into ura3-52 of DF5a. Clones were selected for URA auxotrophy, and 
positive transformants were identified by colony-PCR and subsequent KpnI digestion of the PCR 
fragment (a KpnI site is introduced by the mutation). Positive clones (2/10) were streaked twice on 
5’FOA and single colonies were selected. These clones were then analyzed by Western blot for Shp1 
expression and by PCR for the SHP1 ORF to exclude aberrant pop-out events that remove entire 
sequence stretches. 2/12 positive clones identified: shp1-7 and shp1-9. All mutants were then 
sequenced, either by cloning the ORF +/- 1kb (shp1-7/9) or by sequencing of a PCR product of the 
mutated region (shp1-a1, shp-b1, glc7-129, ipl1-321). 
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5.2.4.7 Mating of yeast strains 
Overnight cultures of two strains with the opposite mating types were inoculated to OD600 of 0.1 and 
incubated for approximately 3 h so that logarithmic growth phase was reached. 10 µl of each culture, 
adjusted to an equal OD600, were spotted on top of each other on a pre-warmed YPD plate. After at 
least 6 hours of incubation at 30°C, zygotes were either selected according to their characteristic 
morphology using a micro-manipulator (MSM100, Singer Instruments), or streaked on appropriate 
selection plates and incubated for 1-2 days. 
5.2.4.8 Mating type test 
To test yeast strains for their mating type or to verify zygotes, plates containing either a (RH449) or 
α (RC757-58) reporter strains were used. The respective reporter strain was resuspended in sterile 
ddH2O from freshly streaked plates, and 30 µl of this suspension were added to 8 ml liquid YPD 1 % 
(w/v) agar. The mixture was briefly vortexed and poured on top of a YPD plate to completely cover its 
surface. After drying the plates, DF5a and α, as well as the strains to be tested were streaked on both 
reporter plates. The plates were incubated at least one day at 30°C and analyzed for the formation of 
halos around cells of opposite mating types. 
5.2.4.9 Sporulation and tetrad dissection 
0.5 ml stationary culture of zygotes were harvested (500 g, 3 min, RT) and washed twice with an equal 
volume of sterile ddH2O. The pellet was then resuspended in 5 ml sporulation medium (2 % KAc) and 
incubated at least 4 days at RT with shaking. For tetrad dissection, 10 µl sporulated culture were 
digested with 10 µl zymolyase solution (1 mg/ml 20T, Seikagaku) for 8-10 min at RT. The spheroplasts 
were carefully transferred to a YPD plate and spread in a line dividing the plate in two halves. Tetrads 
were selected and separated into the four spores using a micro-manipulator (MSM100, Singer 
Instruments). Spores were incubated at least two days at 25°C or 30°C, depending on the 
phenotypes. Genotypes of the haploid progeny were identified using marker selection, colony-PCR 
and Western blot. 
5.2.4.10 Spotting of serial dilutions for phenotypic analysis  
To analyze phenotypes mutants, serial dilutions of yeast cultures were spotted on selective plates or 
plates containing drugs and incubated at varying temperatures. Overnight cultures were diluted with 
sterile ddH2O to OD600 of 0.1 (in some cases 0.3) and five fivefold serial dilutions were prepared in 
microtiter-plates. Approximately 5 µl of each dilution were transferred to the respective plates using a 
replica stamp with 96 pins. The plates were then incubated at the indicated temperatures for 3-7 days. 
5.2.4.11 Interaction studies using directed yeast two hybrid (Y2H) assays 
The coding sequences of bait and prey genes were cloned into pGBD-C1 and pGAD-C1 (James et al., 
1996), respectively. These vectors then express an N-terminal fusion of Gal4 transcriptional activator 
with the prey or an N-terminal fusion of the Gal4 DNA binding domain fused in frame to the bait. 
Different combinations of bait and prey plasmids were transformed into PJ69-4a yeast cells (James et 
al., 1996) and selected on SC-Leu-Trp plates. After 2-3 days the amount of cells in 1 ml OD600=0.5 
was spotted on SC-Leu-Trp (control), SC-Leu-Trp-His and SC-Leu-Trp-Ade and incubated 3-7 days at 
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30°C. To reduce background on SC-Leu-Trp-His plates 3 mM 3’amino triazole (3AT, Sigma Aldrich) 
was added to the plates.  
5.2.4.12 Robot-based Y2H screen 
The robot-based Y2H screens were conducted using a library of yeast strains expressing each of the 
>6000 yeast ORFs N-terminally fused to the Gal4 AD, spatially ordered on arrays (Cagney et al., 
2000; Gera et al., 2002). To introduce the bait plasmid into the strains of this array a mating strategy 
was used. PJ69-4α was transformed with the Gal4 BD fusion of the bait and mated to the Y2H array. 
Diploids carrying both plasmids were selected by growth on SC-Leu-Trp plates. Interaction of bait and 
prey was analyzed by growth on SC-Leu-Trp-His and SC-Leu-Trp-Ade plates. To increase stringency 
3 mM 3AT (Sigma Aldrich) was added to the SC-Leu-Trp-His plates. Plates were incubated for 
5- 7 days at 30°C and then scored for positive interactors. All steps were carried out using the Biomek 
FX automated workstation (Beckman Coulter) and a 384 pin replica tool. 
5.2.4.13 Live-cell microscopy (fluorescence and spinning disk confocal) 
Yeast strains were grown in the applicable sterile filtered SC or SC-complete media to avoid high 
background fluorescence. To immobilize cells, the cover slips were coated with 1 mg/ml 
concanavalin A (Type 5, Sigma Aldrich) and incubated for at least 30 min. The undiluted logarithmic 
culture was spotted on the cover slip, shortly incubated and sealed with Vaseline. Live-cell microscopy 
was carried out using different microscopes and software:  
 DM RXA (Leica) Axiovert 200M (Zeiss) Spinning Disk Confocal 
Camera Orca-ER (Hamatsu) AxioCam MRm TV2/3” 0.63x (Zeiss) 
D-977 iXon EMCCD+ 
and twofold magnification 
(Andor Technology) 
Software OpenLab 5.2 (Improvision) AxioVision LE (Zeiss) (Andor Technology) 
Objective  PL APO (Leica) 100x/1.4-0.7 oil  
Axio Apochrom (Zeiss) 
100x/1.4 oil  
TIRFM (Olympus) 
100x/1.45 oil 
Detection of green 
fluorophores (GFP) 
GFP 
excitation      BP 470/40 
beamsplitter  FT 500 
emission       BP 525/50 
FITC (#10) 
excitation      BP 450-490 
beamsplitter  FT 510 
emission       BP 515-565 
diode pumped solid state 
lasers (488 nm and 
561 nm) 
 
Samrock emission filters 
in a Sutter filter wheel 
Detection of red 
fluorophores 
(Mars) 
TexasRed 
excitation      BP 62/40 
beamsplitter  LP 593 
emission       BP 624/40 
Rhodamine (#20) 
excitation      BP 546/12 
beamsplitter  FT 560 
emission       BP 575-640 
Table 5. Details of microscope setups used in this study. BP: bandpass, FT:”farb teiler” beamsplitter, LP: longpass 
Data sets were analyzed and processed using ImageJ software (http://imagej.nih.gov/ij/) and the MBF 
ImageJ for Microscopy collection of plug-ins (http://www.macbiophotonics.ca/imagej/).  
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5.2.5 Cell cycle experiments in S. cerevisiae 
5.2.5.1 Analysis of DNA content by flow cytometry (FACS) 
Flow cytometry of yeast was carried out essentially as described (Lew et al., 1992). Yeast cultures 
were inoculated to an OD600 0.1 in YPD or SC medium and grown to a final OD600 of 0.7- 1.0 at RT. 
The amount of cells corresponding to 1 ml of OD600=0.6 was harvested by centrifugation (3500 g, 
3 min, 4°C) and washed once with 5 ml ddH2O. The cell pellet was then resuspended in 70% ethanol 
under constant vortexing to avoid clumping of cells. Fixation in ethanol at 4°C was carried out for at 
least 1 h, but mostly overnight. After fixation the cells were again harvested by centrifugation and 
washed once with 5 ml PBS. The cell pellet was then resuspended in 0.9 ml PBS and briefly sonified 
(6 pulses on lowest setting). To remove RNA 0.5 mg/ml RNase (Sigma Aldrich) were added and the 
sample was incubated overnight at 37°C (in case of shorter incubation times the RNase concentration 
was increased to 1 mg/ ml). Before propidium iodide (PI, Sigma Aldrich) staining, the cells were 
washed once with 5 ml PBS. DNA was stained overnight by gentle shaking at 4°C in 1 ml PBS/ 
0.05 mg/ml PI. For FACS measurement the cells were resuspended in PBS/ 0.005 mg/ml PI, sonified 
briefly and diluted approximately 1:4 in PBS. FACS analysis was carried using either a BD FACS 
Calibur and Cell Quest Pro software, a BD FACS Canto and FACS Diva software, or, for some 
measurements, a Beckman Coulter FC500 and CXP software. For post-acquisition analysis and 
quantification, WinMDI software (http://facs.scripps.edu/software.html) was used. 
5.2.5.2 α-factor arrest/ release 
Overnight cultures of wild-type and mutant strains were diluted to OD600 of 0.1 (for shp1 0.15) in 50 ml 
YPD for arrest/ release experiments or in 15 ml for arrests only. The cultures were then grown at 24°C 
for approximately four hours until reaching a maximal OD600 of 0.3-0.35. For a G1 arrest in BAR1 
strains, 10 μM α-factor in DMSO (Core facility, MPI of Biochemistry, Martinsried) were added and the 
cells were allowed to arrest for three hours, at 25°C. Directly before addition of α-factor, a control 
sample from the asynchronous culture was collected, and the pellet was frozen in liquid nitrogen. The 
efficiency of the arrest was determined by FACS analysis and/ or Western blot for Clb2 levels after 
three hours of arrest. In case of release experiments, the cultures were then washed two times with 
equal volumes of YPD (500 g, 3 min, 24°C) and resuspended to a final OD600 of approximately 0.5 in 
YPD. The released cultures were incubated at 25°C and samples for each time-point of the release 
were taken. Per time-point, an amount of cells corresponding to 1 ml of OD600=0.6 was removed from 
the culture, quickly pelleted and frozen in liquid nitrogen. Time-point 0 min was taken after the two 
washing steps, as shaking incubation of the cultures was continued. Typically time-points every 
20 min were taken for at least 180 min. The pellets were then subjected to TCA precipitation (see 
5.2.1.3) and were resuspended in 50 μl HU/DTT. Fluctuation of Clb2 or other cell cycle marker 
proteins was analyzed by Western blot. For some experiments FACS samples were taken in addition 
to Western blot samples. As for the Western blot samples, the amount of cells corresponding to 1 ml 
of OD600=0.6 was collected per time-point, but processed directly for FACS analysis rather than frozen 
in liquid nitrogen.  
 
Material and Methods 
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5.2.5.3 Nocodazole arrest/ release 
For mitotic arrests the spindle depolymerizing drug nocodazole (Sigma Aldrich, Enzo Life Sciences) 
was added to logarithmic yeast cultures. A protocol similar to the α-factor arrest was used, but cells 
were arrested with 150 µg/ml nocodazole in YPD. (A 1.5 mg/ml nocodazole stock solution in water-
free DMSO (Sigma Aldrich) was stored at -80°C and thawed only once prior to use.) After three hours, 
the arrest efficiency was monitored by Western blot of Clb2 levels or FACS profiles of DNA content. 
For release experiments, the cultures were washed twice with YPD/ 1% DMSO to remove all traces of 
the water insoluble nocodazole. The release was then monitored as described above for the α-factor 
arrest.  
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7. Abbreviations 
3AT 3’amino-1,2,4-triazole 
5’FOA 5-fluoroorotic acid 
AAA ATPases associated with diverse cellular activities 
AD Gal4 activation domain 
Amp ampicillin 
APC/C anaphase promoting complex/ cyclosome 
APS ammonium-peroxo-disulfate 
ATM ataxia-telangiectasia-mutated 
ATP adenosine 5’-triphosphate 
ATR ATM and Rad3-related protein 
BD Gal4 binding domain 
BUB budding uninhibited by benomyl 
cdc cell division cycle 
Cdk cyclin dependent kinase 
CEN centromeric 
CHX cycloheximide 
CIN chromosomal instability 
CP core particle 
CPC chromosomal passenger complex 
cs cold sensitive 
C-terminal carboxy-terminal 
ddH2O double distilled water 
DIC differential interference contrast 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dNTP deoxy nucleoside triphosphate 
DTT 1,4-dithiothreitol 
DUB deubiquitinating enzyme 
E. coli Escherichia coli 
ECL enhanced chemiluminescence 
EDTA ethylene diamine tetra-acetic acid 
ER endoplasmatic reticulum 
ERAD endoplasmatic reticulum associated degradation 
FACS fluorescence activated cell sorting 
FEAR fourteen early anaphase release  
FITC  fluorescein isothiocyanate 
g gravitational constant 9.81m/s2 
G1/G2 gap phases G1 and G2 
G418 geneticine disulfate 
GAP GTPase activating complex 
gDNA genomic DNA 
GEF guanine nucleotide exchange factor 
GFP green fluorescent protein 
GTP guanosine-5‘-triphosphate 
h hours 
HA hemagglutinin 
HECT Homologous to E6AP Carboxy Terminus 
His histidine 
HRP horseradish peroxidase 
HU hydroxyurea 
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Hyg hygromycin 
I-2 inhibitor 2 
IP immunoprecipitation 
Kan kanamycin 
kb kilo basepairs 
kD kilo Dalton 
LB Luria-Bertani 
Leu leucine 
LP 
BP 
FT 
longpass 
bandpass 
“farb teiler” 
LUBAC linear ubiquitin chain assembly complex 
mA milli-ampere 
MAD mitotic arrest deficient 
MCC mitotic checkpoint complex 
MEN mitotic exit network 
min minutes 
n.d. not determined 
NAT nourseothricin 
Noc nocodazole 
NP-40 Nonidet P-40 
NSF N-ethylmaleimide-sensitive fusion protein 
N-terminal amino-terminus 
OD optical density 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PD pull-down 
PEG polyethylene glycol 
PI propidium iodide 
Pkc1 protein kinase C 
PMSF phenylmethanesulfonyl fluoride 
PNGase peptidyl-N-glycanase 
PP1 protein phosphatase 1 
PVDF polyvinylidene fluoride 
RING Really Interesting New Gene 
RNA ribonucleic acid 
RNA Pol II RNA polymerase II 
RNase ribonuclease 
rpm rounds per minute 
RT room temperature, 24°C 
S. cerevisiae Saccharomyces cerevisiae 
SAC spindle assembly checkpoint 
SC synthetic complete 
SCF Skp1-Cullin-F-box complex 
SDS sodium dodecyl sulfate 
sec seconds 
SEP Shp1 Eyc p47 
SL synthetically lethal 
SNARE soluble NSF attachment protein 
SPB spindle pole body 
SRH second region of homology 
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SUMO small ubiquitin-like modifier 
TBE tris-borate-EDTA 
TBS tris-buffered saline 
TCA trichloroacetic acid 
TOR target of rapamycin 
Tris tris (hydroxymethyl)aminomethane 
Trp tryptophan 
ts temperature sensitive 
Ub ubiquitin 
UBA ubiquitin associated domain 
UBC ubiquitin conjugating enzyme 
U-box UFD2 homology 
UBX ubiquitin regulatory ‘X’ 
UFD ubiquitin fusion degradation 
UIM ubiquitin interaction motif 
UPS ubiquitin proteasome system 
Ura uracil 
V volt 
VCP Valosin containing protein 
Vol volume 
w/v weight per volume 
WT wild-type 
Y2H yeast two hybrid 
YPD yeast peptone dextrose 
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